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dichlorophenyl)-2-(2,4-dichlorobenzyloxy)ethyl]-1H-imidazolium chloride; CaM: 
calmodulin; CD11b/c: cluster of differentiation 11b/c, the rat CR3 complement receptor; 
CNPase: 2', 3'-cyclic nucleotide 3'-phosphodiesterase; CNS: central nervous system; DIV: 
days in vitro; DMEM: Dulbecco's Modified Eagle's Medium; FBS: fetal bovine serum; 
GAPDH: glyceraldehyde 3-phosphate dehydrogenase (EC 1.2.1.12); GFAP: glial fibrillar 
acidic protein; HLA: human leukocyte antigens; Iba1: ionized calcium binding adaptor 
molecule 1; Ki67: proliferation marker antigen identified by the monoclonal antibody Ki67; 
LPS: bacterial lipopolysaccharide; MHC: major histocompatibility complex; mRNA: 
messenger ribonucleic acid; PBS: phosphate-buffered saline; RT: room temperature; S.D.: 
standard deviation; S.E.M.: standard error of mean; subDIV: subcloned days in vitro; TBS: 
Tris-buffered saline; TFP: trifluoperazine (10-[3-(4-methylpiperazin-1-yl)propyl]-2-
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SUMMARY 
Selected morphological, immunocytochemical and functional aspects of various microglial 
cell populations were characterized in mixed neuronal/glial and pure microglial cultures. The 
mixed primary cortical cultures were prepared from the forebrains of embryonic (E18) rats 
and maintained for up to 28 days (DIV1–DIV28) using routine culturing techniques. The pure 
microglial cells were subcloned (subDIV4) from the mixed primary cultures and maintained 
for up to 7 days (DIV7). During culturing, expansion of the microglial cells was observed, as 
evidenced by quantitative assessment of selected monocyte/macrophage/microglial cell-
specific markers (HLA DP, DQ, DR, CD11b/c and Iba1) via immunocyto- and histochemistry 
and Western blot analysis. The Iba1 immunoreactivity in Western blots steadily increased 
about 750-fold, and the number of Iba1-immunoreactive cells rose at least 67-fold between 
DIV1 and DIV28. Morphometric analysis on binary (digital) silhouettes of the microglia 
revealed their evolving morphology during culturing. Microglial cells were mainly ameboid in 
the early stages of in vitro differentiation, while mixed populations of ameboid and ramified 
cell morphologies were characteristic of older cultures as the average transformation index 
(TI) increased from 1.96 (DIV1) to 15.17 (DIV28). Multiple immunofluorescence labeling of 
selected biomarkers revealed different microglial phenotypes during culturing. For example, 
while HLA DP, DQ, DR immunoreactivity was present exclusively in ameboid microglia (TI 
< 3) between DIV1 and DIV10, CD11b/c- and Iba1-positive microglial cells were moderately 
(TI < 13) and progressively (TI < 81) more ramified, respectively, and always present 
throughout culturing. Regardless of the age of the cultures, proliferating microglia were Ki67-
positive and characterized by low TI values (TI < 3). The microglial function was assessed by 
an in vitro phagocytosis assay. Unstimulated microglia with low TI values were significantly 
more active in phagocytosing fluorescent microspheres than the ramified forms. 
The roles of calmodulin (CaM), a multifunctional intracellular calcium receptor protein, 
as concerns selected morphological and functional characteristics of pure microglial cells 
were investigated through use of the CaM antagonists calmidazolium (CALMID) and 
trifluoperazine (TFP). The intracellular localization of the CaM protein relative to phalloidin, 
a bicyclic heptapeptide that binds only to filamentous actin, and the ionized calcium-binding 
adaptor molecule 1 (Iba1), a microglia-specific actin-binding protein, was determined by 
immunocytochemistry, with quantitative analysis by immunoblotting. In unchallenged and 
untreated (control) microglia, high concentrations of CaM protein were found mainly 
perinuclearly in ameboid microglia, while the cell cortex had a smaller CaM content that 
diminished progressively deeper into the branches in the ramified microglia. The amounts and 
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intracellular distributions of both Iba1 and CaM proteins were altered after lipopolysaccharide 
(LPS) challenge in activated microglia. CALMID and TFP exerted different, sometimes 
opposing, effects on many morphological, cytoskeletal and functional characteristics of the 
microglial cells. They affected the CaM and Iba1 protein expressions and their intracellular 
localizations differently, inhibited cell proliferation, viability and fluid-phase phagocytosis to 
different degrees both in unchallenged and in LPS-treated (immunologically challenged) cells, 
and differentially affected the reorganization of the actin cytoskeleton in the microglial cell 
cortex, influencing lamellipodia, filipodia and podosome formation. 
We concluded that in vitro studies on microglial population dynamics combined with 
phenotypic characterization can be of importance when different in vivo pathophysiological 
situations are modeled in vitro. Moreover, the CaM antagonists altered different aspects of 
filamentous actin-based cell morphology and related functions with variable efficacy, which 
could be important in deciphering the roles of CaM in regulating microglial functions in 
health and disease. 
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1. INTRODUCTION 
Microglial cells, the resident immune cells of the central nervous system (CNS), share a 
number of phenotypic characteristics and lineage properties with other bone marrow-derived 
myeloid cell populations, and are regarded as members of the monocyte/macrophage lineage 
(Gehrmann et al., 1995; Geissmann et al., 2003, 2010; Ginhoux et al., 2010; Kreutzberg, 
1996; Prinz and Mildner, 2011; Prinz et al., 2011). Recent in vivo lineage tracing studies 
demonstrated that adult microglial cells originate from primitive myeloid progenitors that 
arise early in embryonic development, and constitute an ontogenetically distinct population in 
the mononuclear phagocyte system (Ginhoux et al., 2010; Saijo and Glass, 2011). Microglia 
are highly plastic and, by virtue of their location and current role in the nervous tissue, are 
able to undergo a variety of morphological and functional changes in response to various 
stimuli. In their non-activated or resting state, they display a ramified morphology 
characterized by numerous, fine-branched processes with relatively small somata and subdued 
macrophage-like functional properties. In response to neural injury, infection and 
inflammatory or other signals, however, microglial cells become activated and undergo a 
series of morphological, molecular and functional changes in proportion to the severity of the 
damage to the neuronal tissue (Kreutzberg, 1996; Ling and Wong, 1993). Shortly after their 
initial activation, microglial cells become progressively less ramified and quickly develop an 
enlarged cell body with several short, thickened processes (activated microglia) that may 
eventually completely retract (phagocytic microglia). This morphological transformation 
parallels microglial proliferation, homing and adhesion to damaged cells (Raivich et al., 1999; 
Streit et al., 1999). The development of the ameboid appearance and phagocytic nature of the 
microglial cells coincides with their antigen presentation ability and cytotoxic and 
inflammation-mediating signalization (Drew and Chavis, 2000; Kreutzberg, 1996; Ling and 
Wong, 1993; Prinz and Miller, 2014; Saijo and Glass, 2011; Streit at al., 1999; Town et al., 
2005; Werry et al., 2011). 
As regards origin, there are two populations of microglial cells in the CNS at any given 
time. The resident microglia comprise a distinct pool of cells that respond to stimuli and 
proliferate accordingly, and regulate their population dynamics in a manner dependent on the 
severity of the tissue damage. They are distributed more or less evenly throughout the nervous 
tissue (Milligan et al., 1991a) and exhibit an extremely slow turnover with the bone marrow 
or the peripheral blood under normal conditions. The resting microglia with ramified 
morphology lack the major histocompatibility complex (MHC) class I/MHC class II proteins, 
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interferon-γ, cytokines, CD45 antigens and many other surface receptors required to serve in 
the antigen-presenting, phagocytic and cytotoxic roles characteristic of the normal 
macrophage functions. Another population of cells, however, among which the perivascular 
microglial cells are prominent in number, is located in the close vicinity of blood vessels, and 
can be replaced regularly by bone marrow-derived precursor cells (Eglitis and Mezey, 1997; 
Hickey and Kimura, 1988) that express MHC class II antigens, indicating their 
monocyte/macrophage origin (Gehrmann et al., 1995; Streit et al., 1989). In cases of extreme 
damage to the CNS, as in infection or stroke, the blood-brain barrier may weaken 
considerably, and hematogenous, bone marrow-derived cells, such as myeloid progenitor cells 
and macrophages, may enter the brain (Priller et al., 2001). Once the damage has abated, the 
peripheral and central systems are disconnected for the recovery and regrowth period 
(Gehrmann, 1996). Although macrophages and microglia may have similar roles, the 
populations of resident microglia and recently migrated hematogenous myeloid 
progenitors/macrophages differ in many important aspects (Geissmann et al., 2003; Ladeby et 
al., 2005; Wirenfeldt et al., 2007). 
Similarly to the extensive studies on the origin and the morphological and functional 
development of the microglial phenotype in vivo (Dalmau et al., 1997, 1998, 2003; 
Geissmann et al., 2010; Ling and Wong, 1993; Ling et al., 1990; Milligan et al., 1991a, b; 
Orłowski et al., 2003; Streit et al., 1999), a large body of information is available on the 
characteristics of the different microglial populations maintained in cell cultures. However, as 
a variety of proinflammatory factors are produced by activated microglial cells on the one 
hand (Kreutzberg, 1996), and activation of microglial cells by a number of agents has been 
demonstrated on the other (Berger et al., 2012; Liu et al., 2000; Werry et al., 2011), 
characterization of the activated microglial cells in response to an in vitro 
stimulation/challenge predominates in the literature. Recent studies have demonstrated, for 
example, that under specific polarization conditions microglial cells, similarly to peripheral 
macrophages, develop into different inflammation-related phenotypes, termed M1 and M2 
(Gordon, 2003; Mosser and Edwards, 2008). 
Microglial functions such as motility and phagocytosis are closely associated with 
dynamic changes in the cytoskeleton and related to intracellular calcium (Ca2+) signaling 
(Greenberg, 1995; Kalla et al., 2003; Mitchison and Cramer, 1996). The ubiquitous Ca2+-
binding proteins participate in Ca2+-elicited intracellular events, either as Ca2+-
sensing/receptor/trigger or as Ca2+-buffering/transport proteins, by binding intracellularly 
stored Ca2+ (Ikura, 1996). They contribute to nearly all aspects of the functioning of the cell, 
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and are important in numerous intracellular signaling processes, from the regulation of 
cellular homeostasis to learning and memory (Berridge et al., 2010; Clapham, 2007). 
Calmodulin (CaM), one of the most important intracellular Ca2+ receptors, exerts its 
biological action through its heterogenous population of target proteins, which are involved in 
a number of cellular regulatory processes (Kennedy, 1989; Palfi et al., 2002). 
The nervous tissue is especially abundant in CaM. While its distribution has been 
characterized in detail for a number of neuronal cell types (Kovacs and Gulya, 2002, 2003; 
Palfi et al., 1999, 2001, 2005), its localization and functions in glial cells are much less known. 
Astrocytes express CaM protein in low quantities (Kortvely et al., 2003), but mRNA 
populations from all three CaM genes could still be localized both perinuclearly and in the 
astrocytic endfeet (Palfi et al., 2005). The expression of CaM in oligodendroglia is similarly 
low and has not been characterized extensively, albeit the regulatory effects of this protein on 
a number of membrane-bound target proteins such as the myelin basic protein (Libich and 
Harauz, 2008) or the 2',3'-cyclic nucleotide 3'-phosphodiesterase (Myllykoski et al., 2012) 
have been established. Of all the glial components, only the microglia seem to have a 
considerable amount of CaM. They express a relatively large amount of CaM when activated 
(Casal ez al., 2001; Solá et al., 1997), and many aspects of their Ca2+ signaling are well 
documented (Färber and Kettelmann, 2006; Wong and Schlichter, 2014). 
CaM immunoreactivity or CaM gene-specific transcripts are often colocalized with 
those of the target enzymes of CaM within the same cytoplasmic compartments (Erondu and 
Kennedy, 1985; Sanabria et al., 2008; Seto-Ohshima et al., 1983; Strack et al., 1996). For 
example, actin is accompanied by CaM in the cell cortex, helping to remodel the actin-based 
cytoskeleton in accordance with the actual (patho)physiological signals (Mitchison and 
Cramer, 1996; Psatha et al., 2004). Ionized calcium-binding adaptor molecule 1 (Iba1) is 
another intracellular Ca2+-binding protein with actin-binding capability that is expressed in 
macrophages and microglia, and is widely used to detect both resting and activated microglial 
phenotypes (Imai et al., 1996). CaM and Iba1 proteins share a number of molecular structural 
variants that are related to either their Ca2+ binding or their target protein recognition 
(Yamada et al., 2006). In contrast with the wide-ranging regulatory roles of CaM, Iba1 plays a 
much more restricted role in microglial functions, e.g. remodeling the actin cytoskeleton 
during migration (Siddiqui et al., 2012; Vincent et al., 2012). 
The modulatory action of Ca2+-bound CaM on multiple target proteins can be regulated 
by a number of compounds. Calmidazolium (CALMID; 1-[bis(4-chlorophenyl)methyl]-3-[2-
(2,4-dichlorophenyl)-2-(2,4-dichlorobenzyloxy)ethyl]-1H-imidazolium chloride) and 
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trifluoperazine (TFP; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-trifluoromethyl-10H-
phenothiazine dihydrochloride) are potent inhibitors of CaM-related cellular activities (Borsa 
et al., 1986; Sunagawa et al., 2000). It is presumed that, apart from binding to the CaM 
protein (Mashushima et al., 2000; Vandonselaar et al., 1994; Vertessy et al., 1998), they can 
also exert their effects on some of the CaM-regulated targets directly (Sunagawa et al., 2000). 
 
2. SPECIFIC AIMS 
Under physiological conditions, the vast majority of the resident microglial cells in the CNS 
are certainly unstimulated and characterized by ramified morphology. Despite the recent in 
vivo experimental approaches that unveiled new aspects of the functional, developmental and 
lineage characteristics of the microglial cell populations (Auffray et al., 2009; Durafourt et al., 
2012; Geissmann et al., 2003, 2010; Ginhoux et al., 2010; Xu et al., 2012), only limited data 
are available on the development of the microglial phenotype in vitro under 
unstimulated/immunologically unchallenged conditions. 
In an attempt to shed more light on the nature of the unstimulated microglia in vitro, we 
set out to characterize selected morphological, immunocytochemical and functional aspects of 
such cells, partially by quantitative techniques, in rat primary cortical cell cultures maintained 
routinely up to DIV28, in order to monitor the “normal” development of their phenotype. We 
analyzed the population dynamics of the microglial cells in terms of their percentage of the 
total number of cells during culturing, quantitatively characterized the different microglial 
populations according to their transformation indices, and differentially localized some of the 
canonical microglial markers to these distinct morphologies. As far as we are aware, a 
similarly detailed study for a period of up to 28 days on the characteristics of the in vitro 
development of unstimulated and unchallenged microglial cells of embryonic origin has not 
been reported previously. 
The actin cytoskeleton is of paramount importance in many microglial functions. Its 
reorganization during cell migration, phagocytosis, or under several pathophysiological 
conditions, is in the forefront of research. One of the main regulators of the actin cytoskeleton 
reorganization is CaM. Relatively little is known, however, as concerns the possible 
involvement of CaM mediation in such important microglial functions as phagocytosis and 
the cellular functions associated with it, e.g. dynamic cytoskeletal reorganization. Thus, in 
view of the importance of CaM-mediated cell functions and the paucity of data on specific 
microglial functions related to and possibly regulated by CaM, we set out to investigate the 
localization and intracellular distribution of CaM in pure microglial cell populations derived 
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from rat primary mixed forebrain cultures by using immunocytochemical and Western blot 
techniques. Selected CaM inhibitors such as CALMID and TFP, previously reported to have 
different modes of action (Matsushima et al., 2000; Sunagawa et al., 2000), were 
quantitatively tested for their ability to modify the microglial morphology (cell area, perimeter, 
transformation index), as well as lamellipodia, filipodia and podosome formation. Stimulation 
with LPS was used to evaluate the ability of microglial cells to respond to activation (Fricker 
et al., 2012; Song et al., 2014; Tokes et al., 2011). 
Our specific aims were: 
1) To determine the cellular composition and the rate of microglial proliferation in 
primary mixed cultures (DIV1–DIV28) prepared from rat embryonic forebrain tissues; 
2) To quantitatively characterize the different microglial populations according to 
morphological parameters during culturing (DIV1–DIV28); 
3) To localize some of the canonical microglial markers to these distinct morphologies 
during culturing (DIV1–DIV28); 
4) To quantitatively characterize and localize microglial CaM immunoreactivities in 
relation to their morphologies in pure, secondary microglial cultures (subDIV4); 
5) To characterize the effects of two CaM inhibitors (CALMID and TFP) on the 
morphological, including cytoskeletal, and immunocytochemical characteristics of pure 
microglial cultures (subDIV4). 
 
3. EXPERIMENTAL PROCEDURES 
3.1. Animals 
All animal experiments were carried out in strict compliance with the European Council 
Directive (86/609/EEC) and EC regulations (O.J. of EC No. L 358/1, 18/12/1986) regarding 
the care and use of laboratory animals for experimental procedures, and followed the relevant 
Hungarian and local legislation requirements. The experimental protocols were approved by 
the Institutional Animal Welfare Committee of the University of Szeged (I-74-II/2009/MÁB). 
The pregnant Sprague-Dawley rats (170-200 g; one animal per cage) were kept under 
standard housing conditions and fed ad libitum. 
 
3.2. Antibodies 
The antibodies used in our immunohistochemical, immunocytochemical and Western blot 
studies are listed in Table 1. For a thorough characterization of different microglial 
phenotypes developed in vitro, antibodies against the ionized calcium binding adaptor 
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molecule 1 (Iba1), the human leukocyte antigen (HLA) class II genes HLA DP, DQ, DR and 
the rat CR3 complement receptor (CD11b/c) were used in our immunohistochemical and 
Western blot analyses. 
 
Table 1. Antibodies used in immunocytochemistry and immunohistochemistry 
 
Primary 
antibody, 
abbrev. 
name 
Primary 
antibody, full 
name 
Final 
dilution 
Company Secondary 
antibody with 
fluorochrome, 
full name 
Company Final 
dilution 
Iba1 Rabbit anti-Iba1 
polycl. ab. 
1/300 Wako, 
Osaka, 
Japan 
Alexa Fluor 568 
goat anti-rabbit 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
CD11b/c 
(OX42) 
Mouse anti-
CD11b/c 
equivalent 
monocl. ab., 
clone OX42 
1/200 Abcam, 
Cambridge, 
England  
Alexa Fluor 488 
goat anti-mouse 
or Alexa Fluor 
568 goat anti-
mouse 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
HLA DP, 
DQ, DR 
Mouse anti-
HLA-DP, DQ, 
DR, monocl. 
ab., clone 
CR3/43 
1/100 Dako, 
Glostrup, 
Denmark 
Alexa Fluor 488 
goat anti-mouse 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
HLA DRα Rabbit anti-
HLA-DRα, FL-
254, polycl. ab., 
SC-25614 
1/50 Santa Cruz 
Biotechnol., 
Inc., Santa 
Cruz, CA, 
USA 
Alexa Fluor 488 
goat anti-rabbit 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
β tubulin 
III 
Mouse anti-
tubulin, β-III, 
monocl. ab., 
clone TU-20 
1/400 Abcam, 
Cambridge, 
England 
Alexa Fluor 488 
goat anti-mouse 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
Ki67 Rabbit anti-
Ki67, monocl. 
ab., clone SP6 
1/200 Thermo 
Scientific, 
Fremonz, 
CA, USA 
Alexa Fluor 488 
goat anti-rabbit 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
CaM Mouse anti-
CaM, monocl. 
ab. 
1/100 Millipore Alexa Fluor 488 
goat anti-mouse 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
CaM Rabbit anti-
CaM, monocl. 
ab., clone 
EP799Y 
1/100 Abcam, 
Cambridge, 
UK 
Alexa Fluor 568 
goat anti-rabbit 
Invitrogen, 
Carlsbad, 
CA, USA 
1/1,000 
 
 
The anti-Iba1 antibody recognizes the Iba1 protein, an intracellular Ca2+-binding protein 
expressed in the CNS specifically in macrophages and microglia (Imai et al., 1996), and has 
been used to detect both resting and activated microglial phenotypes (Ito et al., 1998). The 
HLA class II genes are composed of three closely linked subregions encoding the 
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polymorphic HLA class II molecules HLA DP, DQ, DR. The anti-HLA DP, DQ, DR antibody 
reacts with the α and β-chains of all products of these subregions and recognizes numerous 
antigen-presenting cells that express these molecules, including the reactive and the resting 
microglia, the perivascular microglial cells, many macrophages and most monocytes in the 
CNS (Horejsí et al., 1986; Ulvestad et al., 1994b). The anti-HLA DRα antibody recognizes 
the α subunit of the class II MHC complex antigen HLA DR, a transmembrane glycoprotein 
constitutively expressed by microglia (Ulvestad et al., 1994a). The anti-CD11b/c antibody 
recognizes a common epitope shared between CD11b and CD11c (integrin αM and αX chains), 
reacts with all monocytes and macrophages (Robinson et al., 1986; Wang et al., 1996), and is 
commonly used as a resident microglial marker in the CNS (Imai et al., 1996). The anti-β 
tubulin III (Banerjee et al., 1990) antibody has been used to detect neurons, the anti-glial 
fibrillar acidic protein (GFAP) antibody (Guillemin et al., 1997) to label astrocytes, and the 
anti-2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) antibody (Zhang et al., 2010) to 
detect oligodendrocytes. The anti-CaM monoclonal antibody has been used to detect both 
Ca2+-bound and Ca2+-free forms of the antigen (Sacks et al., 1991), the anti-Ki67 antibody to 
detect proliferating cells. Ki67 is a nuclear protein expressed in all active phases of the cell 
cycle from the late G1 phase through the end of the M phase but is absent in non-proliferating 
and early G1 phase cells (Scott et al., 2004; Starborg et al., 1996). The anti-glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) antibody has been used as an internal control in Western 
blot experiments (Wu et al., 2012). 
Various dilutions of primary and secondary antibodies, incubation times and blocking 
conditions for each antibody used were carefully tested for both immunocytochemistry/-
histochemistry and Western blot analysis. To detect the specificities of the secondary antisera, 
omission control experiments (staining without the primary antibody) were also performed. In 
such cases, no fluorescent or Western blot signals were detected. 
 
3.3. Paraffin embedding and sectioning 
Forebrain samples of embryonic day 18 (E18) rats were carefully removed, fixed by 
immersion overnight at 4 °C in 0.05 M phosphate-buffered saline (PBS) containing 4% 
formaldehyde, and then embedded in low-melting point paraffin. Coronal sections (8 µm 
thick) were cut in a microtome and mounted on slides coated with (3-aminopropyl) 
triethoxysilane (Menzel, Darmstadt, Germany) to prevent detachment. After deparaffinization 
and rehydration, the slides were placed in a jar filled with 0.01 M citrate buffer (pH 6.0) and 
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heated 3 times for 3 min at 800 W in a microwave oven. The sections were then processed for 
immunohistochemistry. 
 
3.4. Cortical cell cultures 
Mixed primary cortical cell cultures were established from E18 wild-type rat embryos by the 
use of general methods described previously (Kortvely et al., 2003). Briefly, 6-8 fetal rats 
under ether anesthesia were surgically decapitated and the frontal lobe of the cerebral cortex 
was removed, minced with scissors, incubated for 10 min at 37 °C in 9 ml of Dulbecco's 
Modified Eagle's Medium (DMEM; Invitrogen, Carlsbad, CA, USA; containing 1 g/l D-
glucose, 110 mg/l Na-pyruvate, 4 mM L-glutamine, 3.7 g/l NaHCO3, 10,000 U/ml penicillin 
G, 10 mg/ml streptomycin sulfate and 25 µg/ml amphotericin B) supplemented with 0.25% 
trypsin (Invitrogen) and then centrifuged at 1,000g for 10 min at room temperature (RT). The 
pellet was resuspended, washed twice in 5 ml of DMEM containing 10% heat-inactivated 
fetal bovine serum (Invitrogen), and centrifuged for 10 min at 1,000g at RT. The final pellet 
was resuspended in 2 ml of the same solution as above, after which the cells were seeded in 
the same medium and cultured at 37 °C in a humidified air atmosphere supplemented with 5% 
CO2 in one or other of the following ways: 1) in poly-L-lysine-coated coverslips (18 x 18 mm; 
2 x 105 cells/coverslip) for immunocytochemistry; 2) in poly-L-lysine-coated Petri dishes (60 
mm x 15 mm; 106 cells/dish) for Western blot analyses; or 3) in a poly-L-lysine-coated 
culture flask (75 cm2 , 12 x 106 cells/flask) for the subsequent generation of pure microglial 
cell cultures. The mixed primary cultures were maintained up to 28 days (DIV1-DIV28; or 
occasionally with cultures aged up to 2 months. data not shown) for immunocytochemistry 
and Western blot analyses, and for 7 days (DIV7) for the generation of pure microglial cells. 
For culturing periods longer than 3 days, the DMEM was changed every 3 days. Apart from 
the microglial markers, several cell surface and cytoplasmic neuronal, astrocytic and 
oligodendrocytic markers were used to characterize the primary cultures. Cell proliferation 
was assessed by the use of the antibody raised against Ki67.  
 
3.5. Preparation of pure microglial cell cultures 
Pure microglial cell cultures were subcloned from mixed primary cultures (DIV7) maintained 
in a poly-L-lysine-coated culture flask (75 cm2 , 12 x 106 cells/flask) by shaking the cultures at 
150 rpm in a platform shaker for 20 min at 37 °C. Microglia from the supernatant were 
collected by centrifugation at 3,000g for 10 min at RT and resuspended in 2 ml of 
DMEM/10% FBS. The cells were seeded at a density of 2 x 105 cells/Petri dish for Western 
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blots and cell viability assays or 105 cells/coverslip/Petri dish for immunocytochemistry, 
proliferation or phagocytosis assays, and cultured in DMEM in a humidified atmosphere 
supplemented with 5% CO2 for 4 days at 37 °C. The medium was changed on the first day 
after seeding (subDIV1). Immunocytochemistry routinely performed on the pure microglial 
cultures 4 days after seeding (subDIV4) consistently detected a >99% incidence of Iba1-
immunopositive microglial cells for the Hoechst 33258 dye-labeled cell nuclei (Fig. 11). 
 
3.6. Treatment of pure microglial cells with LPS and CaM inhibitors 
On the fourth day of subcloning (subDIV4), the DMEM was replaced and the expanded pure 
microglial cells were treated for 24 h with either LPS (100 ng/ml in final concentration, 
dissolved in DMEM; Sigma, St. Louis, MO, USA), CALMID (5 nM or 50 nM in final 
concentration, dissolved in dimethylsulfoxide (DMSO); Sigma) or TFP (10 µM or 20 µM 
final concentration, dissolved in DMSO; Sigma) alone, or with a combination of LPS and one 
of these CaM inhibitors, and the effects were compared in a variety of morphological and 
functional tests. LPS treatment served as an immunochallenge. Unchallenged and untreated 
(control) cultures were maintained under identical conditions, but without these inhibitors, 
and received 2 µl DMSO solution instead. 
 
3.7. In vitro phagocytosis assay 
The fluid-phase phagocytic capacity of the unstimulated microglial cells was determined 
via the uptake of fluorescent microspheres (2 µm diameter; Sigma, St. Louis, MO, USA) 
using the general methods described by Szabo and Gulya (2013). Cortical cells from E18 
rats were plated on coverslips in 35-mm Petri dishes at a density of 200,000 
cells/coverslip in 2 ml of DMEM containing 10% heat-inactivated fetal bovine serum as 
above, and cultured for 14 days. At the end of the culturing period, 1 µl of a 2.5% 
aqueous suspension of fluorescent microspheres per ml was added to the primary culture, 
which was then incubated for 60 min at 37 °C. The cells were next washed 5 times with 
2 ml of PBS to remove dish- or cell surface-bound residual fluorescent microspheres, 
and fixed with 4% formalin in PBS. Negative controls were treated as above with the 
exception that cultures with beads were incubated for 60 min at 4 °C. For measurement 
of the phagocytotic activity, cells labeled with phagocytosed microbead(s) were counted. 
Twenty random fields with a total of 120 bead-labeled cells were counted under a 
fluorescent microscope with a 10x or 20x objective. For the mixed cultures, the number 
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of phagocytosed microbeads (mean ± S.D.) was analyzed as a function of the 
transformation index (TI). Statistically significant differences were determined by the 
Mann-Whitney Rank Sum test. 
 
3.8. Immunohistochemistry and -cytochemistry 
Immunohistochemistry on paraffin-embedded tissue sections was done essentially the same 
way as immunocytochemistry on cultured cells. For immunocytochemistry, primary cortical 
cells (DIV1-DIV28) or pure microglial cells (subDIV4) cultured in vitro on poly-L-lysine-
coated coverslips were used. At different time intervals (DIV1, DIV4, DIV7, DIV10, DIV14, 
DIV21, DIV28), or after different treatments (subDIV4), the cultured cells on the coverslips 
were fixed in 4% formaldehyde in 0.05 M PBS (pH 7.4 at RT) for 5 min, and rinsed in 0.05 M 
PBS for 3 x 5 min. After permeabilization and blocking of the nonspecific sites in 0.05 M 
PBS solution containing 5% normal goat serum (Sigma), 1% heat-inactivated bovine serum 
albumin (Sigma) and 0.05% Triton X-100 for 30 min at 37 °C, the cells on the coverslips 
were incubated overnight at 4 °C with the appropriate primary antibody (Table 1) in the above 
solution. The cultured cells were washed for 4 x 10 min at RT in 0.05 M PBS, and then 
incubated with the appropriate Alexa Fluor fluorochrome-conjugated secondary antibody 
(Table 1) in the above solution, but without Triton X-100, in the dark for 3 h at RT. The cells 
on the coverslip were washed for 4 x 10 min in 0.05 M PBS at RT. At this stage, the cells 
were occasionally stained with rhodamine-phalloidin (5 µl in 200 µl PBS; Molecular Probes, 
Eugene, OR, USA) for 30 min at RT, then washed for 2 x 10 min at RT. Finally, the nuclei 
were stained in 0.05 M PBS solution containing 1 mg/ml polyvinylpyrrolidone and 0.5 µl/ml 
Hoechst 33258 dye (Sigma). The coverslips were rinsed in distilled water for 5 min, air-dried 
and mounted on microscope slides in Vectashield mounting medium (Vector Laboratories, 
Burlingame, CA, USA). Cells were viewed on a Nikon Microphot-FXA epifluorescent 
microscope (Nikon Corp., Tokyo, Japan) and photographed with a Spot RT Color CCD 
camera (SPOT RT/ke, Diagnostic Instruments, Inc., Sterling Heights, MI, USA).  
 
3.9. Western blot analysis 
For Western blotting, the protocols were optimized for each antibody as regards epitope 
accessibility, polyacrylamide gel separation, antibody dilution and chemiluminescence signal 
intensity. Cultured primary cells (DIV1-DIV28) or pure microglial cells (subDIV4) with 
different treatment regimens were collected through use of a rubber policeman, homogenized 
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in 50 mM Tris-HCl (pH 7.5) containing 150 mM NaCl, 0.1% Nonidet P40, 0.1% cholic acid, 
2 µg/ml leupeptin, 1 µg/ml pepstatin, 2 mM phenylmethylsulfonyl fluoride and 2 mM EDTA, 
and centrifuged at 10,000 g for 10 min. The pellet was discarded and the protein concentration 
of the supernatant was determined (Lowry et al., 1951). 
 
Table 2. Antibodies used in Western blot analysis 
 
Primary 
antibody, 
abbrev. 
name 
Primary 
antibody, full 
name 
Final 
dilution 
Company Secondary 
antibody with 
fluorochrome, 
full name 
Company Final 
dilution 
Iba1 Rabbit anti-Iba1 
polycl. ab. 
1/1,000 Wako, 
Osaka, 
Japan 
Anti-rabbit IgG, 
peroxidase 
conjug. 
Sigma, St. 
Louis, MO, 
USA 
1/1,000 
or 
1/2,000 
β tubulin 
III 
Mouse anti-
tubulin, β-III, 
monocl. ab., 
clone TU-20 
1/1,000 Abcam, 
Cambridge
, England 
Anti-mouse IgG, 
peroxidase 
conjug. 
Sigma, St. 
Louis, MO, 
USA 
1/3,000 
GFAP Rabbit anti-
GFAP polycl. 
ab. 
1/5,000 Abcam, 
Cambridge
, England 
Anti-rabbit IgG, 
peroxidase 
conjug. 
Sigma, St. 
Louis, MO, 
USA 
1/2,000 
CNPase Mouse anti-
CNPase, 
monocl. ab., 
clone 11-5B 
1/500 Abcam, 
Cambridge
, England 
Anti-mouse IgG, 
peroxidase 
conjug. 
Sigma, St. 
Louis, MO, 
USA 
1/3,000 
CaM Rabbit anti-
CaM, monocl. 
ab., clone 
EP799Y 
1/2,000 Abcam, 
Cambridge
, UK 
Anti-rabbit IGG, 
peroxidase 
conjug. 
Sigma, St. 
Louis, MO, 
USA 
1/2,000 
GAPDH 
 
Mouse anti-
GAPDH, 
monocl. ab., 
clone GAPDH-
71.1 
1/20,00
0 
Sigma, St. 
Louis, MO, 
USA 
Anti-mouse IGG, 
peroxidase 
conjug. 
Sigma, St. 
Louis, MO, 
USA 
1/3,000 
 
For the Western blot analyses of microglial, neuronal, astrocyte or oligodendrocyte 
immunoreactivities, 5-10 µg of protein was separated on an SDS polyacrylamide gel (4-10% 
stacking gel/resolving gel), transferred onto Hybond-ECL nitrocellulose membrane 
(Amersham Biosciences, Little Chalfont, Buckinghamshire, England). Strips of membranes 
with the transferred bands for CaM and Iba1 (both around 17 kDa) and GAPDH (37 kDa) 
were cut and processed separately for CaM, Iba1 or GAPDH immunodetection. The 
membranes were blocked for 1 h in 5% nonfat dry milk (for GFAP, Iba1 and GAPDH 
Westerns) or 5% bovine serum albumin (for CaM, CNPase and anti-β tubulin III Westerns) in 
Tris-buffered saline (TBS) containing 0.1% Tween 20, and incubated for 1 h with the 
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appropriate primary antibodies. After 5 washes in 0.1% TBS–Tween 20, the membranes were 
incubated for 1 h with the appropriate peroxidase-conjugated secondary antibodies (Table 1), 
and washed 5 times as before. The enhanced chemiluminescence method (ECL Plus Western 
blotting detection reagents; Amersham Biosciences) was used to reveal immunoreactive bands 
according to the manufacturer's protocol. For the determination of CaM immunoreactivities in 
Western studies, the immunoreactive densities of equally loaded lanes were quantified, and all 
samples were normalized to internal GAPDH load controls run on the same gels. 
 
3.10. Digital image processing and image analysis 
Gray-scale digital images of the immunoblots were acquired by scanning the autoradiographic 
films with a desktop scanner (Umax PowerLook III; Umax Data Systems, Inc., Taipei, 
Taiwan, or Epson Perfection V750 PRO; Seiko Epson Corp., Japan). The images were 
scanned and processed at identical settings in order to allow comparison between the Western 
blots from different samples. Digital images were acquired with a Nikon Microphot-FXA 
epifluorescent microscope (Nikon Corp., Tokyo, Japan), using a Spot RT Color CCD camera 
and Spot RT software (Spot RT/ke Diagnostic Instruments, Sterling Heights, MI, USA). Color 
correction and cropping of the digital images were occasionally performed when 
photomicrographs were made for publication (Adobe Photoshop; Adobe Systems, Inc., San 
Jose, CA, USA). 
Microglial cells and cell nuclei in the cultures were counted with the use of the plugins 
developed for the computer program ImageJ (version 1.38 and 1.47; developed by W. 
Rasband at the U.S. National Institutes of Health, and available from the Internet at 
http://rsb.info.nih.gov/ij). Cell nuclei were counted with the use of the “Nucleus Counter” 
plugin (Image Processing and Analysis in Java, a collection of plugins and macros) installed 
under ImageJ (www.macbiophotonics.ca). Briefly, digital images in tagged image file formats 
(.tif) were opened in ImageJ, and Plugins→Particle Analysis→Nucleus Counter menus were 
then selected and customized as follows: the smallest and largest particle sizes were set to 50 
and 10,000, respectively. “Otsu” was selected for automatic thresholding, and “mean 3x3” 
was chosen for the performance of smooth filtering (Sezgin and Sankur, 2004). After 
background subtraction, overlapping objects in the resulting binary images were separated, 
via the menu command “Process/Binary/Watershed” (see Abràmoff et al., 2004, for details, 
and the documentation web pages for ImageJ at http://rsb.info.nih.gov/ij/docs/index.html). For 
the counting of microglial cells expressing immunopositivity for the Iba1 antigen, the “Cell 
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Counter” plugin was used (ImageJ for Microscopy). After the appropriate images (.tif) had 
been opened, Plugins→Particle Analysis→Cell Counter menus were selected, and the output 
was copied to a Microsoft Excel spreadsheet (Microsoft Corp., Redmond, WA, USA) for 
statistical analysis. 
Microglial cell silhouettes were acquired by transforming the raw digital files of Iba1-
immunoreactive cells recorded under fluorescent microscope light to binary files by means of 
the ImageJ software. The color cell images were transformed into their binary replicas 
(silhouettes) by using automatic thresholding procedures. After the values of cell perimeter 
(µm) and cell area (µm2) had been determined in at least 3 separate experiments (at least 2 
coverslips in each experiment for each culturing time investigated; around 20 randomly 
selected cells/coverslip), the TI reflecting the degree of process extension was calculated 
through the expression [perimeter of cell (µm)]2/4π[cell area (µm2)] as previously described 
(Fujita et al., 1996). From the mixed cultures, a total of 398 cell silhouettes were analyzed in 
this study. For the analysis of TI values from the pure cultures, a total of 261 cells were 
quantitatively measured (mean ± S.E.M.). Digital image production was performed with 
Adobe Photoshop CS5.1 software (Adobe Systems, Inc., San Jose, CA, USA). Color 
correction (brightness, contrast) and cropping of the fluorescent images were occasionally 
performed when individual photomicrographs were assembled to figure panels for publication. 
No specific feature within an image was enhanced, obscured, introduced, moved or removed. 
 
3.11. Statistical analysis 
For Western blots, values are presented as means ± S.D. from at least 3 blots for each of the 3 
independent experiments for each time period examined. For the counting of microglial cells 
and cell nuclei, at least 10 randomly sampled microscope fields from 2-3 coverslips for each 
culturing time period from each of the 3 separate cell-culturing experiments were counted. In 
the computation of semiquantitative cell silhouette characteristics (digital binary pictures), 
data on 20 cells per coverslip from at least 3 separate experiments for each culturing time 
were used. Values are presented as means ± S.D. Statistical analyses were carried out with the 
Mann-Whitney Rank Sum test (SigmaStat 3.11; Systat Software Inc., Chicago, IL, USA, or 
SigmaPlot v. 12.3, Systat Software Inc., Chicago, IL, USA). For the CaM inhibition studies, 
results for the phagocytosis and viability assays and the cell silhouette characteristics (TI 
values) were analyzed with Kruskal-Wallis one-way analysis of variance, followed by Dunn's 
method for pairwise multiple comparison procedures for statistically significant differences 
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between the groups. For these studies, values were presented as mean ± S.E.M. from at least 
three independent experiments and p<0.05 was considered significant. For Western blots, 
values were presented as mean ± S.E.M. from at least three blots, each representing 
independent experiments for each time period examined. For the determination of the 
homogeneity of the subcloned microglial cells, Iba1-positive cells and Hoechst 33258 dye-
positive cell nuclei from at least 50 randomly sampled microscope fields from 2-3 coverslips 
for each subcloned culture were counted and the results are presented as mean ± S.E.M. 
 
4. RESULTS 
4.1. Microglial cells collected from the forebrains of E18 rats are mainly ameboid 
The microglial cells were collected from E18 rat forebrains and maintained in mixed primary 
neuronal-glial co-cultures. Light microscopic fluorescent immunohistochemistry revealed (Fig. 
1) that on E18 the Iba1-labeled microglial cells in the forebrain cortical tissue appeared to be 
mainly ameboid (arrowheads), though more differentiated forms were also present in smaller 
numbers. Most of the microglial cells were rounded or slightly ovoid and lacked branching 
processes; however, rod-like (double-arrowhead) or slightly ramified microglial cells (arrrow) 
were occasionally also seen in the embryonic rat forebrain. 
 
 
Fig. 1. Microglia in the E18 embryonic rat forebrain. 
The immunofluorescent detection of microglial cells (red) in 8-µm-thick paraffin-embedded coronal 
sections of E18 rat forebrains was achieved through the use of anti-Iba1 antibody. Most Iba1-labeled 
cells displayed ameboid morphology with ovoid (arrowhead) or slightly rod-shaped forms (double-
arrowhead), but occasionally more ramified microglia could also be seen (arrow). Cell nuclei were 
labeled blue with Hoechst 33258. CxP: cortical plate; CxS: cortical subplate; ICx: intermediate cortical 
layer; S: subiculum. Scale bar: 100 µm. 
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4.2. Microglial cells proliferate during in vitro culturing of primary forebrain cells 
As concerns the cell number and the presence of numerous microglia-specific antigens, 
fluorescent immunocytochemistry (Fig. 2) and Western analysis (Fig. 3) demonstrated a 
massive in vitro expansion of the microglial cells between DIV1 and DIV28. The total 
numbers of cells at the beginning and at the end of the culturing period did not differ 
significantly. While the total number of cells exhibited a minimum on DIV10, the number of 
microglia constantly increased from immediately after seeding throughout the entire culturing 
period. 
 
 
Fig. 2. Development of Iba1 immunoreactivity in primary cortical cultures (DIV1-DIV28). 
(A-G) The number and composition of the cultured cells are tightly controlled. While the total number 
of cells remains constant, the microglia proliferate during culturing. The microglial cells (red) were 
first labeled with the rabbit anti-Iba1 primary (polyclonal) antibody, and then with an appropriate 
Alexa Fluor fluorochrome-conjugated secondary (Alexa Fluor 568 goat anti-rabbit) antibody, while 
the cell nuclei (blue) were labeled with Hoechst 33258. Culturing times are indicated at the upper right 
corners of the pictures. Scale bar in A for A-G: 50 µm. (H-J) Microglial cells in characteristic cellular 
environments. For the detection of microglial cells and neurons, anti-Iba1 (red) and anti-β tubulin III 
(green) antibodies, respectively, were used. The cell nuclei (blue) were labeled with Hoechst 33258. 
(H) On day 1, the Iba1-positive microglial cells (red) were mostly ameboid around the developing β 
tubulin III-positive neurons (green). (I) On day 7, the majority of the microglial cells (red) had become 
ramified around a group of β tubulin III-immunopositive developing neurons (green). (J) On day 21, 
the culture was characterized by a heterogeneous, albeit mostly ramified population of microglia (red), 
located around the occasional β tubulin III-positive neurons (green) and many non-neuronal/non-
microglial cells indicated by the blue nuclei. Scale bar in H for H-J: 50 µm. 
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Fig. 3. Quantitative analysis of the cellular composition, the protein content and the amount of 
selected biomarkers during culturing. 
(A) The numbers of cell nuclei (open bars) and Iba1-positive (microglial) cells (solid bars) and the 
protein content (solid line) were quantitative analyzed in primary cortical cultures (DIV1-DIV28). The 
methods of counting cell nuclei and anti-Iba1-immunolabeled cells are described in the Experimental 
procedures section. Error bars indicate means ± S.D. (B) Representative Western blot pictures of Iba1, 
β tubulin III, GFAP and CNPase immunoreactivities in primary cortical cultures (DIV1-DIV28). (C) 
Quantitative Western blot analysis of Iba1, β tubulin III, GFAP and CNPase immunoreactivities in cell 
cultures between DIV1 and DIV28. Iba1: ionized calcium binding adaptor molecule 1, β tub: β tubulin 
III, GFAP: glial fibrillar acidic protein, CNPase: 2', 3'-cyclic nucleotide 3'-phosphodiesterase. Error 
bars indicate means ± S.D.  
 
The microglia were situated in a scattered manner in younger cultures (before and 
around DIV 14; Fig. 2A-E), but when they increased in abundance as the cultures grew older, 
they became more clumped and grouped together around other cells, as seen between DIV 21 
and DIV28 (Fig. 2F, G). Typical relative distributions of neuronal and microglial cells during 
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culturing may be seen in Fig. 2H-J. The microglial cell content originally amounted to less 
than 0.5% of the total cell number at the time of seeding, but steadily rose during culturing. 
On DIV 4 and DIV7, progressively more microglial cells appeared, accounting for 2% and 
8% of the total cell number, respectively (Fig. 3A). On DIV10, the overall morphological 
diversity of the microglial cells in the culture was similar to that on DIV7; at this time, the 
cultures contained barely 50% of the total cell number seen on DIV1, and the microglial cells 
comprised around 18% of the total cell population (see Fig. 2D for comparison). From this 
time onward, most of the gains in the number of total cell counts could be attributed to 
microglial cell proliferation (Fig. 3A). On DIV14, as the majority of the microglia had started 
to differentiate toward the ramified form, approximately 20% of all the cells were microglia. 
The proportion of microglial cells reached 33.7% by DIV28 (Fig. 3A, see Fig. 2G also for 
comparison). This massive, roughly 67-fold multiplication of the microglial cell type was also 
demonstrated by Western blot analysis (Fig. 3B, C). The Iba1 immunoreactivities detected in 
the blots steadily increased some 750-fold between DIV1 and DIV28. The β tubulin III, 
GFAP and CNPase immunoreactivities, quantified by Western blot analyses, demonstrated 
the evolution of other cellular components during culturing (Fig. 3B, C): while the amount of 
the neuronal marker β tubulin III steadily decreased, the immunoreactivity of the 
oligodendrocyte marker CNPase constantly rose between DIV1 and DIV28. A decrease in 
GFAP immunoreactivity at DIV28 was also observed in the cultures (Fig. 3C). 
 
4.3. Mixed microglial populations exist in primary forebrain cultures 
Diverse morphological forms of microglial cells developed and were present throughout the 
culturing (Fig. 4). At one end of the morphological spectrum, on DIV1, the microglial cells 
were virtually exclusively ameboid, frequently with smooth-surfaced spherical cell bodies, 
although ovoid or fusiform cells with a few microspikes could also be seen (Fig. 4A-D). As 
the cultures grew older (DIV7-DIV10), the microglia became more ramified. They acquired 
larger somata bearing typically one or two, but rarely more, large processes (Fig. 4E-H). One 
large, stubby lamellipoda usually formed first, but by DIV10 further processes, or the more 
ramified morphology of a single large lamellipoda could be observed (Fig. 4G-H). After 
DIV10, the microglial cells became more heterogeneous, as a constantly increasing microglia 
population characterized by relatively even cellular processes and enlarging somata 
accompanied the ameboid form (Fig. 4I-K, M). Microglial process formation became 
widespread by DIV14. Incidentally, this was the first time at which the ramified microglia 
(demonstrating morphology similar to that of the resting microglia in the adult rodent CNS) 
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predominated in the cultures (Fig. 4I, J). The Iba1-positive microglial cells were characterized 
morphologically by larger somata with a few long, relatively thin and sparsely ramified 
processes. As the cultures grew older, on both DIV21 and DIV28, the characteristic microglial 
morphology was a ramified form with several axes of symmetry along the processes (Fig. 4K, 
M), albeit ameboid cells were also present (Fig. 4L, N). The typical microglial morphology 
during the later stages of in vitro culturing also included cells with elongated, slightly curved 
somata emanating a few processes of mixed lengths. It must be noted that islands of densely 
grown ameboid microglial cells were persistently present throughout culturing. 
 
 
Fig. 4. Development of the morphology of the microglia in the primary cultures (DIV1-DIV28). 
The microglial cells (red) were first labeled with the anti-Iba1 primary antibody, and then with the 
Alexa Fluor 568 fluorochrome-conjugated goat anti-rabbit secondary antibody, while the cell nuclei 
(blue) were stained with Hoechst 33258. On day 1 (A, B), all the microglial cells had an ameboid 
appearance, with round or slightly ovoid cell forms. Very few, if any, microspikes or lamellipodae 
could be seen (B). On day 4 (C, D), some of the microglial cells had become more asymmetric or rod-
shaped, and some of these cells possessed more pronounced lamellipodae (C). At later stages, from 
day 7 (E, F), the microglia became more ramified. Usually only a few, heavier branches appeared at 
this stage of microglial differentiation (F). From this stage on, the cultures were characterized by two 
distinctly polarized populations, representing the two extremes of the morphological continuum 
displayed by the microglial cells in the cultures, i.e. the ameboid and the ramified microglial cells. 
From day 14 (I, J), the microglia became truly ramified as they usually had 3-4 strongly developed 
branches, but 6-7 equally strong and long branches could sometimes be seen from day 21 (K, M). At 
these times, ameboid forms were also still quite frequent (L, N). Scale bar in A (for A-Y): 10 µm. 
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4.4. Cultured microglia populations can be evaluated by their TI values 
The time course of the morphological changes in the microglia was analyzed on binary 
silhouettes, as depicted in Fig. 5. Quantitative analysis based on the TI value, a dimensionless 
number that is an indicator for identification of the degree of morphological differentiation 
(e.g. the degree of process extension) of a cell, revealed a continuum of the microglial 
phenotype between the ameboid and the extremely ramified morphologies of the microglia. 
Throughout the experiments, microglial cells with TI < 3 were considered ameboid (Fig. 6A-
G; circles). While younger cultures displayed predominantly ameboid cell forms with a 
regular, round outline reflecting the expanding microglia population (Figs. 5 and 6A-D), older 
cultures presented a more heterogeneous morphological repertoire, concurrently involving 
cells with ameboid (proliferating) and ramified (resting) forms, the majority being ramified 
(Figs. 5 and 6E-G). The ramified, resting microglia that developed later during the culturing 
could be characterized by a TI value as high as 81 (Fig. 6H). The ameboid, proliferating 
microglial cells, predominant in the early stages but always present throughout culturing, had 
TI values of less than 3, independently of the age of the culture (Fig. 6H; below dashed line), 
and were always Ki67-positive (Fig. 7). The Ki67 immunoreactivity observed in the ameboid 
microglial nuclei usually exhibited a distinct dotlike pattern representative of the S/G2 phase 
(Fig. 7A-D) unless it was associated with the periphery of the condensed chromosomes of the 
M-phase (Fig. 7E-H). 
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Fig. 5. Morphological heterogeneity of microglial cells after different culturing times. 
The Iba1-positive microglial cells were photographed, digitized and quantitatively analyzed according 
to their morphological characteristics. Area (A), perimeter (P) and transformation index (TI) are 
indicated for each digitized cell. Ten representative cells are shown at each culturing time. While 
younger cultures exhibited predominantly ameboid cell forms with TI < 3, older cultures were 
morphologically heterogeneous, as they developed a continuum of populations with two distinct 
populations of microglial cells at the extrema: the ameboid cell population (TI < 3) and the ramified 
cell population (TI > 3). Younger cultures exhibited predominantly ameboid cell forms, while older 
cultures displayed more ramified forms, but also proliferating ameboid populations (see the few 
ameboid microglia among the mainly heterogeneous microglial cells at DIV28. 
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Fig. 6. Evolution of morphometric parameters of the microglial cells during culturing.  
(A-G) Relationship between the perimeter of the microglial cell and its cell surface area. Cell area and 
perimeter values were measured by using the computer program ImageJ, and TI values were 
calculated as [perimeter of cell (µm)]2/4π[cell area (µm2)]. Each dot represents a digitized microglial 
cell. Some of the dots overlap at this resolution. Dots within the circles almost always indicate a cell 
with TI < 3 and a cell surface area < 500 µm2. The less differentiated microglial cell populations (TI < 
3) are marked with circles. (H) Distribution of TI values as a function of the culturing time. Microglial 
cells with TI < 3 are located below the dashed line. As may be seen here, there are microglial cells 
with extremely high TI values on DIV21 and DIV28.  
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Fig. 7. Relationship between proliferation, ameboid morphology and Ki67 immunoreactivity. 
Representative immunocyochemical pictures of Ki67-positive ameboid microglial cells in DIV7 
cultures. Fluorescent microphotographs of the cultures were taken through the red (A, E), green (B, F) 
and blue (C, G) channels and displayed in this sequence. CD11b/c-positive microglia (A, E), Ki67-
positive cells (B, F) and Hoechst 33258-labeled cell nuclei (C, G) are depicted. The merged pictures 
of CD11b/c- and Ki67-immunolabeled microglial cells are also shown (D, H). The presence of some 
non-microglial and non-dividing cells is indicated by the Hoechst 33258 stain at the upper right corner 
of the pictures. A group of CD11b/c-positive microglial cells is located at the bottom left corner of the 
pictures. Proliferating CD11b/c-positive microglial cells are located in the middle of the pictures. 
Arrow points to the condensed chromatin in an M phase microglia (G). Scales for all pictures: 50 µm. 
 
4.5. Phagocytosis is predominant in ameboid microglia in culture 
Ameboid and ramified microglial cell populations in culture could be differentiated through 
their ability to phagocytose (Fig. 8). Unstimulated microglia readily phagocytosed fluorescent 
microbeads. On DIV14, when mixed populations of ameboid and ramified microglia were 
present in the cultures in about equal numbers, microbeads were significantly more preferred 
by the ameboid forms (characterized by low TI values; Fig. 8A), while the ramified microglia 
(with higher TI values; Fig. 8B) were less active in phagocytosing microbeads. On average, 
microglia with TI < 3 phagocytosed 11.08 ± 8.6 beads per cell (average ± S.D., n = 39), while 
microglia with TI > 3 engulfed 3.16 ± 3.6 beads per cell (n = 81); the difference was 
statistically significant (p < 0.001; Mann-Whitney Rank Sum test). When the number of 
phagocytosed microbeads per microglia was plotted as a function of TI under 
unstimulated/unchallenged conditions, the physiologically distinct populations of ameboid 
and ramified microglia could be readily demonstrated (Fig. 8C). 
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Fig. 8. Phagocytic activity of unstimulated microglial cells in a primary culture (DIV14). 
(A, B) Representative immunocyochemical pictures showing the unstimulated phagocytic capability of 
microglial cells (red) as a function of the TI value from the same 14-day-old culture. Fluorescent dye-
coated latex microbeads (green; d = 2 µm) were added to the medium and phagocytosed by microglia. 
Microglial cells with TI < 3 (A), i.e. ameboid forms with 11.08 ± 8.6 beads per cell, were about 3.5-
times more likely to phagocytose the microbeads than cells with TI > 3 (B), i.e. ramified forms with 
3.16 ± 3.6 beads per cell. Non-phagocytosed microbeads were very rare in the cultures (a solitary bead 
can be seen in both A and B). Scale bar: 50 µm. (C) Distribution of unstimulated microglial cells with 
phagocytosed microbeads as a function of the TI value. The vertical dashed line separates the 
functionally different microglial populations (TI < 3 as ameboid, phagocytosing and proliferating, and 
TI > 3 as ramified, resting microglia). 
 
4.6. Immunocytochemistry reveals microglial populations displaying changing molecular 
phenotypes during culturing 
Double immunofluorescent microscopy revealed that Iba1-labeled microglial cells 
occasionally also expressed the HLA DP, DQ, DR antigens, exclusively in young cultures 
(Fig. 9A, B). HLA DP, DQ, DR-positive Iba1-expressing microglial cells were always 
ameboid, with TI < 3 (Fig. 9A, B). They were sporadically present from seeding up to DIV10, 
but disappeared completely from the cultures thereafter. Cultures older than DIV10 did not 
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express this antigen, even when they had an ameboid shape and proliferated, indicating that 
the HLA antigen expression can be uncoupled from the ameboid morphology. 
 
 
Fig. 9. Colocalizations of specific microglial markers during culturing. 
Representative fluorescent microphotographs of double-immunopositive microglial cells of the 
cultures were taken through the red, green and blue channels and displayed in this sequence together 
with their merged pictures. Cell nuclei (blue) were stained with Hoechst 33258. Culturing times are 
indicated at the upper right corners for each triad. (A, B) Double-immunopositive microglial cells for 
the coexpression of Iba1 and HLA DP, DQ, DR antigens at DIV1 (A) and DIV4 (B). These antigens 
are colocalized only in microglial cells of young cultures (up to DIV10), but solely in those that are 
truly ameboid or have low TI values. (C-D) Double-immunopositive microglial cells for the 
coexpression of CD11b/c and HLA DRα antigens at DIV4 (C) and DIV10 (D). These antigens are 
colocalized exclusively in the young cultures and only in microglia with typical ameboid morphology. 
The CD11b/c-positive microglia are no longer able to express HLA antigens in older cultures. (E-F) 
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Double-immunopositive microglial cells for the coexpression of CD11b/c and Iba1 antigens at DIV7 
(E) and DIV28 (F). These antigens are colocalized only in ameboid, proliferating cells with low TI 
values in both young and old cultures. Iba1-immunopositive microglial cell were morphologically 
heterogenous as both ameboid and ramified forms were labeled throughout culturing. Scale bar for all 
fluorescent microscopic pictures: 50 µm. (G) Relationship between TI values and microglia-specific 
markers. During culturing, only the less differentiated, ameboid microglia (TI < 3) express HLA 
antigens; these cells will eventually die out or differentiate to more ramified morphologies (TI > 3) 
that do not express HLA antigens. CD11b/c-positive cells can be observed throughout culturing, but 
they never become fully ramified (TI < 13). 
 
Microglial cells with typical ameboid morphology and doubly immunopositive for the 
CD11b/c and HLA DRα antigens were also found in young cultures (Fig. 9C, D). The last day 
on which these markers were colocalized was DIV10. CD11b/c-positive microglia in cultures 
older than DIV10 were no longer able to express any of these HLA antigens. CD11b/c-
positive microglial cells, however, were present throughout culturing (Fig. 9C-F). CD11b/c 
could be colocalized with the Iba1 antigen in both young and old cultures, but only in cells 
with ameboid (i.e. activated, proliferating) or slightly ramified forms with TI < 13 (Fig. 9E). 
The Iba1-immunopositive cells predominated throughout culturing, their morphology ranging 
from ameboid (Fig. 9A, B) to the ramified forms (Fig. 6E). Morphologically, Iba1-positive 
microglia were the most heterogeneous with TI values from the whole spectrum during the 
culturing. 
The relationship between TI values and myeloid/microglial cell-specific markers in 
cultured microglial cells is shown in Fig. 9G. We observed that microglial cells either lose 
some of their macrophage characteristics (e.g. HLA DP, DQ, DR or HLA DRα antigens) 
during culturing or restrict them to their less differentiated forms (e.g. CD11b/c), even though 
they retain this latter phenotype for subsequent generations. During culturing, only the less 
differentiated, ameboid microglial cells (TI < 3) expressed HLA DP, DQ, DR (or HLA DRα) 
antigens; these cells will either die out or differentiate to more ramified morphologies with TI 
> 3. CD11b/c-positive cells can be observed throughout culturing, but they never become 
fully ramified, and their TI values are always < 13. 
 
4.7. CaM is differentially localized in ameboid and ramified microglia both in mixed and 
pure cultures 
The quantity and cell type-specific localization of the CaM protein was first established in 
mixed primary cultures under unstimulated and untreated (control) conditions. Fluorescent 
immunocytochemistry (Fig. 10A-P) and Western blot analysis (Fig. 10Q, R) demonstrated 
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that a high concentration of CaM protein was characteristic of the mixed cultures throughout 
culturing. In young cultures (DIV1-DIV7), when only a few cells double-positive for the Iba1 
(Fig. 10A, E) and CaM (Fig. 10B, F) antigens existed (Fig. 10A-H), most of the CaM 
immunoreactivity was associated with non-microglial, e.g. mainly neuronal, cell forms, as 
demonstrated earlier (Szabo and Gulya, 2013). From DIV14 (up to DIV28), as more Iba1-
positive microglia populated the cultures (Fig. 10I, M), the proportion of CaM 
immunoreactivity associated with the microglia (Fig. 10J, N) also grew steadily. Both 
ameboid (Fig. 10A, E) and ramified microglia (a few cells in Fig. 10I, M) expressed CaM 
immunoreactivity. As the cultures aged, the CaM immunoreactivity localized to microglia 
became predominant (compare Fig. 10I, M with Fig. 10K, O). Similarly, Western blot studies 
confirmed the increase in Iba1 immunoreactivity during culturing (Fig. 10Q), during which 
time the CaM content of the cultures remained unchanged (Fig. 10R). Thus, by DIV14, the 
microglia had become the main CaM-expressing cell type in the mixed primary forebrain 
culture. 
Subsequent experiments were performed on pure microglial cultures (subDIV4; Fig. 11). 
In these microglial cells the Iba1 immunoreactivity was most intense in the lamellipodia of the 
ameboid forms (Fig. 12A, D, G), followed by the perinuclear region (Fig. 12D, G). The 
strongest CaM immunoreactivity was always observed in the ameboid microglia, where the 
cell somata, and especially the perinuclear area, were the most intensely labeled (Fig. 12B, E, 
H). In ameboid microglia, the CaM and Iba1 immunoreactivities were distributed in a 
complementary manner, as the Iba1 protein tending to localize in the cell cortex and 
lamellipodia (Fig. 12A, B, C). The ramified microglia displayed an almost homogenous 
cytoplasmic Iba1 distribution (Fig. 12J) with a considerably lower CaM content typically 
localized around the nucleus; the branches had only traces of CaM immunoreactivity (Fig. 
12K, L). 
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Fig. 10. Development of Iba1 and CaM immunoreactivities in primary cultures (DIV1-DIV28). 
At early culturing times (DIV1 (A-D) and DIV7 (E-H)), all seeded cells displayed CaM 
immunoreactivity (green), but only a few of them were Iba1-positive microglia (red). The cell nuclei 
(blue) were labeled with Hoechst 33258. Since most of the cells present early in the culturing are 
neurons (Szabó and Gulya, 2013), most of the CaM immunoreactivity seen at DIV1-DIV7 is of 
neuronal origin. At DIV14 (I-L), a large number of Iba1-positive cells showed CaM positivity, a 
number of them were ramified. At DIV28 (M-P), the predominant cell type in the culture was the 
CaM-positive microglia. Note the visibly different Iba1 (M) and CaM contents (N) of the ameboid and 
ramified microglia at this culturing time. The merged pictures show cells double-positive for Iba1 and 
CaM (D, H, L, P). The development of Iba1 (Q) and CaM (R) immunoreactivities during culturing 
(DIV1-DIV28) was quantitatively analyzed on Western blots. Protein samples from primary cultures 
were separated by gel electrophoresis, transferred to nitrocellulose membranes and probed with either 
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the Iba1 (Q) or CaM (R) antibody. Gray scale digital images of the immunoblots were acquired by 
scanning the autoradiographic films with a desktop scanner. The images were scanned and processed 
at identical settings to allow comparisons between the Western blots from different samples. Error bars 
indicate integrated optical density values (mean ± S.E.M.). Representative Western blot pictures are 
shown below the graphs. During culturing (DIV1-DIV28), a massive increase in the number of cells 
with microglial phenotype was observed in the mixed primary cultures, while the CaM content of the 
cultures remained constant. Most of the gain in Iba1 content occurred between DIV10 and DIV14. 
Culturing times are indicated at the upper right corners (A, E, I, M). Scale bar in A for all pictures: 50 
µm. 
 
 
Fig. 11. Localization of Iba1 immunoreactivity in pure microglial cell cultures (subDIV4). 
Representative photomicrograph of Iba1 imunoreactive microglial cells in culture. The purity of this 
culture is close to 100%, since every Hoechst 33258-labeled cell nuclei (blue) is surrounded by Iba1 
immunopositive cytoplasm (green). Scale bar: 100 µm. 
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Fig. 12. Distribution of Iba1 and CaM immunoreactivities in pure microglial cells (subDIV4).  
In pure microglial cultures (subDIV4), the majority of the unchallenged cells were ameboid or slightly 
ramified. While the Iba1 immunoreactivity (red) could be localized into two subcellular compartments, 
the perinuclear and the cell cortex domains (A, D, G, J), the CaM immunoreactivity (green) was 
largely confined to the perinuclear region (B, E, H, K), with the cell cortex having a considerably 
smaller CaM content, which progressively diminished deeper into the branches. Merged pictures (C, F, 
I, L) show the cell nuclei (blue) and the overlapping Iba1 and CaM immunoreactivities predominantly 
localized to the perinuclear area. Ameboid microglia have predominantly cortically localized Iba1 
immunoreactivity in the leading edges of large lamellipodia (A, arrows), a cytoplasmic domain largely 
devoid of CaM immunoreactivity (B). Arrowheads (D, G) point to large lamellipodia. Scale bar in A 
for all pictures: 10 µm. 
 
 
4.8. CaM inhibition affects cell morphology and actin cytoskeleton reorganization 
The microglial morphology in the control and experimental groups was analyzed through 
binary silhouettes (Fig. 13). The quantitative analysis was based on the area, perimeter and TI, 
the latter being a dimensionless number that is an indicator for the degree of process extension 
of a cell. 
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Fig. 13. Representative binary silhouettes from pure microglial cultures after different treatment 
regimens. 
Iba1-positive microglial cells from pure microglial cultures (subDIV4) were photographed, digitized 
and quantitatively analyzed according to their morphological characteristics. Five representative 
binary silhouettes are shown at each culturing time. CALMID50, in either control or LPS-challenged 
microglia, increased the number of filipodia, while the complete absence of filipodia was seen both in 
TFP10 and in LPS+TFP10-treated microglia. Area (A) in µm2, perimeter (P) in µm, and TI values 
(calculated as [perimeter of cell (µm)]2/4π[cell area (µm2)]) are indicated for each digitized cell. LPS: 
100 ng/ml; CALMID50: 50 nM CALMID; TFP10: 10 µM TFP. Scale bar for all silhouettes: 50 µm. 
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Throughout the experiments, microglial cells with TI < 3 were considered ameboid. The 
unchallenged, untreated 4-day-old pure microglia culture (subDIV4) consisted mainly of 
ameboid cells (Fig. 13, control row; see also controls in Figs. 15, 16) with an average area of 
412.91 ± 27.2 µm2, perimeter of 100.73 ± 5.4 µm and a TI of 2.02 ± 0.1 (Fig. 14). When 
administered alone, CALMID and TFP affected TI and the microglial cell surface area and 
perimeter differently. For example, both CALMID5 and CALMID50 resulted in increased 
area, perimeter and TI, whereas TFP alone strongly inhibited these characteristics. When 
challenged with LPS, the microglia became enlarged and acquired significantly larger 
perimeter and TI (A = 777.23 ± 40.1 µm2, P = 238.97 ± 8.6 µm, TI = 6.14 ± 0.4), consistent 
with these cells becoming activated (Figs. 13, 14 and Fig. 15D-F). Interestingly, CALMID5 or 
CALMID50 alone was not effective but when used in combination with LPS, they 
significantly increased the cell surface area, perimeter and TI (Fig. 13, Fig. 14A, C, E, Fig. 
15G-I). TFP sigificantly inhibited the expansion of cell surface area and perimeter both in 
unchallenged and LPS-challenged cells (Fig. 14B, D). As an example, the cell surface area 
was decreased substantially after TFP or LPS+TFP treatment, to 46.4 or 44.5% of the 
unchallenged or LPS-challenged control value, respectively. TFP treatment was also very 
effective in decreasing TI, to 25.53% of the LPS-challenged value (Fig. 13, 14). 
CaM inhibition affected the microglial morphology through reorganization of the actin 
cytoskeleton (Fig. 15). In unchallenged and untreated (control) cultures, the Iba1- and 
phalloidin-related fluorescence signals largely overlapped in the cell cortex of the mainly 
ameboid microglia, often in lamellipodia (Fig. 15A-C) as expected, since they both bind to the 
actin cytoskeleton. When treated with LPS, the microglia that became activated and enlarged 
displayed a phalloidin distribution much fuzzier than that in the case of Iba1, probably due to 
the rapid association of fibrous actin, to which phalloidin preferentially binds (Fig. 15D-F). 
However, spot-like concentrations of phalloidin fluorescence resembling podosomes were 
often visible in LPS-treated cells (Fig. 15E, arrow). CaM inhibitors affected the Iba1 and 
phalloidin distributions in different ways. CALMID50 treatment resulted in phalloidin 
fluorescence that was clearly distributed in two distinct concentric rings in the cytoplasm, one 
ring in the cell cortex, and the other as a perinuclearly localized cytoplasmic streaming of 
freshly synthesized fibrous actin (Fig. 15H, K, arrows). Phalloidin-containing filipodia were 
also obvious in these cells. Similar, albeit less dense, Iba1 distribution was observed after 
CALMID50 treatments (Fig. 15G). TFP treatment resulted in an overlapping and almost 
homogenous distribution of both Iba1 immunoreactivity and phalloidin fluorescence 
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(Fig.15M-O) in the surviving cells. While the Iba1 immunoreactivity remained relatively 
intact (Fig. 15M), most of the phalloidin fluorescence intensity was lost in TFP-treated 
microglia (Fig. 15N) indicating that TFP affected actin polymerization. 
 
 
Fig. 14. Effects of CaM inhibitors on selected morphological parameters of pure microglial cells. 
Surface area (A, B) in µm2, perimeter (C, D) in µm, and TI values (E, F) of the microglia for 
CALMID (A, C, E) and TFP (B, D, F) were analyzed in pure unchallenged and LPS-challenged 
microglial cell cultures. All statistical comparisons were made by using SigmaPlot (v. 12.3, Systat 
Software Inc., Chicago, IL, USA) and analyzed with Kruskal-Wallis one-way analysis of variance, 
followed by Dunn's method for pairwise multiple comparison procedures for statistically significant 
differences between the groups. Values (mean ± S.E.M.) were computed from at least three 
independent culturing experiments. *Statistically significant from control (p<0.05); #statistically 
significant from LPS-treated cells. LPS: 100 ng/ml; CALMID5: 5 nM CALMID; CALMID50: 50 nM 
CALMID; TFP10: µM TFP. 
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Fig. 15. Immunocytochemical localization of actin-binding proteins in pure microglial cells. 
Iba1 immunoreactivity (A, D, G, J, M; shown here in green) and phalloidin fluorescence (B, E, H, K, 
N; shown in red) were colocalized in unchallenged and untreated (control) cells and in microglia 
treated with LPS or CaM inhibitors in pure microglial cultures (subDIV4). Merged pictures (C, F, I, L, 
O) show the Hoechst 33258-labeled cell nuclei (blue) and the colocalization of Iba1 immunoreactivity 
and phalloidin fluorescence. Filamentous actin often forms continuous ring-like lamellipodia in 
unchallenged microglia (B). In LPS-challenged microglial cells, lamellipodia were less dominant, but 
the toxin stimulated podocyte formation, as indicated by several puncta delineated by phalloidin 
fluorescence (arrow, E). When CALMID50 was used, strong lamellipodia formation was observed, 
often accompanied by a perinuclear cytoplasmic streaming of filamentous actin (arrows, H, K), giving 
a double-ringed appearance of these cells. TFP treatment abolished the formation of filamentous actin 
bundles as detected by phalloidin fluorescence microscopy (N). LPS: 100 ng/ml; CALMID50: 50 nM 
CALMID; TFP10: 10 µM TFP. Scale bar in panel A for all pictures: 50 µm. 
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4.9. CaM inhibitors differentially alter the intracellular localization of CaM, and affect 
the Iba1 and CaM protein expressions 
CaM inhibitors altered the intracellular localization of CaM protein (Fig. 16). Both 
unchallenged and untreated cells (Fig. 16A-C) and LPS-challenged cells (Fig. 16D-F) 
displayed high CaM content primarily localized in the perinuclear compartment and to a much 
lesser extent with that in the cell cortex (Fig. 16A, B). Some of the cells with larger TI had 
CaM immunoreactivity that progressively diminished toward the cell cortex (Fig. 16C). 
Interestingly, cells treated with CALMID50 alone displayed a more heterogenously 
translocated CaM immunoreactivity often cortically localized in lamellipodia (Fig. 16J-L, 
arrowheads). In TFP10-treated cells, the CaM immunoreactivity was very weak and 
homogenously distributed in the cytoplasm (Fig. 16M-O). 
CaM antagonists inhibited Iba1 and CaM protein expressions with different efficacies 
(Fig. 17). In general, CALMID was less potent than TFP in affecting Iba1 and CaM protein 
expressions. CALMID, either alone or in combination with LPS, was not able to alter the Iba1 
expression significantly (Fig. 17A). TFP was more potent as TFP10 and TFP20 inhibited Iba1 
protein expression in a dose-dependent manner both in unchallenged and LPS-challenged 
cells (Fig. 17C). Similarly to their effects on the Iba1 expression, CALMID and TFP 
antagonized the CaM protein expression with different efficacy (Fig. 17B, D). When 
CALMID was used, the CaM immunoreactivity was observed to decrease somewhat dose-
dependently in the unchallenged microglia as CALMID50 significantly inhibited the CaM 
protein expression to 38.6% of the control level (Fig. 17B). Again, TFP20 had a more 
profound effect on the CaM protein expression (Fig. 17D), as it exhibited a strong inhibition 
both in the unchallenged and in the LPS-activated microglia (20.8% and 23.4% of the control 
value, respectively). 
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Fig. 16. Effects of CaM inhibitors on the intracellular localization of CaM immunoreactivity in 
pure microglial cells. 
Representative immunocytochemical pictures showing the intracellular distribution of CaM 
immunopositivity (red) in pure microglia cells (subDIV4). The merged pictures show the cell nuclei 
(blue) that were stained with Hoechst 33258. The unchallenged and untreated (control) microglia (A-
C) and LPS-challenged cells (D-F) showed mainly perinuclearly localized CaM immunoreactivity. 
LPS-challenged and treated cells (G-I), and more typically CALMID50-treated microglia (J-L) 
displayed CaM distribution often more targeted to the cell cortex and developing lamellipodia 
(arrowheads). TFP treatment resulted in a significant cell death (see Figure 4) and a homogenous 
cytoplasmic distribution of CaM immunoreactivity in the surviving microglia (M-O). LPS: 100 ng/ml; 
CALMID50: 50 nM CALMID; TFP10: 10 µM TFP. Scale bar in panel A for all pictures: 50 µm. 
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Fig. 17. Effects of CaM inhibitors on Iba1 and CaM protein expression in pure microglial cells, 
as detected by Western blot analysis. 
Quantitative Western blot analysis of Iba1 (A, C) and CaM (B, D) immunoreactivities in pure 
microglial cell cultures (subDIV4). Representative Western blot pictures of the respective 
immunoreactivities are shown below the graphs together with the GAPDH immunoreactive bands that 
served as inner standards in the same gel. Protein samples were collected from 3 separate culturings, 
each involving plating on at least 6 Petri dishes, electrophoresed and quantitatively analyzed as 
described in the Materials and methods section. The integrated optical density data (mean ± S.E.M.), 
normalized to GAPDH immunoreactivities, were analyzed with Kruskal-Wallis one-way ANOVA on 
ranks, followed by pairwise multiple comparisons (Dunn’s method). *Statistically significant from 
control (p<0.05); #statistically significant from LPS-treated cells. Iba1: ionized calcium-binding 
adaptor molecule 1; CaM: calmodulin; LPS: 100 ng/ml; CALMID5 and CALMID50: 5 and 50 nM 
CALMID; TFP10 and TFP20: 10 and 20 µM TFP; GAPDH: glyceraldehyde 3-phosphate 
dehydrogenase. 
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5. DISCUSSION 
Ramified microglial cells, the most common form of microglial cells in the normal adult brain, 
are derived from macrophage-like cells of mesodermal origin (Dalmau et al., 1997; Gehrmann 
et al., 1995; Ling and Wong, 1993). Many lines of evidence have recently demonstrated that 
these “true” resident microglial cells can be distinguished from other myeloid monocytic cells 
in the CNS from the aspects of their location, origin, specific cell surface antigens, other 
biochemical markers, their functions and their turnover with the periphery. Adult resting 
microglia with ramified forms reside in the parenchyma of the CNS, their position often being 
juxtavascular (Davalos et al., 2005; Ginhoux et al., 2010). They express a defined set of 
markers differently from other myeloid cell populations of the CNS (including, for example, 
CD11b, F4/80, the chemokine receptor CX3CR1 and Iba1), and function as local immune 
surveyors and scavengers of cell debris; the true, resident microglia population does not 
participate in exchange with the circulation (Prinz et al., 2011). Myeloid cell populations of 
the CNS with specific patroling functions include the perivascular, the meningeal and the 
choroid plexus macrophages, which possess slightly different sets of markers, but always take 
part in extensive exchange with the myeloid cells of the circulation (Bechmann et al., 2001a, 
b; Chinnery et al., 2010; Hawkes and McLaurin, 2009; Kim et al., 2006; Vallières and 
Sawchenko, 2003) and the vessel-patroling resident monocytes and inflammatory monocytes 
that originate from and display a high turnover with the bone marrow (Auffray et al., 2009; 
Geissmann et al., 2003). 
Discrimination between the different myeloid monocytic cell forms with uniquely 
important in vivo functions was beyond the scope of this study when cells were collected for 
the primary culture. Previous studies on the preparation of tissue slices (Hailer et al., 1996, 
1997; Stence et al., 2001) and primary cultures (Floden and Combs, 2006) indicated that 
physical damage to cells during tissue handling and cell harvesting (tissue removal from the 
embryo, sectioning, cell isolation procedure, etc.) can alter the microglial morphology, marker 
expression and function, and the resulting molecular characteristics seen in vitro may not 
necessarily reflect the in vivo phenotype. It is possible, therefore, that the cells we harvested 
from E18 rat forebrains and later identified as Iba1-positive included many of the myeloid 
monocytic cell populations described above, but the prolonged culturing led to the 
development of molecular and functional phenotypes quite different from those seen in vivo, 
and perhaps even sparser, less differentiated myeloid-derived cell populations when cultured. 
Earlier attempts to characterize microglial cells in vitro frequently employed culturing 
times of less than a week (Becher and Antel, 1996; Otani et al., 2011; Tanaka et al., 1998), 
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when changes in microglial population dynamics were not always apparent. Microglia 
cultured from the embryonic or from the adult brain were also found to differ in many 
important ways. Microglia prepared from the adult rat brain became progressively de-
differentiated and acquired a phenotype reminiscent of that of activated microglia in vivo over 
a period of 7 days in culture (Slepko and Levi, 1996). The differences between microglia 
acutely isolated from the CNS and cultured microglia derived from mixed glial cultures were 
most clearly seen in their differential proliferative capacity and cytokine responsiveness (Ford 
et al., 1995; Frei et al., 1994). Unlike microglia from cultures, microglial cells from adults 
were not stimulated by transforming growth factor (Rozovsky et al., 1998), nor did they 
proliferate in response to granulocyte- or macrophage colony-stimulating factor (Ford et al., 
1995). While the concept of M1/M2 macrophage heterogeneity has gained momentum in 
recent years, there is considerable uncertainty as to the extent to which this notion could be 
extrapolated to microglial cells. For example, in a recent study, Durafourt et al. (2012) found 
that M1 and M2 subtypes of macrophages and those of the microglial cells not only 
differentially expressed a number of genes, but phagocytosed myelin quite differently, 
indicating that the expression of similar biomarkers by macrophages and microglia does not 
necessarily mean that they have the same function. 
Our results showed that microglia prepared from embryonic tissue and maintained for 
up to 4 weeks displayed multiple phenotypes with different immunologic, proliferative and 
phagocytic characteristics. While the number of total cells did not vary significantly during 
culturing, their composition exhibited a dramatic change. The number of microglial cells rose 
steadily during culturing, by a factor of 67-fold. The selected microglial antigenic and 
functional (proliferation and phagocytosis) properties in primary mixed cultures of E18 rat 
forebrain tissues revealed a marked morphological and antigenic differentiation during 
culturing.  
Morphometric analysis on binary silhouettes of microglial cells revealed that ameboid 
forms were dominant in the early stages of in vitro differentiation, while older cultures were 
characterized by mixed populations of ameboid and ramified cells, the latter being the 
dominant form. The ameboid microglia, characterized by TI < 3, was the mitotically active, 
Ki67-immunopositive population even in older cultures where it formed a core of 
proliferating cells. The feasibility of a quantitative assessment of different microglial 
populations (resting vs. activated microglia) through morphological features alone was 
recently demonstrated (Kozlowski and Weimer, 2012); the sensitivity of this automated 
method was reported to be comparable to that of immunohistochemical methods. 
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While the morphology of the cultured microglial cells was very similar to that in the 
normal rat brain, their antigenic markers specific for the monocyte/macrophage/microglial 
cell line were distinctly different and exhibited a more restricted immunological phenotypic 
repertoire from those seen in vivo. We found that microglial cell populations in culture, 
without the presence of recruited hematogenous macrophages from the periphery through the 
blood-brain barrier, were more similar to those in the normal adult (or physiologically aging) 
brain (e.g. showing no signs of significant neurodegeneration and therefore almost no 
turnover for the microglial cells with the periphery) than to those in the neuropathologic brain 
(e.g. in Alzheimer’s disease). The large flux of HLA DP, DQ, DR-positive macrophages that 
entered the E18 brain through the blood-brain barrier soon died or differentiated further in the 
culture. As a consequence, cultured microglial cells that were doubly positive for Iba1 and 
HLA DP, DQ, DR antigens were absent from cultures older than DIV10. This is in contrast 
with earlier reports of an upregulation of HLA class II proteins upon phagocytosis (Becher 
and Antel, 1996; Beyer et al., 2000; Smith, 2001), a function displayed by ameboid microglial 
cells throughout the entire culturing, although they were negative for the HLA DP, DQ, DR 
antigens after DIV10. 
The loss of a large number of cells, which peaked on DIV10, concomitantly with the 
formation of neuronal clumps in the culture, could be coupled causatively to microglial 
activation and proliferation in two ways: either the massive neuronal death triggered microglia 
proliferation or, conversely, the proliferating microglial cells adversely influenced and 
eventually killed some other cells in the culture. This neuronal loss, most prominent around 
DIV10, was documented by Western analysis and was accompanied by an increase in the 
phagocytic activity of these cells. Interestingly, microglia proliferation could also be linked to 
the observed increase in CNPase activity during culturing. Similar phenomenon was observed 
in neonatal mouse brain cultures (Amur-Umarjee et al., 1990). Such microglia-
oligodendrocyte interactions could be due to factors secreted by activated microglia that 
promote oligodendrocyte proliferation and differentiation (Deierborg et al., 2010).  
One of the main roles of microglia is phagocytosis, a process that is critical for the 
uptake and degradation of infectious agents and senescent cells, and which contributes to the 
immune response and inflammation (Aderem and Underhill, 1999; Marín-Teva et al., 2004). 
As reviewed by Neumann et al. (2009), the recent evidence suggests that the phagocytic 
clearance by the microglia plays a fundamental role in facilitating the reorganization of 
neuronal circuits and triggering repair mechanisms. For example, there are substantial 
differences in microglial phagocytosis during the restructuring of neuronal connections 
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(Marín-Teva et al., 2004), in acute CNS injury (Cullheim and Thams, 2007), in multiple 
sclerosis (Takahashi et al., 2007), in normal development and ageing (Streit, 2006) or in 
Alzheimer's disease (Meyer-Luehmann et al., 2008), and the insufficient level of clearance 
seen in certain neurodegenerative diseases might be associated with an inadequate 
regenerative response such as that in Alzheimer’s disease. 
We used unstimulated microglial cells to measure phagocytic activity for two reasons: 
1) certain immunomodulatory functions could be reduced in stimulated microglia (Magnus et 
al., 2004), and 2) there could be a differential expression of a number of microglial enzymes 
and markers upon stimulation (Imamura et al., 1991). Both such effects could lead to the 
ameboid microglial phenotype being favored, which could interfere with our statistical 
analysis. The fact that unstimulated ramified microglia do not proliferate (Imamura et al., 
1991) ruled out the possibility that the conversion to the ameboid form would be induced, 
thereby biasing the actual composition of the microglial pool. We found that unstimulated 
microglial phagocytosis was tightly coupled to the ameboid morphology, as cells with low TI 
values exhibited much higher phagocytic activity. The ameboid morphology was also related 
to the proliferation of the microglial cells, as low TI values were always present in the 
cultures. 
As microglial cells participate in both protective and pathogenic mechanisms in the 
healthy and in the diseased CNS, further correlative morphological, molecular and functional 
characterizations of cultured rat microglial cell populations similar to that presented here 
could provide further information concerning the specific roles of the different microglia cells 
in the physiology and the pathophysiology of the CNS. In vitro phenotyping of these cells 
could also be important in providing detailed information on how different signals may 
activate the microglial cell populations, on their relation to each other and their origin, on the 
regulation of their migration, etc. Furthermore, therapeutic approaches through which to 
modify the microglial responses could also benefit from in vitro studies similar to that 
presented here. 
One of the most ubiquitous Ca2+-sensing proteins is CaM. Its distributions in the 
developing and the adult rodent brain have been well documented (Caceres et al., 1983; Seto-
Ohshima et al., 1983). It is encoded by three different genes in mammals (Palfi et al., 2002; 
Toutenhoofd and Strehler, 2000). The expression patterns corresponding to the three CaM 
genes display a broad differential distribution in the developing (Kortvely et al., 2002) and the 
adult rat CNS under both physiological (Kovacs and Gulya, 2002, 2003; Palfi et al., 1999; 
Solá et al., 1996) and pathophysiological conditions (Palfi et al., 2001; Palfi and Gulya, 1999; 
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Vizi et al., 2000). Quantitative analysis of the expression patterns of these genes indicated a 
differential dendritic targeting of the CaM mRNAs (Kortvely et al., 2003; Palfi et al., 1999, 
2005); differential intracellular targeting of selected CaM mRNA populations could serve for 
the local translation of the necessary CaM proteins that regulate the numerous target proteins 
in that particular cytoplasmic compartment (Kortvely and Gulya, 2004). 
CaM expression could be regulated by a number of different physiological and 
pathophysiological cues. Although its gene expression is generally very stable (Kortvely and 
Gulya, 2004; Palfi et al., 2002), we have identified many factors that could differentially 
affect the expressions of the individual CaM genes in neurons with distinct phenotypes from 
different brain regions (Orojan et al., 2006; Palfi et al., 1999, 2002; Bakota et al., 2005), e.g. 
inflammation (Orojan et al., 2008), ischemia (Palfi et al., 2001), dehydration (Palfi and Gulya, 
1999), and chronic ethanol treatment and withdrawal (Vizi et al., 2000). Apart from the 
neurons, the microglia display a considerable amount of CaM. This CaM expression, however, 
is strongly dependent on the phenotype. After a kainic acid challenge, CaM immunoreactivity 
was earlier demonstrated in reactive microglia of the hippocampus (Solá et al., 1997), where 
the thickened and shortened microglial processes accumulated CaM protein. 
In our studies, CaM was localized both in developing microglial cells of primary 
cortical cultures established from E18 wild-type rat embryos maintained for up to 28 days 
(DIV1-28) and in pure microglial cells subcultured from DIV7 cultures for 4 days (subDIV4). 
Moreover, the presence of CaM protein was demonstrated not only in reactive microglia 
(treated with LPS alone or in combination with one of the CaM inhibitors), but also, at a 
lower protein level, in unchallenged proliferating ameboid or even ramified, microglial cells. 
We observed morphologically and functionally different microglial populations within the 
range from weak to strong levels of CaM expression during culturing, as evidenced by their 
quantitative assessment by fluorescent immunocytochemical and Western blotting methods. 
In mixed primary cortical cultures, ameboid microglia, the predominant form in the early 
stages but always present (in much smaller numbers) during culturing (Szabo and Gulya, 
2013), expressed strong CaM immunoreactivity throughout the cytoplasm, while ramified 
microglia, the typical form in the later stages of microglial development, showed a weaker 
and more evenly distributed CaM immunoreactivity. A similar intracellular distribution of 
CaM protein expression was observed in pure microglial cultures. In unchallenged and LPS-
challenged cultures, most of the microglia was ameboid and had strong CaM 
immunoreactivity throughout the cytoplasm. Treatments with CaM inhibitors, both in 
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unchallenged and LPS challenged cells, resulted in a weaker and more homogenously 
localized CaM immunoreactivity. 
We found that the intracellular localization of CaM immunoreactivity described above 
was closely related, and typically complementary, to the filamentous actin cytoskeleton, 
comprised mainly of branched F-actin (Rotty et al., 2013). F-actin was visualized in our 
studies by the distributions of an actin-binding protein, Iba1, and phalloidin, a bicyclic 
heptapeptide that recognizes F-actin only, e.g. the form that possesses cellular functionality. 
Iba1 is an intracellular Ca2+-binding protein that plays an important role in regulation of the 
intracellular actin dynamics through the direct binding of actin, enhances membrane ruffling 
and participates in phagocytosis and cell motility (Ohsawa et al., 2000, 2004), functions that 
require large amounts of cortical F-actin. Our immunocytochemical observations showed that 
ramified cells (characterized by larger TI values) that displayed minimal or no ruffling at all 
had only modest quantities of CaM proteins in the cell cortex as compared with ameboid or 
reactive microglia. Coincidentally, the amount of cortical F-actin was likewise less in ramified 
microglia, and the reorganization of the actin cytoskeleton determined the intracellular 
distribution of CaM. Concomitantly increased levels of Iba1 and CaM protein expression, 
however, were evident both in unchallenged ameboid and in LPS- or LPS and CaM inhibitor-
challenged, e.g. activated/reactive microglia. Our observations relating to the intracellularly 
redistributed CaM vs. F-actin are consistent with the findings in mast cells in previous studies. 
For example, Sullivan et al. (2000) demonstrated that CaM promoted the disassembly of 
cortical F-actin, while Psatha et al. (2004) found that the disassembly of the actin cytoskeleton 
eliminated CaM localization. 
LPS activation renders microglia ameboid, induces several pro- and anti-inflammatory 
signaling molecules (Lim et al., 2015; Zhu et al., 2014) and neurotoxic substances through 
binding to the CD14/MD-2/Toll-like receptor 4-complex (Fricker et al., 2012; Tokes et al., 
2011), and gives rise, among others, to cell spreading by interfering with the organization of 
the actin cytoskeleton through the alteration of integrin clustering (Abram and Lowell, 2009). 
Microglia activation was shown to involve the signaling pathways nuclear factor κB and p38 
mitogen-activated protein kinase (Bachstetter et al., 2007; Cao et al., 2014; Kaushal et al., 
2007). It must be noted, however, that the activation of microglial cells by LPS is not 
proliferative (Suzumura et al., 1991).  
In our studies, LPS challenge resulted in significant cell spreading, documented in 
increases in cell surface, perimeter and TI, and in a repositioning of intracellular actin 
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filaments toward podosome and filipodia formation. In spite of this lack of interaction 
between the LPS challenge and CaM protein expression, some of the effects of LPS are 
mediated through CaM-related phenomena in macrophages (Sweet and Hume, 1996). An LPS 
challenge, for example, elevated the intracellular Ca2+ concentration in brain macrophages via 
the activation of phosphatidylinositol (3,4,5)-trisphosphate-sensitive stores that, in turn, 
activated the actin cytoskeleton (Bader et al., 1994). Such an inflammatory response was 
recently identified as one developed through the activation of CaM-dependent kinase kinase 2 
via Toll-like receptors (Racioppi et al., 2012). Thus, the effects of LPS could be attributed, at 
least in part, to CaM-related phenomena regulating the actin cytoskeleton without directly 
affecting the CaM protein expression. In another study, CaM was involved in spontaneous 
microglial ramification and the activation of proliferation from quiescence as it inhibited the 
spontaneous ramification and decreased the proliferation of these cells (Casal et al., 2001). 
The loss of ramification was reported to be induced by the elevation of intracellular Ca2+ via 
direct or indirect routes (Kalla et al., 2003) that eventually resulted in CaM activation and/or 
accumulation in the cell cortex. 
The ability of CaM to activate many target proteins depends on its highly flexible 
conformation, enabling it to interact with a wide variety of proteins (Yamniuk and Vogel, 
2004). We hypothesize that this conformational flexibility is limited to different degrees when 
CaM inhibitors are applied; consequently, many of the CaM-regulated effects will be 
differentially affected by CaM inhibition. Thus, given the number of CaM-interacting target 
proteins and their participation in the various intracellular signaling pathways involved in, for 
example, the remodeling of the actin cytoskeleton during lamellipodia, filipodia or podosome 
formation (Evans et al., 2003; Murphy and Courtneidge, 2011; Sunagawa et al., 2000; Vincent 
et al., 2012), it is difficult at present to give an accurate explanation as to how different CaM 
antagonists might interfere with the outcome of the signaling processes. It seems clear, 
however, that CaM inhibition interferes strongly with both morphological and functional 
aspects of the microglial cells. Future experiments may shed light on whether the effects of 
CaM inhibition seen in selected morphological and functional properties of microglia are 
uniquely characteristic of these cells or may perhaps be typical of other cell types too, and 
may promote an understanding of the cell type-specific roles of CaM. 
 
6. CONCLUSION 
In our studies, selected morphological, immunocytochemical and functional aspects of various 
microglial cell populations were characterized in mixed neuronal/glial and pure microglial 
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cultures. The mixed primary cortical cultures were prepared from the forebrains of embryonic 
(E18) rats and maintained for up to 28 days (DIV1–DIV28) using routine culturing techniques. 
The pure microglial cells were subcloned (subDIV4) from the mixed primary cultures and 
maintained for up to 7 days (DIV7). During culturing, expansion of the microglial cells was 
observed, as evidenced by quantitative assessment of selected monocyte/macro-
phage/microglial cell-specific markers (HLA DP, DQ, DR, CD11b/c and Iba1) via 
immunocyto- and -histochemistry and Western blot analysis. The Iba1 immunoreactivity in 
Western blots steadily increased about 750-fold, and the number of Iba1-immunoreactive cells 
rose at least 67-fold between DIV1 and DIV28. Morphometric analysis on binary (digital) 
silhouettes of the microglia revealed their evolving morphology during culturing. Microglial 
cells were mainly ameboid in the early stages of in vitro differentiation, while mixed 
populations of ameboid and ramified cell morphologies were characteristic of older cultures 
as the average transformation index (TI) increased from 1.96 (DIV1) to 15.17 (DIV28). 
Multiple immunofluorescence labeling of selected biomarkers revealed different microglial 
phenotypes during culturing. For example, while HLA DP, DQ, DR immunoreactivity was 
present exclusively in ameboid microglia (TI < 3) between DIV1 and DIV10, CD11b/c- and 
Iba1-positive microglial cells were moderately (TI < 13) and progressively (TI < 81) more 
ramified, respectively, and always present throughout culturing. Regardless of the age of the 
cultures, proliferating microglia were Ki67-positive and characterized by low TI values (TI < 
3). The microglial function was assessed by an in vitro phagocytosis assay. Unstimulated 
microglia with low TI values were significantly more active in phagocytosing fluorescent 
microspheres than the ramified forms. In vitro studies on microglial population dynamics 
combined with phenotypic characterization can be of importance when different in vivo 
pathophysiological situations are modeled in vitro. 
The roles of CaM, a multifunctional intracellular calcium receptor protein, as concerns 
selected morphological and functional characteristics of pure microglial cells were 
investigated through use of the CaM antagonists calmidazolium (CALMID) and 
trifluoperazine (TFP). The intracellular localization of the CaM protein relative to phalloidin, 
a bicyclic heptapeptide that binds only to filamentous actin, and the Iba1 protein was 
determined by immunocytochemistry, with quantitative analysis by immunoblotting. In 
unchallenged and untreated (control) microglia, high concentrations of CaM protein were 
found mainly perinuclearly in ameboid microglia, while the cell cortex had a smaller CaM 
content that diminished progressively deeper into the branches in the ramified microglia. The 
amounts and intracellular distributions of both Iba1 and CaM proteins were altered after 
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lipopolysaccharide (LPS) challenge in activated microglia. CALMID and TFP exerted 
different, sometimes opposing, effects on many morphological, cytoskeletal and functional 
characteristics of the microglial cells. They influenced the CaM and Iba1 protein expressions 
and their intracellular localizations differently, and differentially affected the reorganization 
of the actin cytoskeleton in the microglial cell cortex, influencing lamellipodia, filipodia and 
podosome formation. 
Acting on many target proteins, CaM is a key factor in the regulation of a number of 
morphological aspects of the microglia through the modulation of the actin cytoskeleton that 
affects the formation and maintenance of lamellipodia, filipodia and podosomes of these cells. 
CALMID and TFP, two prototypical CaM antagonists acting through different molecular 
mechanisms on the CaM protein, have differential effects on these morphological and certain 
fuctional aspects, including Iba1 and CaM protein expression, when tested both in 
unchallenged and LPS-challenged pure microglial cells. In general, TFP was more potent in 
provoking these structural alterations. Deciphering the roles of CaM in microglial functions, 
perhaps through use of different CaM-specific inhibitors, could be important in understanding 
the roles and modes of action of microglia in health and disease. 
In summary, the main findings of our studies are: 
1) In mixed primary cultures, TI values revealed the evolving microglial morphology and 
functions during culturing as microglia with TI < 3 were more active in phagocytosing 
than the ramified forms characterized with TI > 3. 
2) The macrophage/microglia markers labelled different microglial phenotypes in culture: 
HLA DP, DQ, DR-positive microglia were exclusively ameboid, while CD11b/c-
labeled microglia were typically less ramified than the Iba1-labeled cells. 
3) When CaM inhibitors were tested in unchallenged and in LPS-challenged pure 
microglia, they affected many morphological and functional aspects of microglial cells. 
CALMID and TFP differentially affected the intracellular distributions of CaM and Iba1, 
and the actin cytoskeleton reorganization. 
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DEVELOPMENT OF THE MICROGLIAL PHENOTYPE IN CULTURE
M. SZABO AND K. GULYA *
Department of Cell Biology and Molecular Medicine, University of
Szeged, Szeged, Hungary
Abstract—Selected morphological, molecular and func-
tional aspects of various microglial cell populations were
characterized in cell cultures established from the fore-
brains of E18 rat embryos. The mixed primary cortical cul-
tures were maintained for up to 28 days using routine
culturing techniques when the microglial cells in the culture
were not stimulated or immunologically challenged. During
culturing, expansion of the microglial cell populations was
observed, as evidenced by quantitative assessment of
selected monocyte/macrophage/microglial cell-speciﬁc
markers (human leukocyte antigen (HLA) DP, DQ, DR,
CD11b/c and Iba1) via immunocyto- and histochemistry
and Western blot analysis. The Iba1 immunoreactivity in
Western blots steadily increased about 750-fold, and the
number of Iba1-immunoreactive cells rose at least 67-fold
between one day in vitro (DIV1) and DIV28. Morphometric
analysis on binary (digital) silhouettes of the microglia
revealed their evolving morphology during culturing.
Microglial cells were mainly ameboid in the early stages of
in vitro diﬀerentiation, while mixed populations of ameboid
and ramiﬁed cell morphologies were characteristic of older
cultures as the average transformation index (TI) increased
from 1.96 (DIV1) to 15.17 (DIV28). Multiple immunoﬂuores-
cence labeling of selected biomarkers revealed diﬀerent
microglial phenotypes during culturing. For example, while
HLA DP, DQ, DR immunoreactivity was present exclusively
in ameboid microglia (TI < 3) between DIV1 and DIV10,
CD11b/c- and Iba1-positive microglial cells were moderately
(TI < 13) and progressively (TI < 81) more ramiﬁed, respec-
tively, and always present throughout culturing. Regardless
of the age of the cultures, proliferating microglia were Ki67-
positive and characterized by low TI values (TI < 3). The
microglial function was assessed by an in vitro phagocyto-
sis assay. Unstimulated microglia with low TI values were
signiﬁcantly more active in phagocytosing ﬂuorescent
microspheres than the ramiﬁed forms. In vitro studies on
microglial population dynamics combined with phenotypic
characterization can be of importance when diﬀerent
in vivo pathophysiological situations are modeled in vitro.
 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
Key words: immunocytochemistry, microglia, phagocytosis,
primary culture, transformation index, Western blotting.
INTRODUCTION
Microglial cells, the resident immune cells of the central
nervous system (CNS), share a number of phenotypic
characteristics and lineage properties with other bone
marrow-derived myeloid cell populations, and are
regarded as members of the monocyte/macrophage
lineage (Gehrmann et al., 1995; Kreutzberg, 1996;
Geissmann et al., 2003, 2010; Ginhoux et al., 2010;
Prinz and Mildner, 2011; Prinz et al., 2011). Recent
in vivo lineage-tracing studies demonstrated that adult
microglial cells originate from primitive myeloid
progenitors that arise early in embryonic development,
and constitute an ontogenetically distinct population in
the mononuclear phagocyte system (Ginhoux et al.,
2010). Microglia are highly plastic and, by virtue of their
location and current role in the nervous tissue, are able
to undergo a variety of morphological and functional
changes in response to various stimuli. In their non-
activated or resting state, they display a ramiﬁed
morphology characterized by numerous, ﬁne-branched
processes with relatively small somata and subdued
macrophage-like functional properties. In response to
neural injury, infection and inﬂammatory or other
signals, however, microglial cells become activated and
undergo a series of morphological, molecular and
functional changes in proportion to the severity of the
damage to the neuronal tissue (Ling and Wong, 1993;
Kreutzberg, 1996). Shortly after their initial activation,
microglial cells become progressively less ramiﬁed and
quickly develop an enlarged cell body with several short,
thickened processes (activated microglia) that may
eventually completely retract (phagocytic microglia).
This morphological transformation parallels microglial
proliferation, homing and adhesion to damaged cells
(Raivich et al., 1999; Streit et al., 1999). The
development of the ameboid appearance and
phagocytic nature of the microglial cells coincides with
their antigen presentation ability and cytotoxic and
inﬂammation-mediating signalization (Ling and Wong,
1993; Kreutzberg, 1996; Town et al., 2005; Werry et al.,
2011).
As regards origin, there are two populations of
microglial cells in the CNS at any given time. The
0306-4522/13 $36.00  2013 IBRO. Published by Elsevier Ltd. All rights reserved.
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resident microglia comprise a distinct pool of cells that
respond to stimuli and proliferate accordingly, and
regulate their population dynamics in a manner
dependent on the severity of the tissue damage. They
are distributed more or less evenly throughout the
nervous tissue (Milligan et al., 1991a) and exhibit an
extremely slow turnover with the bone marrow or the
peripheral blood under normal conditions. The resting
microglia with ramiﬁed morphology lack the major
histocompatibility complex (MHC) class I/MHC class II
proteins, interferon-c, cytokines, CD45 antigens and
many other surface receptors required to serve in the
antigen-presenting, phagocytic and cytotoxic roles
characteristic of the normal macrophage functions.
Another population of cells, however, among which the
perivascular microglial cells are prominent in number, is
located in the close vicinity of blood vessels, and can be
replaced regularly by bone marrow-derived precursor
cells (Hickey and Kimura, 1988; Eglitis and Mezey,
1997) that express MHC class II antigens, indicating
their monocyte/macrophage origin (Streit et al., 1989;
Gehrmann et al., 1995). In cases of extreme damage to
the CNS, as in infection or stroke, the blood–brain
barrier may weaken considerably, and hematogenous,
bone marrow-derived cells, such as myeloid progenitor
cells and macrophages, may enter the brain (Priller
et al., 2001). Once the damage has abated, the
peripheral and central systems are disconnected for the
recovery and regrowth period (Gehrmann, 1996).
Although macrophages and microglia may have similar
roles, the populations of resident microglia and recently
migrated hematogenous myeloid progenitors/
macrophages diﬀer in many important respects
(Geissmann et al., 2003; Ladeby et al., 2005; Wirenfeldt
et al., 2007).
Similar to the extensive studies on the origin and the
morphological and functional development of the
microglial phenotype in vivo (Ling et al., 1990; Milligan
et al., 1991a,b; Ling and Wong, 1993; Dalmau et al.,
1997, 1998, 2003; Streit et al., 1999; Orłowski et al.,
2003; Geissmann et al., 2010), a large body of
information is available on the characteristics of the
diﬀerent microglial populations maintained in cell
cultures. However, as a variety of proinﬂammatory
factors are produced by activated microglial cells on the
one hand (see Kreutzberg, 1996, for references), and
activation of microglial cells by a number of agents has
been demonstrated on the other (Liu et al., 2000; Werry
et al., 2011; Berger et al., 2012), characterization of the
activated microglial cells in response to an in vitro
stimulation/challenge predominates in the literature.
Recent studies have demonstrated, for example, that
under speciﬁc polarization conditions microglial cells, in
a similar way to peripheral macrophages, develop into
diﬀerent inﬂammation-related phenotypes, termed M1
and M2 (Gordon, 2003; Mosser and Edwards, 2008).
Under physiological conditions, the vast majority of
the resident microglial cells in the CNS are certainly
unstimulated and characterized by ramiﬁed morphology.
Despite the recent in vivo experimental approaches that
unveiled new aspects of the functional, developmental
and lineage characteristics of the microglial cell
populations (Geissmann et al., 2003, 2010; Auﬀray
et al., 2009; Ginhoux et al., 2010; Durafourt et al., 2012;
Xu et al., 2012), only limited data are available on the
development of the microglial phenotype in vitro under
unstimulated/immunologically unchallenged conditions.
In an attempt to shed more light on the nature of the
unstimulated microglia in vitro, we set out to
characterize selected morphological, molecular and
functional aspects of such cells, partially by quantitative
techniques, in rat primary cortical cell cultures
maintained routinely up to DIV28, in order to monitor the
‘‘normal’’ development of their phenotype. We analyzed
the population dynamics of the microglial cells in terms
of their percentage of the total number of cells during
culturing, quantitatively characterized the diﬀerent
microglial populations according to their transformation
indices, and diﬀerentially localized some of the
canonical microglial markers to these distinct
morphologies. As far as we are aware, a similarly
detailed study for a period of up to 28 days on the
characteristics of the in vitro development of
unstimulated and unchallenged microglial cells of
embryonic origin has not been reported previously.
EXPERIMENTAL PROCEDURES
Animals
All animal experiments were carried out in strict compliance with
the European Council Directive (86/609/EEC) and EC regulations
(O.J. of EC No. L 358/1, 18/12/1986) regarding the care and use
of laboratory animals for experimental procedures, and followed
the relevant Hungarian and local legislation requirements. The
experimental protocols were approved by the Institutional
Animal Welfare Committee of the University of Szeged (I-74-II/
2009/MA´B). The pregnant Sprague–Dawley rats (170–190 g;
one animal per cage) were kept under standard housing
conditions and fed ad libitum.
Antibodies
The antibodies used in our immunohistochemical,
immunocytochemical and Western blot studies are listed in
Table 1. For a thorough characterization of diﬀerent microglial
phenotypes developed in vitro, antibodies against the ionized
calcium-binding adaptor molecule 1 (Iba1), the human
leukocyte antigen (HLA) class II genes HLA DP, DQ, DR and
cluster of diﬀerentiation 11b/c, the rat CR3 complement
receptor (CD11b/c) were used in our immunohistochemical and
Western blot analyses. The anti-Iba1 antibody recognizes the
Iba1 protein, an intracellular Ca2+-binding protein expressed in
the CNS speciﬁcally in macrophages and microglia (Imai et al.,
1996), and has been used to detect both resting and activated
microglial phenotypes (Ito et al., 1998). The HLA class II genes
are composed of three closely linked subregions encoding the
polymorphic HLA class II molecules HLA DP, DQ, DR. The
anti-HLA DP, DQ, DR antibody reacts with the a and b-chains
of all products of these subregions and recognizes numerous
antigen-presenting cells that express these molecules, including
the reactive and the resting microglia, the perivascular
microglial cells, many macrophages and most monocytes in the
CNS (Horejsı´ et al., 1986; Ulvestad et al., 1994b). The anti-
HLA DRa antibody recognizes the a subunit of the class II
MHC complex antigen HLA DR, a transmembrane glycoprotein
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constitutively expressed by microglia (Ulvestad et al., 1994a).
The anti-CD11b/c antibody recognizes a common epitope
shared between CD11b and CD11c (integrin aM and aX
chains), reacts with all monocytes and macrophages (Robinson
et al., 1986; Wang et al., 1996), and is commonly used as a
resident microglial marker in the CNS (Imai et al., 1996). The
anti-b tubulin III (Banerjee et al., 1990) antibody has been used
to detect neurons, the anti-glial ﬁbrillar acidic protein (GFAP)
antibody (Guillemin et al., 1997) to label astrocytes, and the
anti-20,30-cyclic nucleotide 30-phosphodiesterase (CNPase)
antibody (Zhang et al., 2010) to detect oligodendrocytes. The
anti-Ki67 antibody has been used to detect proliferating cells.
Ki67 is a nuclear protein expressed in all active phases of the
cell cycle from the late G1 phase through the end of the M
phase but is absent in non-proliferating and early G1 phase
cells (Starborg et al., 1996; Scott et al., 2004).
Various dilutions of primary and secondary antibodies,
incubation times and blocking conditions for each antibody
used were carefully tested for both immunohistochemistry/
immunocytochemistry and Western blot analysis. To detect the
speciﬁcities of the secondary antisera, omission control
experiments (staining without the primary antibody) were also
performed. In such cases, no ﬂuorescent or Western blot
signals were detected.
Paraﬃn embedding and sectioning
Forebrain samples of embryonic day 18 (E18) rats were carefully
removed, ﬁxed by immersion overnight at 4 C in 0.05 M
phosphate-buﬀered saline (PBS) containing 4% formaldehyde,
and then embedded in low-melting point paraﬃn. Coronal
sections (8 lm thick) were cut in a microtome and mounted on
slides coated with (3-aminopropyl)triethoxysilane (Menzel,
Darmstadt, Germany) to prevent detachment. After
deparaﬃnization and rehydration, the slides were placed in a
jar ﬁlled with 0.01 M citrate buﬀer (pH 6.0) and heated three
times for 3 min at 800 W in a microwave oven. The sections
were then processed for immunohistochemistry.
Cortical cell cultures
Mixed primary cortical cell cultures were established from E18
wild-type rat embryos by the use of general methods described
previously (Kortvely et al., 2003). Brieﬂy, 6–8 fetal rats under
ether anesthesia were surgically decapitated and the frontal
lobe of the cerebral cortex was removed, minced with scissors,
incubated for 10 min at 37 C in 9 ml of Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM; Invitrogen, Carlsbad, CA, USA;
containing 1 g/l D-glucose, 110 mg/l Na-pyruvate, 4 mM L-
glutamine, 3.7 g/l NaHCO3, 10,000 U/ml penicillin G, 10 mg/ml
streptomycin sulfate and 25 lg/ml amphotericin B)
supplemented with 0.25% trypsin (Invitrogen) and then
centrifuged at 1000g for 10 min at room temperature (RT). The
pellet was resuspended, washed twice in 5 ml of DMEM
containing 10% heat-inactivated fetal bovine serum (Invitrogen),
and centrifuged for 10 min at 1000g at RT. The ﬁnal pellet was
resuspended in 2 ml of the same solution as above, after which
the cells were seeded either in poly-L-lysine-coated coverslips
(15  15 mm; 200,000 cells/coverslip) or in poly-L-lysine-coated
Petri dishes (60 mm  15 mm; 1,000,000 cells/dish) and
cultured at 37 C in a humidiﬁed air atmosphere supplemented
with 5% CO2. All experiments were performed with cultures
aged 1–28 days (DIV1–DIV28), or occasionally with cultures
aged up to 2 months (data not shown). For culturing periods
longer than 3 days, the DMEM was changed every 3 days.
Apart from the microglial markers, several cell surface and
cytoplasmic neuronal, astrocytic and oligodendrocytic markers
Table 1. Antibodies used in immunohistochemistry, immunocytochemistry and Western blot analysis
Primary
antibody,
abbrev. name
Primary antibody, full
name
Final
dilution
Company Secondary antibody
with ﬂuorochrome,
full name
Company Final
dilution
Antibodies used in immunohistochemistry and immunocytochemistry
Iba1 Rabbit anti-Iba1 polycl.
ab.
1/300 Wako, Osaka, Japan Alexa Fluor 568 goat
anti-rabbit
Invitrogen, Carlsbad, CA,
USA
1/1000
CD11b/c (OX42) Mouse anti-CD11b/c
equivalent monocl. ab.,
clone OX42
1/200 Abcam, Cambridge,
England
Alexa Fluor 488 goat
anti-mouse or Alexa
Fluor 568 goat anti-
mouse
Invitrogen, Carlsbad, CA,
USA
1/1000
HLA DP, DQ,
DR
Mouse anti-HLA-DP, DQ,
DR, monocl. ab., clone
CR3/43
1/100 Dako, Glostrup,
Denmark
Alexa Fluor 488 goat
anti-mouse
Invitrogen, Carlsbad, CA,
USA
1/1000
HLA DRa Rabbit anti-HLA-DRa,
FL-254, polycl. ab., SC-
25614
1/50 Santa Cruz
Biotechnol., Inc.,
Santa Cruz, CA, USA
Alexa Fluor 488 goat
anti-rabbit
Invitrogen, Carlsbad, CA,
USA
1/1000
b Tubulin III Mouse anti-tubulin, b-III,
monocl. ab., clone TU-20
1/400 Abcam, Cambridge,
England
Alexa Fluor 488 goat
anti-mouse
Invitrogen, Carlsbad, CA,
USA
1/1000
Ki67 Rabbit anti-Ki67, monocl.
ab., clone SP6
1/200 Thermo Scientiﬁc,
Fremonz, CA, USA
Alexa Fluor 488 goat
anti-rabbit
Invitrogen, Carlsbad, CA,
USA
1/1000
Antibodies used in Western blot studies
Iba1 Rabbit anti-Iba1 polycl.
ab.
1/1000 Wako, Osaka, Japan Anti-rabbit IgG,
peroxidase conjug.
Sigma, St. Louis, MO,
USA
1/1000
b Tubulin III Mouse anti-tubulin, b-III,
monocl. ab., clone TU-20
1/1000 Abcam, Cambridge,
England
Anti-mouse IgG,
peroxidase conjug.
Sigma, St. Louis, MO,
USA
1/3000
GFAP Rabbit anti-GFAP polycl.
ab.
1/5000 Abcam, Cambridge,
England
Anti-rabbit IgG,
peroxidase conjug.
Sigma, St. Louis, MO,
USA
1/2000
CNPase Mouse anti-CNPase,
monocl. ab., clone 11–5B
1/500 Abcam, Cambridge,
England
Anti-mouse IgG,
peroxidase conjug.
Sigma, St. Louis, MO,
USA
1/3000
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were used to characterize the primary cultures. Cell proliferation
was assessed by the use of the antibody raised against Ki67.
In vitro phagocytosis assay
The ﬂuid-phase phagocytic capacity of the unstimulated
microglial cells was determined via the uptake of ﬂuorescent
microspheres (2 lm diameter; Sigma, St. Louis, MO, USA).
Cortical cells from E18 rats were plated on coverslips in 35-mm
Petri dishes at a density of 200,000 cells/coverslip in 2 ml of
DMEM containing 10% heat-inactivated fetal bovine serum as
above, and cultured for 14 days. At the end of the culturing
period, 1 ll of a 2.5% aqueous suspension of ﬂuorescent
microspheres per ml was added to the primary culture, which
was then incubated for 60 min at 37 C. The cells were next
washed ﬁve times with 2 ml of PBS to remove dish- or cell
surface-bound residual ﬂuorescent microspheres, and ﬁxed
with 4% formalin in PBS. For measurement of the phagocytotic
activity, cells labeled with phagocytosed microbead(s) were
counted. Twenty random ﬁelds with a total of 120 bead-labeled
cells were counted under a ﬂuorescent microscope with a 10
or 20 objective. The number of phagocytosed microbeads
(mean ± SD) was analyzed as a function of the transformation
index (TI). Statistically signiﬁcant diﬀerences were determined
by the Mann–Whitney Rank Sum test.
Immunohistochemistry and -cytochemistry
For immunohistochemistry, primary cortical cells cultured in vitro
on poly-L-lysine-coated coverslips for 1–28 days (DIV1–DIV28)
were used. At diﬀerent time intervals, the cultured cells on the
coverslips were ﬁxed in 4% formaldehyde in 0.05 M PBS (pH
7.4 at RT) for 5 min, and rinsed in 0.05 M PBS for 3  5 min.
After permeabilization and blocking of the nonspeciﬁc sites in
0.05 M PBS solution containing 5% normal goat serum
(Sigma), 1% heat-inactivated bovine serum albumin (Sigma)
and 0.05% Triton X-100 for 30 min at 37 C, the cells on the
coverslips were incubated overnight at 4 C with the
appropriate primary antibody (Table 1) in the above solution.
The cultured cells were washed for 4  10 min at RT in 0.05 M
PBS, and then incubated with the appropriate Alexa Fluor
ﬂuorochrome-conjugated secondary antibody (Table 1) in the
above solution, but without Triton X-100, in the dark for 3 h at
RT. The cells on the coverslip were washed for 4  10 min in
0.05 M PBS at RT, and the nuclei were stained in 0.05 M PBS
solution containing 1 mg/ml polyvinylpyrrolidone and 0.5 ll/ml
Hoechst 33258 dye (Sigma). The coverslips were rinsed in
distilled water for 5 min, air-dried and mounted on microscope
slides in a Vectashield mounting medium (Vector Laboratories,
Burlingame, CA, USA). Cells were viewed on a Nikon
Microphot-FXA epiﬂuorescent microscope (Nikon Corp., Tokyo,
Japan) and photographed with a Spot RT Color CCD camera
(SPOT RT/ke, Diagnostic Instruments, Inc., Sterling Heights,
MI, USA).
Western blot analysis
For Western blotting, the protocols were optimized for each
antibody as regards epitope accessibility, polyacrylamide gel
separation, antibody dilution and chemiluminescence signal
intensity. Cultured primary cells (DIV1–DIV28) were collected
through the use of a rubber policeman, homogenized in 50 mM
Tris–HCl (pH 7.5) containing 150 mM NaCl, 0.1% Nonidet P40,
0.1% cholic acid, 2 lg/ml leupeptin, 1 lg/ml pepstatin, 2 mM
phenylmethylsulfonyl ﬂuoride and 2 mM EDTA, and centrifuged
at 10,000g for 10 min. The pellet was discarded and the protein
concentration of the supernatant was determined (Lowry et al.,
1951). For the Western blot analyses of microglial, neuronal,
astrocyte or oligodendrocyte immunoreactivities, 5–10 lg of
protein was separated on a sodium dodecyl sulfate (SDS)–
polyacrylamide gel (4–10% stacking gel/resolving gel),
transferred onto Hybond-ECL nitrocellulose membrane
(Amersham Biosciences, Little Chalfont, Buckinghamshire,
England), blocked for 1 h in 5% nonfat dry milk in Tris-buﬀered
saline (TBS) containing 0.1% Tween 20, and incubated for 1 h
with the appropriate primary antibodies. After ﬁve washes in
0.1% TBS–Tween 20, the membranes were incubated for 1 h
with the appropriate peroxidase-conjugated secondary
antibodies (Table 1), and washed ﬁve times as before. The
enhanced chemiluminescence method (ECL Plus Western
blotting detection reagents; Amersham Biosciences) was used
to reveal immunoreactive bands according to the
manufacturer’s protocol.
Digital image processing and image analysis
Gray-scale digital images of the immunoblots were acquired by
scanning the autoradiographic ﬁlms with a desktop scanner
(Umax PowerLook III; Umax Data Systems, Inc., Taipei,
Taiwan). The images were scanned and processed at identical
settings in order to allow comparison between the Western
blots from diﬀerent samples. Digital images were acquired with
a Nikon Microphot-FXA epiﬂuorescent microscope (Nikon
Corp., Tokyo, Japan), using a Spot RT Color CCD camera and
Spot RT software (Spot RT/ke Diagnostic Instruments, Sterling
Heights, MI, USA). Color correction and cropping of the digital
images were occasionally performed when photomicrographs
were made for publication (Adobe Photoshop; Adobe Systems,
Inc., San Jose, CA, USA).
Microglial cells and cell nuclei in the cultures were counted
with the use of the plugins developed for the computer program
ImageJ (version 1.38; developed by W. Rasband at the U.S.
National Institutes of Health, and available from the Internet at
http://rsb.info.nih.gov/ij). Cell nuclei were counted with the use
of the ‘‘Nucleus Counter’’ plugin (Image Processing and
Analysis in Java, a collection of plugins and macros) installed
under ImageJ (www.macbiophotonics.ca). Brieﬂy, digital
images in tagged image ﬁle formats (.tif) were opened in
ImageJ, and Plugins? Particle Analysis? Nucleus Counter
menus were then selected and customized as follows: the
smallest and largest particle sizes were set to 50 and 10,000,
respectively. ‘‘Otsu’’ was selected for automatic thresholding,
and ‘‘mean 3  3’’ was chosen for the performance of smooth
ﬁltering (Sezgin and Sankur, 2004). After background
subtraction, overlapping objects in the resulting binary images
were separated, via the menu command ‘‘Process/Binary/
Watershed’’ (see Abra`moﬀ et al., 2004, for details, and the
documentation web pages for ImageJ at http://rsb.info.nih.gov/
ij/docs/index.html). For the counting of microglial cells
expressing immunopositivity for the Iba1 antigen, the ‘‘Cell
Counter’’ plugin was used (ImageJ for Microscopy). After the
appropriate images (.tif) had been opened, Plugins? Particle
Analysis? Cell Counter menus were selected, and the output
was copied to a Microsoft Excel spreadsheet (Microsoft Corp.,
Redmond, WA, USA) for statistical analysis.
Microglial cell silhouettes were acquired by transforming the
raw digital ﬁles of Iba1-immunoreactive cells recorded under
ﬂuorescent microscope light to binary ﬁles by means of the
ImageJ software. The color cell images were transformed into
their binary replicas (silhouettes) by using automatic
thresholding procedures. After the values of cell perimeter (lm)
and cell area (lm2) had been determined in at least three
separate experiments (at least two coverslips in each
experiment for each culturing time investigated; around 20
randomly selected cells/coverslip), the TI reﬂecting the degree
of process extension was calculated through the expression
[perimeter of cell (lm)]2/4p [cell area (lm2)] as previously
described (Fujita et al., 1996). A total of 398 cell silhouettes
were analyzed in this study.
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Statistical analysis
For Western blots, values are presented as means ± SD from at
least three blots for each of the three independent experiments
for each time period examined. For the counting of microglial cells
and cell nuclei, at least 10 randomly sampled microscope ﬁelds
from 2 to 3 coverslips for each culturing time period from each of
the three separate cell-culturing experiments were counted. In the
computation of semiquantitative cell silhouette characteristics
(digital binary pictures), data on 20 cells per coverslip from at
least three separate experiments for each culturing time were
used. Values are presented as means ± SD. Statistical analyses
were carried out with the Mann–Whitney Rank Sum test
(SigmaStat 3.11; Systat Software Inc., Chicago, IL, USA).
RESULTS
Microglial cells collected from the forebrains of E18
rats are mainly ameboid
The microglial cells were collected from E18 rat forebrains
and maintained in mixed primary neuronal-glial co-
cultures. Light microscopic ﬂuorescent
immunohistochemistry revealed (Fig. 1) that on E18 the
Iba1-labeled microglial cells in the forebrain cortical
tissue appeared to be mainly ameboid (arrowheads),
though more diﬀerentiated forms were also present in
smaller numbers. Most of the microglial cells were
rounded or slightly ovoid and lacked branching
processes; however, rod-like (double-arrowhead) or
slightly ramiﬁed microglial cells (arrrow) were
occasionally also seen in the embryonic rat forebrain.
Microglial cells proliferate during in vitro culturing of
primary forebrain cells
As concerns the cell number and the presence of
numerous microglia-speciﬁc antigens, ﬂuorescent
immunocytochemistry (Fig. 2) and Western analysis
(Fig. 3) demonstrated a massive in vitro expansion of
the microglial cell type between DIV1 and DIV28. The
total numbers of cells at the beginning and at the end of
the culturing period did not diﬀer signiﬁcantly. While the
total number of cells exhibited a minimum on DIV10, the
number of microglia constantly increased from
immediately after seeding throughout the entire culturing
period. The microglia were situated in a scattered
manner in younger cultures (before and around DIV14;
Fig. 2A–E), but when they increased in abundance as
the cultures grew older, they became more clumped and
grouped together around other cells, as seen between
DIV21 and DIV28 (Fig. 2F, G). Typical relative
distributions of neuronal and microglial cells during
culturing may be seen in Fig. 2H–J. The microglial cell
content originally amounted to less than 0.5% of the
total cell number at the time of seeding, but steadily
rose during culturing. On DIV4 and DIV7, progressively
more microglial cells appeared, accounting for 2% and
8% of the total cell number, respectively (Fig. 3A). On
DIV10, the overall morphological diversity of the
microglial cells in the culture was similar to that on
DIV7; at this time, the cultures contained barely 50% of
the total cell number seen on DIV1, and the microglial
cells comprised around 18% of the total cell population
(see Fig. 2D for comparison). From this time onward,
most of the gains in the number of total cell counts
could be attributed to microglial cell proliferation
(Fig. 3A). On DIV14, as the majority of the microglia
had started to diﬀerentiate toward the ramiﬁed form,
approximately 20% of all the cells were microglia. The
proportion of microglial cells reached 33.7% by DIV28
(Fig. 3A, see Fig. 2G also for comparison). This
massive, roughly 67-fold multiplication of the microglial
cell type was also demonstrated by Western blot
analysis (Fig. 3B, C). The Iba1 immunoreactivities
detected in the blots steadily increased some 750-fold
between DIV1 and DIV28. The b tubulin III, GFAP and
CNPase immunoreactivities, quantiﬁed by Western blot
analyses, demonstrated the evolution of other cellular
components during culturing (Fig. 3B, C): while the
amount of the neuronal marker b tubulin III steadily
decreased, the immunoreactivity of the oligodendrocyte
marker CNPase constantly rose between DIV1 and
DIV28. A decrease in GFAP immunoreactivity at DIV28
was also observed in the cultures (Fig. 3C).
Mixed microglial populations exist in primary
forebrain cultures
Diverse morphological forms of microglial cells developed
and were present throughout the culturing (Fig. 4). At one
end of the morphological spectrum, on DIV1, the
microglial cells were virtually exclusively ameboid,
frequently with smooth-surfaced spherical cell bodies,
although ovoid or fusiform cells with a few microspikes
could also be seen (Fig. 4A–D). As the cultures grew
older (DIV7–DIV10), the microglia became more
ramiﬁed. They acquired larger somata bearing typically
one or two, but rarely more, large processes (Fig. 4E–
H). One large, stubby lamellipoda usually formed ﬁrst,
Fig. 1. Microglia in the E18 embryonic rat forebrain. The immuno-
ﬂuorescent detection of microglial cells (red) in 8-lm-thick paraﬃn-
embedded coronal sections of E18 rat forebrains was achieved
through the use of anti-Iba1 antibody. Most Iba1-labeled cells
displayed ameboid morphology with ovoid (arrowhead) or slightly
rod-shaped forms (double-arrowhead), but occasionally more rami-
ﬁed microglia could also be seen (arrow). Cell nuclei were labeled
blue with Hoechst 33258. CxP: cortical plate; CxS: cortical subplate;
ICx: intermediate cortical layer; S: subiculum. Scale bar = 100 lm.
(For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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but by DIV10 further processes, or the more ramiﬁed
morphology of a single large lamellipoda could be
observed (Fig. 4G, H). After DIV10, the microglial cells
became more heterogeneous, as a constantly
increasing microglia population characterized by
relatively even cellular processes and enlarging somata
accompanied the ameboid form (Fig. 4I–K, M).
Microglial process formation became widespread by
DIV14. Incidentally, this was the ﬁrst time at which the
ramiﬁed microglia (demonstrating morphology similar to
that of the resting microglia in the adult rodent CNS)
predominated in the cultures (Fig. 4I, J). The Iba1-
positive microglial cells were characterized
morphologically by larger somata with a few long,
relatively thin and sparsely ramiﬁed processes. As the
cultures grew older, on both DIV21 and DIV28, the
characteristic microglial morphology was a ramiﬁed form
with several axes of symmetry along the processes
(Fig. 4K, M), albeit ameboid cells were also present
(Fig. 4L, N). The typical microglial morphology during
the later stages of in vitro culturing also included cells
with elongated, slightly curved somata emanating a few
processes of mixed lengths. It must be noted that
islands of densely grown ameboid microglial cells were
persistently present throughout culturing.
Cultured microglia populations can be evaluated by
their TI values
The time course of the morphological changes in the
microglia was analyzed on binary silhouettes, as
depicted in Fig. 5. Quantitative analysis based on the TI
value, a dimensionless number that is an indicator for
the identiﬁcation of the degree of morphological
diﬀerentiation (e.g. the degree of process extension) of
a cell, revealed a continuum of the microglial phenotype
between the ameboid and the extremely ramiﬁed
morphologies of the microglia. Throughout the
experiments, microglial cells with TI < 3 were
considered ameboid (Fig. 6A–G; circles). While younger
cultures displayed predominantly ameboid cell forms
with a regular, round outline reﬂecting the expanding
microglia population (Figs. 5 and 6A–D), older cultures
presented a more heterogeneous morphological
repertoire, concurrently involving cells with ameboid
(proliferating) and ramiﬁed (resting) forms, the majority
being ramiﬁed (Figs. 5 and 6E–G). The ramiﬁed, resting
microglia that developed later during the culturing could
be characterized by a TI value as high as 81 (Fig. 6H).
The ameboid, proliferating microglial cells, predominant
in the early stages but always present throughout
Fig. 2. Development of Iba1 immunoreactivity in primary cortical cultures (DIV1–DIV28). (A–G) The number and composition of the cultured cells
are tightly controlled. While the total number of cells remains constant, the microglia proliferate during culturing. The microglial cells (red) were ﬁrst
labeled with the rabbit anti-Iba1 primary (polyclonal) antibody, and then with an appropriate Alexa Fluor ﬂuorochrome-conjugated secondary (Alexa
Fluor 568 goat anti-rabbit) antibody, while the cell nuclei (blue) were labeled with Hoechst 33258. Culturing times are indicated at the upper right
corners of the pictures. Scale bar in A for A–G= 50 lm. (H–J) Microglial cells in characteristic cellular environments. For the detection of microglial
cells and neurons, anti-Iba1 (red) and anti-b tubulin III (green) antibodies, respectively, were used. The cell nuclei (blue) were labeled with Hoechst
33258. (H) On day 1, the Iba1-positive microglial cells (red) were mostly ameboid around the developing b tubulin III-positive neurons (green). (I) On
day 7, some of the microglial cells (red) had become ramiﬁed around a group of b tubulin III-immunopositive developing neurons (green). (J) On day
21, the culture was characterized by a heterogeneous, albeit mostly ramiﬁed population of microglia (red), located around the occasional b tubulin
III-positive neurons (green) and many non-neuronal/non-microglial cells indicated by the blue nuclei. Scale bar in H for H–J = 50 lm. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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culturing, had TI values of less than 3, independently of
the age of the culture (Fig. 6H; below dashed line), and
were always Ki67-positive (Fig. 7). The Ki67
immunoreactivity observed in the ameboid microglial
nuclei usually exhibited a distinct dotlike pattern
representative of the S/G2 phase (Fig. 7A–D) unless it
was associated with the periphery of the condensed
chromosomes of the M-phase (Fig. 7E–H).
Phagocytosis is predominant in ameboid microglia in
culture
Ameboid and ramiﬁed microglial cell populations in
culture could be diﬀerentiated through their ability to
phagocytose (Fig. 8). Unstimulated microglia readily
phagocytosed ﬂuorescent microbeads. On DIV14, when
mixed populations of ameboid and ramiﬁed microglia
were present in the cultures in about equal numbers,
microbeads were signiﬁcantly more preferred by the
ameboid forms (characterized by low TI values;
Fig. 8A), while the ramiﬁed microglia (with higher TI
values; Fig. 8B) were less active in phagocytosing
microbeads. On average, microglia with TI < 3
phagocytosed 11.08 ± 8.6 beads per cell
(average ± SD, n= 39), while microglia with TI > 3
engulfed 3.16 ± 3.6 beads per cell (n= 81); the
diﬀerence was statistically signiﬁcant (p< 0.001; Mann–
Whitney Rank Sum test). When the number of
phagocytosed microbeads per microglia was plotted as
a function of TI under unstimulated/unchallenged
conditions, the physiologically distinct populations of
ameboid and ramiﬁed microglia could be readily
demonstrated (Fig. 8C).
Immunocytochemistry reveals microglial populations
displaying changing molecular phenotypes during
culturing
Double immunoﬂuorescent microscopy revealed that
Iba1-labeled microglial cells occasionally also expressed
Fig. 3. Quantitative analysis of the cellular composition, the protein content and the amount of selected biomarkers during culturing. (A) The
numbers of cell nuclei (striped bars) and Iba1-positive (microglial) cells (solid bars) and the protein content (solid line) were quantitative analyzed in
primary cortical cultures (DIV1–DIV28). The methods of counting cell nuclei and anti-Iba1-immunolabeled cells are described in the Experimental
procedures section. Error bars indicate means ± SD. (B) Representative Western blot pictures of Iba1, b tubulin III, GFAP and CNPase
immunoreactivities in primary cortical cultures (DIV1–DIV28). (C) Quantitative Western blot analysis of Iba1, b tubulin III, GFAP and CNPase
immunoreactivities in cell cultures between DIV1 and DIV28. Iba1: ionized calcium-binding adaptor molecule 1, b tub: b tubulin III, GFAP: glial
ﬁbrillar acidic protein, CNPase: 20,30-cyclic nucleotide 30-phosphodiesterase. Error bars indicate means ± SD.
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the HLA DP, DQ, DR antigens, exclusively in young
cultures (Fig. 9A, B). HLA DP, DQ, DR-positive Iba1-
expressing microglial cells were always ameboid, with
TI < 3 (Fig. 9A, B). They were sporadically present
from seeding up to DIV10, but disappeared completely
from the cultures thereafter. Cultures older than DIV10
did not express this antigen, even when they had an
ameboid shape and proliferated, indicating that the HLA
antigen expression can be uncoupled from the ameboid
morphology. Microglial cells with typical ameboid
morphology and doubly immunopositive for the CD11b/c
and HLA DRa antigens were also found in young
cultures (Fig. 9C, D). The last day on which these
markers were colocalized was DIV10. CD11b/c-positive
microglia in cultures older than DIV10 were no longer
able to express any of these HLA antigens. CD11b/c-
positive microglial cells, however, were present
throughout culturing (Fig. 9C–F). CD11b/c could be
colocalized with the Iba1 antigen in both young and old
cultures, but only in cells with ameboid (i.e. activated,
proliferating) or slightly ramiﬁed forms with TI < 13
(Fig. 9E). The Iba1-immunopositive cells predominated
throughout culturing, their morphology ranging from
ameboid (Fig. 9A, B) to the ramiﬁed forms (Fig. 9E).
Morphologically, Iba1-positive microglia were the most
heterogeneous with TI values from the whole spectrum
during the culturing.
The relationship between TI values and myeloid/
microglial cell-speciﬁc markers in cultured microglial
cells is shown in Fig. 9G. We observed that microglial
cells either lose some of their macrophage
characteristics (e.g. HLA DP, DQ, DR or HLA DRa
antigens) during culturing or restrict them to their less
diﬀerentiated forms (e.g. CD11b/c), even though they
retain this latter phenotype for subsequent generations.
During culturing, only the less diﬀerentiated, ameboid
microglial cells (TI < 3) expressed HLA DP, DQ, DR (or
HLA DRa) antigens; these cells will either die out or
diﬀerentiate to more ramiﬁed morphologies with TI > 3.
CD11b/c-positive cells can be observed throughout
culturing, but they never become fully ramiﬁed, and their
TI values are always < 13.
DISCUSSION
Ramiﬁed microglial cells, the most common form of
microglial cells in the normal adult brain, are derived
from macrophage-like cells of mesodermal origin (Ling
and Wong, 1993; Gehrmann et al., 1995; Dalmau et al.,
1997). Many lines of evidence have recently
demonstrated that these ‘‘true’’ resident microglial cells
can be distinguished from other myeloid monocytic cells
in the CNS from the aspects of their location, origin,
speciﬁc cell surface antigens, other biochemical
markers, their functions and their turnover with the
periphery. Adult resting microglia with ramiﬁed forms
reside in the parenchyma of the CNS, their position
often being juxtavascular (Davalos et al., 2005; Ginhoux
Fig. 4. Development of the morphology of the microglial cells in the primary forebrain cultures (DIV1–DIV28). The microglial cells (red) were ﬁrst
labeled with the anti-Iba1 primary antibody, and then with the Alexa Fluor 568 ﬂuorochrome-conjugated goat anti-rabbit secondary antibody, while
the cell nuclei (blue) were stained with Hoechst 33258. On day 1 (A, B), all the microglial cells had an ameboid appearance, with round or slightly
ovoid cell forms. Very few, if any, microspikes or lamellipodae could be seen (B). On day 4 (C, D), some of the microglial cells had become more
asymmetric or rod-shaped, and some of these cells possessed more pronounced lamellipodae (C). At later stages, from day 7 (E, F), the microglia
became more ramiﬁed. Usually only a few, heavier branches appeared at this stage of microglial diﬀerentiation (F). From this stage on, the cultures
were characterized by two distinctly polarized populations, representing the two extremes of the morphological continuum displayed by the
microglial cells in the cultures, i.e. the ameboid and the ramiﬁed microglial cells. From day 14 (I, J), the microglia became truly ramiﬁed as they
usually had 3–4 strongly developed branches, but 6–7 equally strong and long branches could sometimes be seen from day 21 (K, M). At these
times, ameboid cell forms were also still quite frequent (L, N). Scale bar in A (for all pictures) = 10 lm. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 5. Morphological heterogeneity of microglial cells after diﬀerent culturing times. The Iba1-positive microglial cells were photographed, digitized
and quantitatively analyzed according to their morphological characteristics. Area (A), perimeter (P) and transformation index (TI) are indicated for
each digitized cell. Ten representative cells are shown at each culturing time. While younger cultures exhibited predominantly ameboid cell forms
with TI < 3, older cultures were morphologically heterogeneous, as they developed a continuum of populations with two distinct microglial cell
populations at the extrema: the ameboid cell population (TI < 3) and the ramiﬁed cell population (TI > 3). Younger cultures exhibited predominantly
ameboid cell forms, while older cultures displayed more ramiﬁed forms, but also proliferating ameboid populations (see the few ameboid microglia
among the mainly heterogeneous microglial cells at DIV28.
3
Fig. 6. Evolution of morphometric parameters of the microglial cells during culturing. (A–G) Relationship between the perimeter of the microglial cell
and its cell surface area. Cell area and perimeter values were measured by using the computer program ImageJ, and TI values were calculated as
[perimeter of cell (lm)]2/4p [cell area (lm2)]. Each dot represents a digitized microglial cell. Some of the dots overlap at this resolution. The less
diﬀerentiated microglial cell populations (TI < 3) are marked with circles. Dots within the circles almost always indicate a cell with TI < 3 and a cell
surface area < 500 lm2. (H) Distribution of TI values as a function of the culturing time. Microglial cells with TI < 3 are located below the dashed
line. As may be seen here, there are microglial cells with extremely high TI values on DIV21 and DIV28.
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et al., 2010). They express a deﬁned set of markers
diﬀerently from other myeloid cell populations of the
CNS (including, for example, CD11b, F4/80, the
chemokine receptor CX3CR1 and Iba1), and function as
local immune surveyors and scavengers of cell debris;
the true, resident microglia population does not
participate in exchange with the circulation (Prinz et al.,
2011). Myeloid cell populations of the CNS with speciﬁc
patroling functions include the perivascular, the
meningeal and the choroid plexus macrophages, which
possess slightly diﬀerent sets of markers, but always
take part in extensive exchange with the myeloid cells of
the circulation (Bechmann et al., 2001a,b; Vallie`res and
Sawchenko, 2003; Kim et al., 2006; Hawkes and
McLaurin, 2009; Chinnery et al., 2010) and the vessel-
patroling resident monocytes and inﬂammatory
monocytes that originate from and display a high
turnover with the bone marrow (Geissmann et al., 2003;
Auﬀray et al., 2009).
Discrimination between the diﬀerent myeloid
monocytic cell forms with uniquely important in vivo
functions was beyond the scope of this study when cells
were collected for the primary culture. Previous studies
on the preparation of tissue slices (Hailer et al., 1996,
1997; Stence et al., 2001) and primary cultures (Floden
and Combs, 2006) indicated that physical damage to
cells during tissue handling and cell harvesting (tissue
removal from the embryo, sectioning, cell isolation
procedure, etc.) can alter the microglial morphology,
marker expression and function, and the resulting
molecular characteristics seen in vitro may not
necessarily reﬂect the in vivo phenotype. It is possible,
therefore, that the cells we harvested from E18 rat
forebrains and later identiﬁed as Iba1-positive included
many of the myeloid monocytic cell populations
described above, but the prolonged culturing led to the
development of molecular and functional phenotypes
quite diﬀerent from those seen in vivo, and perhaps
even sparser, less diﬀerentiated myeloid-derived cell
populations when cultured.
Earlier attempts to characterize microglial cells in vitro
frequently employed culturing times of less than a week
(Becher and Antel, 1996; Tanaka et al., 1998; Otani
et al., 2011), when changes in microglial population
dynamics were not always apparent. Microglia cultured
from the embryonic or from the adult brain were also
found to diﬀer in many important ways. Microglia
prepared from the adult rat brain became progressively
de-diﬀerentiated and acquired a phenotype reminiscent
of that of activated microglia in vivo over a period of
7 days in culture (Slepko and Levi, 1996). The
diﬀerences between microglia acutely isolated from the
CNS and cultured microglia derived from mixed glial
cultures were most clearly seen in their diﬀerential
proliferative capacity and cytokine responsiveness (Frei
et al., 1994; Ford et al., 1995). Unlike microglia from
cultures, microglial cells from adults were not stimulated
by transforming growth factor (Rozovsky et al., 1998),
nor did they proliferate in response to granulocyte- or
macrophage colony-stimulating factor (Ford et al.,
1995). While the concept of M1/M2 macrophage
heterogeneity has gained momentum in recent years,
there is considerable uncertainty as to the extent to
which this notion could be extrapolated to microglial
cells. For example, in a recent study, Durafourt et al.
(2012) found that M1 and M2 subtypes of macrophages
and those of the microglial cells not only diﬀerentially
expressed a number of genes, but phagocytosed myelin
Fig. 7. Relationship between proliferation, ameboid morphology and Ki67 immunoreactivity. Representative immunocyochemical pictures of Ki67-
positive ameboid microglial cells in DIV7 cultures. Fluorescent microphotographs of the cultures were taken through the red (A, E), green (B, F) and
blue (C, G) channels and displayed in this sequence. CD11b/c-positive microglia (A, E), Ki67-positive cells (B, F) and Hoechst 33258-labeled cell
nuclei (C, G) are depicted. The merged pictures of CD11b/c- and Ki67-immunolabeled microglial cells are also shown (D, H). The presence of some
non-microglial and non-dividing cells is indicated by the Hoechst 33258 stain at the upper right corner of the pictures. A group of CD11b/c-positive
microglial cells is located at the bottom left corner of the pictures. Proliferating CD11b/c-positive microglial cells are located in the middle of the
pictures. Arrow points to the condensed chromatin in an M phase microglia (G). Scales for all pictures: 50 lm. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
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quite diﬀerently, indicating that the expression of similar
biomarkers by macrophages and microglia does not
necessarily mean that they have the same function.
Our results showed that microglia prepared from
embryonic tissue and maintained for up to 4 weeks
displayed multiple phenotypes with diﬀerent
immunologic, proliferative and phagocytic
characteristics. While the number of total cells did not
vary signiﬁcantly during culturing, their composition
exhibited a dramatic change. The number of microglial
cells rose steadily during culturing, by a factor of 67-
fold. The selected microglial antigenic and functional
(proliferation and phagocytosis) properties in primary
mixed cultures of E18 rat forebrain tissues revealed a
marked morphological and antigenic diﬀerentiation
during culturing.
Morphometric analysis on binary silhouettes of
microglial cells revealed that ameboid forms were
dominant in the early stages of in vitro diﬀerentiation,
while older cultures were characterized by mixed
populations of ameboid and ramiﬁed cells, the latter
being the dominant form. The ameboid microglia,
characterized by TI < 3, was the mitotically active,
Ki67-immunopositive population even in older cultures
where it formed a core of proliferating cells. The
feasibility of a quantitative assessment of diﬀerent
microglial populations (resting vs. activated microglia)
through morphological features alone was recently
demonstrated (Kozlowski and Weimer, 2012); the
sensitivity of this automated method was reported to be
comparable to that of immunohistochemical methods.
While the morphology of the cultured microglial cells
was very similar to that in the normal rat brain, their
antigenic markers speciﬁc for the monocyte/
macrophage/microglial cell line were distinctly diﬀerent
and exhibited a more restricted immunological
phenotypic repertoire from those seen in vivo. We found
that microglial cell populations in culture, without the
Fig. 8. Phagocytic activity of unstimulated microglial cells in a primary culture (DIV14). (A, B) Representative immunocytochemical pictures
showing the unstimulated phagocytic capability of microglial cells (red) as a function of the TI value from the same 14-day-old culture. Fluorescent
dye-coated (green) latex microbeads (d= 2 lm) were added to the medium and phagocytosed by microglia. Microglial cells with TI < 3 (A), i.e.
ameboid forms with 11.08 ± 8.6 beads per cell, were about 3.5-times more likely to phagocytose the microbeads than cells with TI > 3 (B), i.e.
ramiﬁed forms with 3.16 ± 3.6 beads per cell. Non-phagocytosed microbeads were very rare in the cultures (a solitary bead can be seen in both A
and B). Scale bar = 50 lm. (C) Distribution of unstimulated microglial cells with phagocytosed microbeads as a function of the TI value. The vertical
dashed line separates the functionally diﬀerent microglial populations (TI < 3 as ameboid, phagocytosing and proliferating, and TI > 3 as ramiﬁed,
resting microglia). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
M. Szabo, K. Gulya /Neuroscience 241 (2013) 280–295 291
Author's personal copy
presence of recruited hematogenous macrophages from
the periphery through the blood–brain barrier, were
more similar to those in the normal adult (or
physiologically aging) brain (e.g. showing no signs of
signiﬁcant neurodegeneration and therefore almost no
turnover for the microglial cells with the periphery) than
to those in the neuropathologic brain (e.g. in Alzheimer’s
disease). The large ﬂux of HLA DP, DQ, DR-positive
macrophages that entered the E18 brain through the
blood–brain barrier soon died or diﬀerentiated further in
the culture. As a consequence, cultured microglial cells
that were doubly positive for Iba1 and HLA DP, DQ, DR
antigens were absent from cultures older than DIV10.
This is in contrast with earlier reports of an upregulation
of HLA class II proteins upon phagocytosis (Becher and
Antel, 1996; Beyer et al., 2000; Smith, 2001), a function
displayed by ameboid microglial cells throughout the
entire culturing, although they were negative for the HLA
DP, DQ, DR antigens after DIV10.
The loss of a large number of cells, which peaked on
DIV10, concomitantly with the formation of neuronal
clumps in the culture, could be coupled causatively to
microglial activation and proliferation in two ways: either
the massive neuronal death triggered microglia
Fig. 9. Colocalizations of speciﬁc microglial markers during culturing. Representative ﬂuorescent microphotographs of double-immunopositive
microglial cells of the cultures were taken through the red, green and blue channels. Cell nuclei (blue) were stained with Hoechst 33258. The red and
green channels, together with the Hoechst-stained nuclei are displayed as their merged pictures. Culturing times are indicated at the upper right
corners for each triad. (A, B) Double-immunopositive microglial cells for the coexpression of Iba1 and HLA DP, DQ, DR antigens at DIV1 (A) and
DIV4 (B). These antigens are colocalized only in microglial cells of young cultures (up to DIV10), but solely in those that are truly ameboid or have
low TI values. (C, D) Double-immunopositive microglial cells for the coexpression of CD11b/c and HLA DRa antigens at DIV4 (C) and DIV10 (D).
These antigens are colocalized exclusively in the young cultures and only in microglia with typical ameboid morphology. The CD11b/c-positive
microglia are no longer able to express HLA antigens in older cultures. (E, F) Double-immunopositive microglial cells for the coexpression of CD11b/
c and Iba1 antigens at DIV7 (E) and DIV28 (F). These antigens are colocalized only in ameboid, proliferating cells with low TI values in both young
and old cultures. Iba1-immunopositive microglial cell were morphologically heterogenous as both ameboid and ramiﬁed forms were labeled
throughout culturing. Scale bar for all ﬂuorescent microscopic pictures: 50 lm. (G) Relationship between TI values and microglia-speciﬁc markers.
During culturing, only the less diﬀerentiated, ameboid microglia (TI < 3) express HLA antigens; these cells will eventually die out or diﬀerentiate to
more ramiﬁed morphologies (TI > 3) that do not express HLA antigens. CD11b/c-positive cells can be observed throughout culturing, but they never
become fully ramiﬁed (TI < 13). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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proliferation or, conversely, the proliferating microglial
cells adversely inﬂuenced and eventually killed some
other cells in the culture. This neuronal loss, mostly
prominent around DIV10, was documented by Western
analysis and was accompanied by an increase in the
phagocytic activity of these cells. Interestingly, microglia
proliferation could also be linked to the observed
increase in CNPase activity during culturing. Similar
phenomenon was observed in neonatal mouse brain
cultures (Amur-Umarjee et al., 1990). Such microglia–
oligodendrocyte interactions could be due to factors
secreted by activated microglia that promote
oligodendrocyte proliferation and diﬀerentiation
(Deierborg et al., 2010).
One of the main roles of microglia is phagocytosis, a
process that is critical for the uptake and degradation of
infectious agents and senescent cells, and which
contributes to the immune response and inﬂammation
(Aderem and Underhill, 1999; Marı´n-Teva et al., 2004).
As reviewed by Neumann et al. (2009), the recent
evidence suggests that the phagocytic clearance by the
microglia plays a fundamental role in facilitating the
reorganization of neuronal circuits and triggering repair
mechanisms. For example, there are substantial
diﬀerences in microglial phagocytosis during the
restructuring of neuronal connections (Marı´n-Teva et al.,
2004), in acute CNS injury (Cullheim and Thams, 2007),
in multiple sclerosis (Takahashi et al., 2007), in normal
development and ageing (Streit, 2006) or in Alzheimer’s
disease (Meyer-Luehmann et al., 2008), and the
insuﬃcient level of clearance seen in certain
neurodegenerative diseases might be associated with
an inadequate regenerative response such as that in
Alzheimer’s disease.
We used unstimulated microglial cells to measure
phagocytic activity for two reasons: (1) certain
immunomodulatory functions could be reduced in
stimulated microglia (Magnus et al., 2004), and (2) there
could be a diﬀerential expression of a number of
microglial enzymes and markers upon stimulation
(Imamura et al., 1991). Both such eﬀects could lead to
the ameboid microglial phenotype being favored, which
could interfere with our statistical analysis. The fact that
unstimulated ramiﬁed microglia do not proliferate
(Imamura et al., 1991) ruled out the possibility that the
conversion to the ameboid form would be induced,
thereby biasing the actual composition of the microglial
pool. We found that unstimulated microglial
phagocytosis was tightly coupled to the ameboid
morphology, as cells with low TI values exhibited much
higher phagocytic activity. The ameboid morphology
was also related to the proliferation of the microglial
cells, as low TI values were always present in the
cultures.
As microglial cells participate in both protective and
pathogenic mechanisms in the healthy and in the
diseased CNS, further correlative morphological,
molecular and functional characterizations of cultured
rat microglial cell populations similar to that presented
here could provide further information concerning the
speciﬁc roles of the diﬀerent microglia cells in the
physiology and the pathophysiology of the CNS. In vitro
phenotyping of these cells could also be important in
providing detailed information on how diﬀerent signals
may activate the microglial cell populations, on their
relation to each other and their origin, on the regulation
of their migration, etc. Therapeutic approaches through
which to modify the microglial responses could also
beneﬁt from in vitro studies similar to that presented here.
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The  roles  of  calmodulin  (CaM),  a multifunctional  intracellular  calcium  receptor  protein,  as  concerns
selected  morphological  and  functional  characteristics  of pure  microglial  cells  derived  from  mixed  primary
cultures  from  embryonal  forebrains  of  rats,  were  investigated  through  use  of  the  CaM  antagonists  calmi-
dazolium  (CALMID)  and  triﬂuoperazine  (TFP).  The  intracellular  localization  of the  CaM  protein  relative  to
phalloidin,  a bicyclic  heptapeptide  that  binds  only  to ﬁlamentous  actin,  and  the  ionized  calcium-binding
adaptor  molecule  1  (Iba1),  a microglia-speciﬁc  actin-binding  protein,  was  determined  by immunocy-
tochemistry,  with  quantitative  analysis  by immunoblotting.  In  unchallenged  and  untreated  (control)
microglia,  high  concentrations  of CaM  protein  were  found  mainly  perinuclearly  in  ameboid  microglia,
while  the cell  cortex  had  a smaller  CaM  content  that diminished  progressively  deeper into  the branches
in  the  ramiﬁed  microglia.  The  amounts  and  intracellular  distributions  of both  Iba1 and CaM  proteins  were
altered  after  lipopolysaccharide  (LPS)  challenge  in activated  microglia.  CALMID  and  TFP  exerted  different,
sometimes  opposing,  effects on  many  morphological,  cytoskeletal  and  functional  characteristics  of the
microglial  cells.  They  affected  the CaM  and Iba1 protein  expressions  and  their  intracellular  localizations
differently,  inhibited  cell  proliferation,  viability  and  ﬂuid-phase  phagocytosis  to different  degrees  both
in  unchallenged  and  in LPS-treated  (immunologically  challenged)  cells,  and  differentially  affected  the
reorganization  of  the  actin  cytoskeleton  in  the  microglial  cell  cortex,  inﬂuencing  lamellipodia,  ﬁlopodia
and  podosome  formation.  In summary,  these  CaM  antagonists  altered  different  aspects  of  ﬁlamentous
actin-based  cell  morphology  and  related  functions  with  variable  efﬁcacy,  which  could  be important  in
deciphering  the  roles  of  CaM  in  regulating  microglial  functions  in  health  and  disease.
© 2015 Elsevier  Inc.  All  rights  reserved.. IntroductionMicroglia originate from bone marrow-derived myeloid precur-
ors as a unique class of the monocyte/macrophage lineage that
Abbreviations: Ca2+, calcium ion; CALMID, calmidazolium,
-[bis(4-chlorophenyl)methyl]-3-[2-(2,4-dichlorophenyl)-2-(2,4-
ichlorobenzyloxy)ethyl]-1H-imidazolium chloride; CaM, calmodulin; CNS,
entral nervous system; DIV, days in vitro; DMEM, Dulbecco’s Modiﬁed Eagle’s
edium;  GAPDH, glyceraldehyde 3-phosphate dehydrogenase (EC 1.2.1.12); Iba1,
onized calcium binding adaptor molecule 1; Ki67, proliferation marker antigen
dentiﬁed  by the monoclonal antibody Ki67; LPS, bacterial lipopolysaccharide;
RNA,  messenger ribonucleic acid; PBS, phosphate-buffered saline; RT, room
emperature;  S.E.M., standard error of mean; subDIV, subcloned days in vitro;
BS,  tris-buffered saline; TFP, triﬂuoperazine, 10-[3-(4-methylpiperazin-1-yl)
ropyl]-2-triﬂuoromethyl-10H-phenothiazine dihydrochloride; TI, transformation
ndex.
∗ Corresponding author at: Department of Cell Biology and Molecular Medicine,
niversity  of Szeged, 4 Somogyi u., Szeged H-6720, Hungary. Fax: +36 62 544 569.
E-mail address: gulyak@bio.u-szeged.hu (K. Gulya).
ttp://dx.doi.org/10.1016/j.brainresbull.2015.11.003
361-9230/© 2015 Elsevier Inc. All rights reserved.inﬁltrates the central nervous system (CNS) during its early devel-
opment (Ginhoux et al., 2010; Saijo and Glass, 2011). They respond
rapidly to inﬂammatory cues and injury by transforming from a
ramiﬁed, resting state to an activated, phagocytic ameboid cell type
(Kreutzberg, 1996). In their non-activated or resting state, they
display a ramiﬁed morphology and subdued macrophage-like func-
tional properties. In response to injury, infection, inﬂammatory or
other signals, the microglia become activated and a series of mor-
phological, molecular and functional changes take place that affect
proliferation, homing and adhesion to damaged cells, phagocytosis,
antigen presentation and cytotoxic and inﬂammation-mediating
signaling (Drew and Chavis, 2000; Prinz and Priller, 2014; Saijo and
Glass, 2011; Streit et al., 1999; Town et al., 2005).
Microglial functions such as motility and phagocytosis are
closely associated with dynamic changes in the cytoskeleton
2+and related to intracellular calcium (Ca ) signaling (Greenberg,
1995; Kalla et al., 2003; Mitchison and Cramer, 1996). The
ubiquitous Ca2+-binding proteins participate in Ca2+-elicited intra-
cellular events, either as Ca2+-sensing/receptor/trigger or as
4 arch B
C
C
t
s
t
C
r
u
r
t
c
2
k
e
s
(
s
t
b
H
(
p
o
v
t
2
o
t
S
F
i
a
P
(
b
a
p
b
C
2
I
r
2
m
n
1
(
t
t
i
S
t
1
s
C
t
t
t
C
c
c2 M. Szabo et al. / Brain Rese
a2+-buffering/transport proteins, by binding intracellularly stored
a2+ (Ikura, 1996). They contribute to nearly all aspects of the func-
ioning of the cell, and are important in numerous intracellular
ignaling processes, from the regulation of cellular homeostasis
o learning and memory (Berridge et al., 2000; Clapham, 2007).
almodulin (CaM), one of the most important intracellular Ca2+
eceptors, exerts its biological action through its heterogenous pop-
lation of target proteins, which are involved in a number of cellular
egulatory processes (Kennedy, 1989; Palﬁ et al., 2002).
The  nervous tissue is especially abundant in CaM. While its dis-
ribution has been characterized in detail for a number of neuronal
ell types (Kovacs and Gulya, 2002, 2003; Palﬁ et al., 1999, 2001,
005), its localization and functions in glial cells are much less
nown. Astrocytes express CaM protein in low quantities (Kortvely
t al., 2003), but mRNA populations from all three CaM genes could
till be localized both perinuclearly and in the astrocytic endfeet
Palﬁ et al., 2005). The expression of CaM in oligodendroglia is
imilarly low and has not been characterized extensively, albeit
he regulatory effects of this protein on a number of membrane-
ound target proteins such as the myelin basic protein (Libich and
arauz, 2008) or the 2′,3′-cyclic nucleotide 3′-phosphodiesterase
Myllykoski et al., 2012) have been established. Of all the glial com-
onents, only the microglia seem to have a considerable amount
f CaM. They express a relatively large amount of CaM when acti-
ated (Casal et al., 2001; Solá et al., 1997), and many aspects of
heir Ca2+ signaling are well documented (Färber and Kettenmann,
006; Wong and Schlichter, 2014).
CaM immunoreactivity or CaM gene-speciﬁc transcripts are
ften colocalized with those of the target enzymes of CaM within
he same cytoplasmic compartments (Erondu and Kennedy, 1985;
anabria et al., 2008; Seto-Ohshima et al., 1983; Strack et al., 1996).
or example, actin is accompanied by CaM in the cell cortex, help-
ng to remodel the actin-based cytoskeleton in accordance with the
ctual (patho) physiological signals (Mitchison and Cramer, 1996;
satha et al., 2004). Ionized calcium-binding adaptor molecule 1
Iba1) is another intracellular Ca2+-binding protein with actin-
inding capability that is expressed in macrophages and microglia,
nd is widely used to detect both resting and activated microglial
henotypes (Imai et al., 1996). CaM and Iba1 proteins share a num-
er of molecular structural variants that are related to either their
a2+ binding or their target protein recognition (Yamada et al.,
006). In contrast with the wide-ranging regulatory roles of CaM,
ba1 plays a much more restricted role in microglial functions, e.g.
emodeling the actin cytoskeleton during migration (Siddiqui et al.,
012; Vincent et al., 2012).
The  modulatory action of Ca2+-bound CaM on
ultiple target proteins can be regulated by a
umber of compounds. Calmidazolium (CALMID;
-[bis(4-chlorophenyl) methyl]-3-[2-(2,4-dichlorophenyl)-2-
2,4-dichlorobenzyloxy)ethyl]-1H-imidazolium chloride) and
riﬂuoperazine (TFP; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-
riﬂuoromethyl-10H-phenothiazine dihydrochloride) are potent
nhibitors of CaM-related cellular activities (Borsa et al., 1986;
unagawa et al., 2000). It is presumed that, apart from binding
o the CaM protein (Matsushima et al., 2000; Vandonselaar et al.,
994; Vertessy et al., 1998), they can also exert their effects on
ome of the CaM-regulated targets directly (Sunagawa et al., 2000).
In contrast with the extensive studies on the involvement of
aM in a number of neuronal phenomena, only limited informa-
ion is available on its role in the development and maintenance of
he microglial phenotype and its speciﬁc functions. Relatively lit-
le is known, for example, as concerns the possible involvement of
aM mediation in such important microglial functions as phago-
ytosis and the cellular functions associated with it, e.g. dynamic
ytoskeletal reorganization. Thus, in view of the importance ofulletin 120 (2016) 41–57
CaM-mediated  cell functions and the paucity of data on speciﬁc
microglial functions related to and possibly regulated by CaM, we
set out to investigate the localization and intracellular distribution
of CaM in pure microglial cell populations derived from rat pri-
mary mixed forebrain cultures by using immunocytochemical and
Western blot techniques. Selected CaM inhibitors such as CALMID
and TFP, previously reported to have different modes of action
(Matsushima et al., 2000; Sunagawa et al., 2000), were quantita-
tively tested for their ability to modify the microglial morphology,
lamellipodia, ﬁlopodia and podosome formation, and speciﬁc func-
tions such as cell proliferation and survival, protein expression
and phagocytosis in unchallenged (control) and lipopolysaccharide
(LPS)-challenged cells. Stimulation with LPS was used to evaluate
the ability of microglial cells to respond to activation (Fricker et al.,
2012; Song et al., 2014; Tokes et al., 2011).
2. Material and methods
All  animal experiments were carried out in strict compliance
with the European Council Directive (86/609/EEC) and EC regula-
tions (O.J. of EC No. L 358/1, 18/12/1986) regarding the care and
use of laboratory animals for experimental procedures, and fol-
lowed the relevant Hungarian and local legislation requirements.
The experimental protocols were approved by the Institutional
Animal Welfare Committee of the University of Szeged (I-74-
11/2009/MÁB). The pregnant Sprague-Dawley rats (180–200 g)
were kept under standard housing conditions and fed ad libitum.
2.1.  Antibodies
The antibodies used in the immunocytochemical and Western
blot studies are listed in Table 1. For a thorough characterization
of different microglial phenotypes developed in vitro, an anti-
body against Iba1, an intracellular actin- and Ca2+-binding protein
expressed in the CNS speciﬁcally in macrophages and microglia
(Imai et al., 1996; Ahmed et al., 2007), was used in our immuno-
cytochemical and Western blot analyses. An anti-CaM monoclonal
antibody was used to detect both Ca2+-bound and Ca2+-free forms
of the antigen (Sacks et al., 1991). The anti-Ki67 antibody was used
to detect proliferating cells. Ki67 is a nuclear protein expressed in
all active phases of the cell cycle from the late G1 phase through
the end of the M phase but is absent in non-proliferating and
early G1 phase cells (Scott et al., 2004). The anti-glyceraldehyde
3-phosphate dehydrogenase (GAPDH) antibody was used as an
internal control in Western blot experiments (Wu et al., 2012).
Dilutions of primary and secondary antibodies, and also incuba-
tion times and blocking conditions for each antibody used were
carefully tested for both immunocytochemistry and Western blot
analysis. To detect the speciﬁcities of the secondary antisera, omis-
sion control experiments (staining without the primary antibody)
were performed. In such cases, no ﬂuorescent or Western blot sig-
nals were detected.
2.2.  Preparation of primary mixed cortical cell cultures
Mixed primary cortical cell cultures were established from
embryonic day 18 (E18) wild-type rat embryos by the use of the
methods described previously (Szabo and Gulya, 2013). Brieﬂy,
6–8 fetal rats under deep ether anesthesia were surgically decap-
itated and the frontal lobe of the cerebral cortex was removed,
minced with scissors, and incubated in 9 ml  Dulbecco’s Modiﬁed
Eagle’s Medium (DMEM; Invitrogen, Carlsbad, CA, USA) contain-
ing 1 g/l d-glucose, 110 mg/l Na-pyruvate, 4 mM  l-glutamine, 3.7 g/l
NaHCO3, 10,000 U/ml penicillin G, 10 mg/ml streptomycin sul-
fate and 25 g/ml amphotericin B, and supplemented with 0.25%
trypsin (Invitrogen) for 10 min  at 37 ◦C, then centrifuged at 1000 × g
M. Szabo et al. / Brain Research Bulletin 120 (2016) 41–57 43
Fig. 1. Development of Iba1 and CaM immunoreactivities in primary mixed cortical cultures (DIV1-DIV28). (For interpretation of the references to colour in this ﬁgure legend,
the  reader is referred to the web version of this article.)
At  early culturing times (DIV1 (A–D) and DIV7 (E–H)), all seeded cells displayed CaM immunoreactivity (green), but only a few of them were Iba1-positive microglia (red). The
cell  nuclei (blue) were labeled with Hoechst 33,258. Since most of the cells present early in the culturing are neurons [48], most of the CaM immunoreactivity seen at DIV1-
DIV7  is of neuronal origin. At DIV14 (I–L), a large number of Iba1-positive cells showed CaM positivity, a number of them were ramiﬁed. At DIV28 (M–P), the predominant
cell type in the culture was  the CaM-positive microglia. Note the visibly different Iba1 (M)  and CaM contents (N) of the ameboid and ramiﬁed microglia at this culturing time.
The  merged pictures show cells double-positive for Iba1 and CaM (D, H, L, P). The development of Iba1 (Q) and CaM (R) immunoreactivities during culturing (DIV1-DIV28)
was  quantitatively analyzed on Western blots. Protein samples from primary cultures were separated by gel electrophoresis, transferred to nitrocellulose membranes and
probed  with either the Iba1 (Q) or CaM (R) antibody. Gray scale digital images of the immunoblots were acquired by scanning the autoradiographic ﬁlms with a desktop
scanner. The images were scanned and processed at identical settings to allow comparisons between the Western blots from different samples. Error bars indicate integrated
optical density values (mean ± S.E.M.). Representative Western blot pictures are shown below the graphs. During culturing (DIV1-DIV28), a massive increase in the number
of  cells with microglial phenotype was  observed in the mixed primary cultures, while the CaM content of the cultures remained constant. Most of the gain in Iba1 content
occurred between DIV10 and DIV14. Culturing times are indicated at the upper right corners (A, E, I, M).  Scale bar in A for all pictures: 50 m.
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Table  1
Antibodies used in immunocytochemistry and Western blot analyses.
Antibodies used in immunocytochemistry
Primary
antibody,
abbrev. name
Full name Final dilution Company name Secondary antibody
with  ﬂuorochrome
Final dilution
Iba1 Rabbit anti-Iba1
monocl. ab.
1/300 Wako, Osaka, Japan Alexa Fluor 568 goat
anti-rabbit,
Invitrogen,  Carlsbad,
CA,  USA
1/1,000
Iba1  Rabbit anti-Iba1
monocl. ab.
1/300 Wako, Osaka, Japan Alexa Fluor 488 goat
anti-rabbit,
Invitrogen,  Carlsbad,
CA,  USA
1/1,000
CaM  Mouse anti-CaM,
monocl. ab.
1/100 Millipore Alexa Fluor 488 goat
anti-mouse,
Invitrogen,  Carlsbad,
CA,  USA
1/1,000
CaM  Rabbit anti-CaM,
monocl. ab., clone
EP799Y
1/100 Abcam, Cambridge,
UK
Alexa Fluor 568 goat
anti-rabbit,
Invitrogen,  Carlsbad,
CA,  USA
1/1,000
Ki67  Rabbit anti-Ki67,
monocl. ab., clone
SP6
1/100 Thermo Scientiﬁc,
Fremont, CA, USA
Alexa Fluor 488 goat
anti-rabbit,  Invitrogen,
Carlsbad,  CA, USA
1/1,000
Antibodies  used in Western studies
Primary
antibody,
abbrev. name
Full name Final dilution Company name Secondary antibody Final dilution
Iba1  Rabbit anti-Iba1
monocl. ab.
1/1,000 Wako, Osaka, Japan Anti-rabbit IGG,
peroxidase conjug.,
Sigma,  St. Louis, MO,
USA
1/2,000
CaM  Rabbit anti-CaM,
monocl. ab., clone
EP799Y
1/2,000 Abcam, Cambridge,
UK
Anti-rabbit IGG,
peroxidase conjug.,
Sigma,  St. Louis, MO,
USA
1/2,000
GAPDH  Mouse 1/20,000 Sigma, St. Louis,
MO
Anti-mouse IGG, 1/3,000
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monocl. ab., clone
GAPDH-71.1
or 10 min  at room temperature (RT). The pellet was resuspended
nd washed twice in 5 ml  DMEM containing 10% heat-inactivated
etal bovine serum (FBS; Invitrogen) and centrifuged for 10 min
t 1000 × g at RT. The ﬁnal pellet was resuspended in 2 ml  of
he same solution as above, after which the cells were seeded
n the same medium and cultured at 37 ◦C in a humidiﬁed air
tmosphere supplemented with 5% CO2 in one or other of the fol-
owing ways: (1) in poly-l-lysine-coated coverslips (18 × 18 mm;
 × 105 cells/coverslip) for immunocytochemistry; (2) in poly-l-
ysine-coated Petri dishes (60 mm × 15 mm;  106 cells/dish) for
estern blot analyses; or (3) in a poly-l-lysine-coated culture ﬂask
75 cm2, 12 × 106 cells/ﬂask) for the subsequent generation of pure
icroglial cell cultures. The mixed primary cultures were main-
ained up to 28 days (DIV1-DIV28) for immunocytochemistry and
estern blot analyses, and for 7 days (DIV7) for the generation of
ure microglial cells. For culturing periods longer than 3 days, the
MEM was changed every 3 days.
.3. Preparation of pure microglial cell cultures
Pure microglial cell cultures were subcloned from mixed pri-
ary cultures (DIV7) maintained in a poly-l-lysine-coated culture
ask (75 cm2, 12 × 106 cells/ﬂask) by shaking the cultures at
50 rpm in a platform shaker for 20 min  at 37 ◦C. Microglia from the
upernatant were collected by centrifugation at 3000 × g for 10 min
t RT and resuspended in 2 ml  of DMEM/10% FBS. The cells were
eeded at a density of 2 × 105 cells/Petri dish for Western blots and
ell viability assays or 105 cells/coverslip/Petri dish for immunocy-,  USA peroxidase  conjug.,
Sigma,  St. Louis, MO,
USA
tochemistry, proliferation or phagocytosis assays, and cultured in
DMEM in a humidiﬁed atmosphere supplemented with 5% CO2 for
4 days at 37 ◦C. The medium was  changed on the ﬁrst day after seed-
ing (subDIV1). Immunocytochemistry routinely performed on the
pure microglial cultures 4 days after seeding (subDIV4) consistently
detected a >99% incidence of Iba1-immunopositive microglial cells
for the Hoechst 33,258 dye-labeled cell nuclei (Fig. 2).
2.4.  Treatment of pure microglial cells with LPS and CaM
inhibitors
On  the fourth day of subcloning (subDIV4), the DMEM was
replaced and the expanded pure microglial cells were treated for
24 h with either LPS (100 ng/ml in ﬁnal concentration, dissolved
in DMEM;  Sigma, St. Louis, MO,  USA), CALMID (5 nM or 50 nM
in ﬁnal concentration, dissolved in dimethylsulfoxide (DMSO);
Sigma) or TFP (10 M or 20 M ﬁnal concentration, dissolved in
DMSO; Sigma) alone, or with a combination of LPS and one of
these CaM inhibitors, and the effects were compared in a variety
of morphological and functional tests. LPS treatment served as an
immunochallenge. Unchallenged and untreated (control) cultures
were maintained under identical conditions, but without these
inhibitors, and received 2 l DMSO solution instead.2.5.  Immunocytochemistry
For immunocytochemistry, primary cortical cells (DIV1-DIV28)
or pure microglial cells (subDIV4) cultured in vitro on poly-l-lysine-
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oated coverslips were used. At different time intervals (DIV1,
IV4, DIV7, DIV10, DIV14, DIV21, DIV28), or after different treat-
ents (subDIV4), the cultured cells on the coverslips were ﬁxed
n 4% formaldehyde in 0.05 M phosphate-buffered saline (PBS; pH
.4 at RT) for 5 min  and rinsed in 0.05 M PBS for 3 × 5 min. After
ermeabilization and blocking of the nonspeciﬁc sites in 0.05 M
BS solution containing 5% normal goat serum (Sigma), 1% heat-
nactivated bovine serum albumin (Sigma) and 0.05% Triton X-100
or 30 min  at 37 ◦C, the cells on the coverslips were incubated with
he appropriate primary antibody (Table 1) in the above solution
vernight at 4 ◦C. The cultured cells were washed for 4 × 10 min
t RT in 0.05 M PBS, then incubated with the appropriate Alexa
luor ﬂuorochrome-conjugated secondary antibody (Table 1) in
he above solution, but without Triton X-100, in the dark for 3 h
t RT. The cells on the coverslip were washed for 4 × 10 min  in
.05 M PBS at RT. At this stage, the cells were occasionally stained
ith rhodamine-phalloidin (5 l in 200 l PBS; Molecular Probes,
ugene, OR, USA) for 30 min  at RT, then washed for 2 × 10 min  at
T. Finally, the cell nuclei were stained in a 0.05 M PBS solution
ontaining 1 mg/ml  polyvinylpyrrollidone and 0.5 l/ml Hoechst
3,258 dye (Sigma). The coverslips were rinsed in distilled water
or 5 min, air-dried and mounted on microscope slides in Vec-
ashield mounting medium (Vector Laboratories, Burlingame, CA,
SA). Cells were viewed on a Nikon Microphot-FXA epiﬂuorescent
icroscope (Nikon Corp., Tokyo, Japan) and photographed with a
pot RT Color CCD camera (SPOT RT/ke, Diagnostic Instruments,
nc., Sterling Heights, MI,  USA).
.6. Western blot analysis
For  Western blots, the protocols were optimized for each
ntibody as regards epitope accessibility, polyacrylamide gel sepa-
ation, antibody dilution and chemiluminescence signal intensity.
ultured primary cells (DIV1–DIV28) or pure microglial cells (sub-
IV4) with different treatment regimens were collected through
se of a rubber policeman, homogenized in 50 mM Tris–HCl (pH
.5) containing 150 mM NaCl, 0.1% Nonidet P40, 0.1% cholic acid,
 g/ml leupeptin, 1 g/ml pepstatin, 2 mM phenylmethylsulfonyl
uoride and 2 mM EDTA, and centrifuged at 10,000 × g for 10 min
t 4 ◦C. The pellet was discarded and the protein concentration
f the supernatant was determined (Lowry et al., 1951). For the
estern blot analyses of Iba1, CaM and GAPDH immunoreactivi-
ies, 5–10 g of heat-denatured protein was separated on an SDS
olyacrylamide gel. The stacking gel/resolving gel ratio was  4–10%
or Iba1 and GAPDH, and 4–16% for CaM immunoreactivities; for
aM Westerns, the stacking gel was complemented with 16% urea
nd 16% glycerol. Separated proteins were then transferred onto
ybond-ECL nitrocellulose membrane (Amersham Biosciences, Lit-
le Chalfont, Buckinghamshire, England). Strips of membranes with
he transferred bands for CaM and Iba1 (both around 17 kDa) and
APDH (37 kDa) were cut and processed separately for CaM, Iba1
r GAPDH immunodetection. The membranes were blocked for 1 h
n  5% nonfat dry milk (for Iba1 and GAPDH Westerns) or 5% bovine
erum albumin (for CaM Westerns) in Tris-buffered saline (TBS)
ontaining 0.1% Tween 20, and incubated for 1 h with the appropri-
te primary antibodies (Table 1). After 5 washes in 0.1% TBS–Tween
0, the membranes were incubated for 1 h with the appropriate
eroxidase-conjugated secondary antibodies (Table 1), and washed
 times as before. The enhanced chemiluminescence method (ECL
lus Western blotting detection reagents; Amersham Biosciences)
as used to reveal immunoreactive bands according to the manu-
acturer’s protocol. The immunoreactive densities of equally loaded
anes were quantiﬁed, and all samples were normalized to internal
APDH load controls run on the same gels.ulletin 120 (2016) 41–57 45
2.7.  Cell proliferation and cell viability assays
For the assessment of CaM inhibition on cell proliferation and
survival, pure microglial cells (subDIV4) were cultured in DMEM
with or without the appropriate test compounds in a humidi-
ﬁed atmosphere supplemented with 5% CO2 at 37 ◦C for 24 h. To
analyze the effects of these treatments on cell proliferation, the
cultures were processed for Ki67 immunocytochemistry. Prolif-
eration index (PI) was deﬁned as the number of Ki67-positive
microglial cell nuclei per 1000 analyzed Iba1-positive cells and usu-
ally expressed as % of the total cells analyzed (Brownhill et al., 2014;
Yamaguchi et al., 2013). A total of 1454 ﬁelds of view with 55,565
Iba1-positive and 783 Ki67-positive/Iba1-positive microglia were
analyzed across the groups (mean ± S.E.M.).
To  estimate the surviving microglial cells after treatments, the
cultures were washed twice with 2 ml  of PBS to remove cell debris
and treated with 0.25% trypsin solution for 10 min at 37 ◦C, col-
lected and counted in a Burker cell. The number of viable cells was
presented as mean ± S.E.M.
2.8.  In vitro phagocytosis assay
The ﬂuid-phase phagocytic capacity of the microglial cells was
determined via the uptake of ﬂuorescent microspheres (2 m in
diameter; Sigma) using the general methods described by Szabo
and Gulya (2013). Unstimulated (control) and LPS-stimulated pure
microglial cell cultures with or without CaM inhibition were tested
for 24 h. At the end of the culturing period (subDIV4), 1 l of a 2.5%
aqueous suspension of ﬂuorescent microspheres was  added per ml
of the culture, which was  then further incubated for 60 min  at 37 ◦C.
The cells were next washed 5 times with 2 ml of PBS to remove
dish- or cell surface-bound residual ﬂuorescent microspheres, and
ﬁxed with 4% formalin in PBS. For measurement of the phago-
cytic activity, Iba1-expressing microglia labeled with phagocytosed
microbeads were counted. Negative controls were treated as above
with the exception that microglial cultures with beads were incu-
bated for 60 min  at 4 ◦C. At this temperature, the number of beads
associated with cell surface averaged less than 1 bead per 100 Iba1-
labeled cells. For the study of the effects of CaM inhibitors on the
number of phagocytosed beads (mean ± S.E.M.), a total of 873 bead-
labeled cells were counted in three separate culturing procedures
under a Nikon Microphot-FXA epiﬂuorescent microscope with a
10× or 20× objective.
2.9.  Digital image processing and image analysis
Gray scale digital images of the Western blots were acquired by
scanning the autoradiographic ﬁlms with a desktop scanner (Epson
Perfection V750 PRO; Seiko Epson Corp., Japan). The images were
scanned and processed at identical settings to allow comparisons
of the Western blots from different samples. Digital images were
acquired with a Nikon Microphot-FXA epiﬂuorescent microscope
(Nikon Corp., Tokyo, Japan), using a Spot RT Color CCD camera and
Spot RT software (Spot RT/ke Diagnostic Instruments). Microglial
cell silhouettes were acquired by transforming the raw digital
ﬁles of Iba1-immunoreactive cells made under ﬂuorescent micro-
scope light to binary ﬁles, using the ImageJ software (version 1.47;
developed at the U.S. National Institutes of Health by W.  Rasband,
and available from the Internet at http://rsb.info.nih.gov/ij). The
color  cell images were transformed into their binary replicas (sil-
houettes) through automatic thresholding procedures (Szabo and
Gulya, 2013). After thresholding, values for cell perimeter (m) and
cell area (m2) were determined from at least 3 separate experi-
ments (at least 2 coverslips in each experiment for each culturing
time investigated; about 20 randomly selected cells/coverslip),
and the transformation index (TI) reﬂecting the degree of pro-
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Fig. 2. Localization of Iba1 immunoreactivity in pure microglial cell cultures (sub-
DIV4). (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web  version of this article.)
Representative photomicrograph of Iba1 imunoreactive microglial cells in culture.6 M. Szabo et al. / Brain Rese
ess extension was calculated via an expression [perimeter of cell
m)]2/4[cell area (m2)] as previously described (Fujita et al.,
996). For the analysis of TI values, a total of 261 cells were
uantitatively measured (mean ± S.E.M.). Digital image produc-
ion was performed with Adobe Photoshop CS5.1 software (Adobe
ystems, Inc., San Jose, CA, USA). Color correction (brightness, con-
rast) and cropping of the ﬂuorescent images were occasionally
erformed when individual photomicrographs were assembled to
gure panels for publication. No speciﬁc feature within an image
as enhanced, obscured, introduced, moved or removed.
.10.  Statistical analysis
All  statistical comparisons were made with SigmaPlot (v. 12.3,
ystat Software Inc., Chicago, IL, USA). Results for the phagocytosis
nd viability assays and the cell silhouette characteristics (TI values)
ere analyzed with Kruskal–Wallis one-way analysis of variance,
ollowed by Dunn’s method for pairwise multiple comparison pro-
edures for statistically signiﬁcant differences between the groups.
or these studies, values were presented as mean ± S.E.M. from
t least three independent experiments and p < 0.05 was  con-
idered signiﬁcant. For Western blots, values were presented as
ean ± S.E.M. from at least three blots, each representing inde-
endent experiments for each time period examined. For the
etermination of the homogeneity of the subcloned microglial cells,
ba1-positive cells and Hoechst 33,258 dye-positive cell nuclei from
t least 50 randomly sampled microscope ﬁelds from 2 to 3 cover-
lips for each subcloned culture were counted and the results are
resented as mean ± S.E.M.
.  Results
.1. CaM is differentially localized in ameboid and ramiﬁed
icroglia both in mixed and pure cultures
The quantity and cell type-speciﬁc localization of the CaM
rotein was ﬁrst established in mixed primary cultures under
nstimulated and untreated (control) conditions. Fluorescent
mmunocytochemistry (Fig. 1A–P) and Western blot analysis
Fig. 1Q,R) demonstrated that a high concentration of CaM pro-
ein was characteristic of the mixed cultures throughout culturing.
n young cultures (DIV1–DIV7), when only a few cells double-
ositive for the Iba1 (Fig. 1A,E) and CaM (Fig. 1B,F) antigens existed
Fig. 1A–H), most of the CaM immunoreactivity was associated with
on-microglial, e.g. mainly neuronal, cell forms, as demonstrated
arlier (Szabo and Gulya, 2013). From DIV14 (up to DIV28), as more
ba1-positive microglia populated the cultures (Fig. 1I,M), the pro-
ortion of CaM immunoreactivity associated with the microglia
Fig. 1J,N) also grew steadily. Both ameboid (Fig. 1A,E) and ramiﬁed
icroglia (a few cells in Fig. 1I,M) expressed CaM immunoreactiv-
ty. As the cultures aged, the CaM immunoreactivity localized to
icroglia became predominant (compare Fig. 1I,M with Fig. 1K,O).
imilarly, Western blot studies conﬁrmed the increase in Iba1
mmunoreactivity during culturing (Fig. 1Q), during which time the
aM content of the cultures remained unchanged (Fig. 1R). Thus,
y DIV14, the microglia had become the main CaM-expressing cell
ype in the mixed primary forebrain culture.
Subsequent experiments were performed on pure microglial
ultures (subDIV4; Fig. 2). In these microglial cells the Iba1
mmunoreactivity was most intense in the lamellipodia of the
meboid forms (Fig. 3A,D,G), followed by the perinuclear region
Fig. 3D,G). The strongest CaM immunoreactivity was always
bserved in the ameboid microglia, where the cell somata, and
specially the perinuclear area, were the most intensely labeled
Fig. 3B,E,H). In ameboid microglia, the CaM and Iba1 immunore-The purity of this culture is close to 100%, since every Hoechst 33,258-labeled cell
nuclei (blue) is surrounded by Iba1 immunopositive cytoplasm (green). Scale bar:
100 m.
activities were distributed in a complementary manner, as the
Iba1 protein tending to localize in the cell cortex and lamellipodia
(Fig. 3A–C). The ramiﬁed microglia displayed an almost homoge-
nous cytoplasmic Iba1 distribution (Fig. 3J) with a considerably
lower CaM content typically localized around the nucleus; the
branches had only traces of CaM immunoreactivity (Fig. 3K,L).
3.2.  CALMID and TFP differentially affect microglial proliferation
and  cell survival
When  CaM inhibitors were tested on cell proliferation and cell
viability, CALMID and TFP, either alone or in combination with
LPS, had different effects (Fig. 4A,B). Proliferation was  measured
as a function of Ki67-immunopositivity of the microglial cells
(PI). Unstimulated (control) microglia (subDIV4) had an average PI
value of 2.5% (25.22 ± 8.9 Ki67-positive microglia/1,000 analyzed
microglia in the culture; Fig. 4A). LPS challenge inhibited cell pro-
liferation, albeit without reaching signiﬁcance (PI = 0.41; 16.2% of
the control value). According to Ki67 immunocytochemistry, TFP10
signiﬁcantly decreased microglial cell proliferation both in unchal-
lenged and LPS-challenged microglia with PI values of 0.21% and
0.12%, respectively (Fig. 4A). While CALMID50 treatment alone
had no effect on the proliferation of unchallenged microglia, LPS-
challenged cells treated with CALMID50 showed some but not
signiﬁcant inhibition.
Cell  viability was also investigated in pure microglial cultures
(Fig. 4B). In contrast with the ineffectivity of CALMID50 on cell sur-
vival in unchallenged and in LPS-challenged microglial populations,
TFP10 was highly effective in these cultures. In unchallenged cells,
TFP10 signiﬁcantly decreased cell viability to 62.47% of the control
value. Similarly, when the microglial cells were challenged by LPS
treatment (100 ng/ml), TFP10 effectively decreased the number of
surviving cells to 71.28% of the control (Fig. 4B).
3.3. CaM inhibition affects cell morphology and actin
cytoskeleton reorganizationThe  microglial morphology in the control and experimen-
tal groups was  analyzed through binary silhouettes (Fig. 5). The
quantitative analysis was based on the area, perimeter and TI,
the latter being a dimensionless number that is an indicator
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Fig. 3. Distribution of Iba1 and CaM immunoreactivities in pure microglial cells (subDIV4). (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred  to the web  version of this article.)
In pure microglial cultures (subDIV4), the majority of the unchallenged cells were ameboid or slightly ramiﬁed. While the Iba1 immunoreactivity (red) could be localized
into two subcellular compartments, the perinuclear and the cell cortex domains (A, D, G, J), the CaM immunoreactivity (green) was  largely conﬁned to the perinuclear region
(B,  E, H, K), with the cell cortex having a considerably smaller CaM content, which progressively diminished deeper into the branches. Merged pictures (C, F, I, L) show the
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sell  nuclei (blue) and the overlapping Iba1 and CaM immunoreactivities predomina
ocalized Iba1 immunoreactivity in the leading edges of large lamellipodia (A, arro
)  point to large lamellipodia. Scale bar in A for all pictures: 10 m.
or the degree of process extension of a cell. Throughout the
xperiments, microglial cells with TI <3 were considered ame-
oid. The unchallenged, untreated 4-day-old pure microglia culture
subDIV4) consisted mainly of ameboid cells (Fig. 5, control
ow; see also controls in Figs. 7, 8, 10) with an average area
f 412.91 ± 27.2 m2, perimeter of 100.73 ± 5.4 m and a TI of
.02 ± 0.1 (Fig. 6 ). When administered alone, CALMID and TFP
ffected TI and the microglial cell surface area and perimeter dif-
erently. For example, both CALMID5 and CALMID50 resulted in
ncreased area, perimeter and TI, whereas TFP alone strongly inhib-
ted these characteristics. When challenged with LPS, the microglia
ecame enlarged and acquired signiﬁcantly larger perimeter and
I (A = 777.23 ± 40.1 m2, P = 238.97 ± 8.6 m,  TI = 6.14 ± 0.4), con-
istent with these cells becoming activated (Figs. 5, 6 and 7D–F).ocalized to the perinuclear area. Ameboid microglia have predominantly cortically
 cytoplasmic domain largely devoid of CaM immunoreactivity (B). Arrowheads (D,
Interestingly,  CALMID5 or CALMID50 alone was  not effective but
when used in combination with LPS, they signiﬁcantly increased
the cell surface area, perimeter and TI (Figs. 5, 6A,C,E, 7G–I). TFP
sigiﬁcantly inhibited the expansion of cell surface area and perime-
ter both in unchallenged and LPS-challenged cells (Fig. 6B,D). As an
example, the cell surface area was  decreased substantially after TFP
or LPS + TFP treatment, to 46.4 or 44.5% of the unchallenged or LPS-
challenged control value, respectively. TFP treatment was  also very
effective in decreasing TI, to 25.53% of the LPS-challenged value
(Figs. 5, 6).CaM  inhibition affected the microglial morphology through
reorganization of the actin cytoskeleton (Fig. 7). In unchallenged
and untreated (control) cultures, the Iba1- and phalloidin-related
ﬂuorescence signals largely overlapped in the cell cortex of the
48 M. Szabo et al. / Brain Research Bulletin 120 (2016) 41–57
Fig. 4. Effects of CaM inhibitors on microglia proliferation and viability in pure microglial cell cultures.
The  number of Ki67-positive microglia (A) and the viable cells (B) were quantitatively analyzed in challenged and untreated (control), LPS-challenged and LPS-challenged and
treated  cells. CALMID and TFP were tested at 50 nM and 10 M,  respectively, either alone or in combination with 100 ng/ml LPS. TFP, either alone or in combination with LPS,
signiﬁcantly decreased both microglia proliferation (A) and the number of viable cells (B) in the cultures (subDIV4). Interestingly, while the combined treatment of CALMID50
and  LPS led to some (but not signiﬁcant) inhibition on microglia proliferation, it was  without any effect on cell viability. For proliferation studies, data (mean ± S.E.M.) were
collected from at least 4 independently established cultures, each involving plating on at least 3 Petri dishes. Mean PI values (%) were established as follows: control = 2.52%,
CALMID50 = 2.48%, TFP10 = 0.22%, LPS = 0.41%, LPS+CALMID50 = 0.20%, LPS+TFP10 = 0.12%. For viability studies, data (mean ± S.E.M.) were collected from at least 3 separate
c h Kru
( ﬁcant 
1
m
e
t
d
c
t
s
p
C
d
c
i
i
ﬁ
w
d
T
n
ﬂ
i
p
(
3
l
e
t
L
m
l
c
d
t
t
l
C
tulturings, each involving plating on at least 6 Petri dishes. Data were analyzed wit
Dunn’s method). *Statistically signiﬁcant from control (p < 0.05); #statistically signi
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ainly ameboid microglia, often in lamellipodia (Fig. 7A–C) as
xpected, since they both bind to the actin cytoskeleton. When
reated with LPS, the microglia that became activated and enlarged
isplayed a phalloidin distribution much fuzzier than that in the
ase of Iba1, probably due to the rapid association of ﬁbrous actin,
o which phalloidin preferentially binds (Fig. 7D–F). However,
pot-like concentrations of phalloidin ﬂuorescence resembling
odosomes were often visible in LPS-treated cells (Fig. 7E, arrow).
aM inhibitors affected the Iba1 and phalloidin distributions in
ifferent ways. CALMID50 treatment resulted in phalloidin ﬂuores-
ence that was clearly distributed in two distinct concentric rings
n the cytoplasm, one ring in the cell cortex, and the other as a per-
nuclearly localized cytoplasmic streaming of freshly synthesized
brous actin (Fig. 7H,K, arrows). Phalloidin-containing ﬁlopodia
ere also obvious in these cells. Similar, albeit less dense, Iba1
istribution was observed after CALMID50 treatments (Fig. 7G).
FP treatment resulted in an overlapping and almost homoge-
ous distribution of both Iba1 immunoreactivity and phalloidin
uorescence (Fig. 7M–O) in the surviving cells. While the Iba1
mmunoreactivity remained relatively intact (Fig. 7M),  most of the
halloidin ﬂuorescence intensity was lost in TFP-treated microglia
Fig. 7N) indicating that TFP affected actin polymerization.
.4. CaM inhibitors differentially alter the intracellular
ocalization of CaM, and affect the Iba1 and CaM protein
xpressions
CaM inhibitors altered the intracellular localization of CaM pro-
ein (Fig. 8). Both unchallenged and untreated cells (Fig. 8A–C) and
PS-challenged cells (Fig. 8D–F) displayed high CaM content pri-
arily localized in the perinuclear compartment and to a much
esser extent with that in the cell cortex (Fig. 8A,B). Some of the
ells with larger TI had CaM immunoreactivity that progressively
iminished toward the cell cortex (Fig. 8C). Interestingly, cells
reated with CALMID50 alone displayed a more heterogenously
ranslocated CaM immunoreactivity often cortically localized in
amellipodia (Fig. 8J–L, arrowheads). In TFP10-treated cells, the
aM immunoreactivity was very weak and homogenously dis-
ributed in the cytoplasm (Fig. 8M–O).skal–Wallis one-way ANOVA on ranks, followed by pairwise multiple comparisons
from LPS-treated cells (p < 0.05). LPS: 100 ng/ml; CALMID50: 50 nM CALMID; TFP10:
CaM  antagonists inhibited Iba1 and CaM protein expressions
with different efﬁcacies (Fig. 9). In general, CALMID was less potent
than TFP in affecting Iba1 and CAM protein expressions. CALMID,
either alone or in combination with LPS, was not able to alter
the Iba1 expression signiﬁcantly (Fig. 9A). TFP was more potent
as TFP10 and TFP20 inhibited Iba1 protein expression in a dose-
dependent manner both in unchallenged and LPS-challenged cells
(Fig. 9C). Similarly to their effects on the Iba1 expression, CALMID
and TFP antagonized the CaM protein expression with different
efﬁcacy (Fig. 9B,D). When CALMID was  used, the CaM immunore-
activity was observed to decrease somewhat dose-dependently in
the unchallenged microglia as CALMID50 signiﬁcantly inhibited the
CaM protein expression to 38.6% of the control level (Fig. 9B). Again,
TFP20 had a more profound effect on the CaM protein expression
(Fig. 9D), as it exhibited a strong inhibition both in the unchallenged
and in the LPS-activated microglia (20.8% and 23.4% of the control
value, respectively).
3.5.  CaM inhibition impairs phagocytosis in activated microglia
Cultured  microglia readily phagocytosed ﬂuorescently labeled
beads (Figs. 10, 11, ). On average, unchallenged and untreated
microglia had 3.13 ± 0.1 phagocytosed microbeads per cell
(Fig. 10A–C and Fig. 11). LPS-challenged microglia displayed a
large (about 2.8-fold) increase in phagocytotic activity (8.78 ± 0.3;
Figs. 10D–F and 11). CaM inhibitors affected phagocytosis similarly
but with different degrees of potency. CALMID dose-dependently
inhibited phagocytosis both in unchallenged and LPS-challenged
microglia (Fig. 10G–I and Fig. 11A). TFP proved to be a very strong
inhibitor of phagocytosis both in unchallenged and LPS-challenged
microglia (Fig. 10M–O  and Fig. 11B) as it reduced the number of
phagocytosed microbeads by almost 90% (to 0.33 ± 0.2; 10.6% of the
control value) in unchallenged, and by 76.5% (to 0.75 ± 0.3; 23.5%
of the control value) in LPS-challenged cells.4. Discussion
One of the most ubiquitous Ca2+-sensing proteins is CaM. Its
distributions in the developing and the adult rodent brain have
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Fig. 5. Representative binary silhouettes from pure microglial cultures after different treatment regimens.
Iba1-positive microglial cells from pure microglial cultures (subDIV4) were photographed, digitized and quantitatively analyzed according to their morphological character-
istics.  Five representative binary silhouettes are shown at each culturing time. CALMID50, in either control or LPS-challenged microglia, increased the number of ﬁlopodia,
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een well documented (Caceres et al., 1983; Seto-Ohshima et al.,
983). It is encoded by three different genes in mammals (Palﬁ et al.,
002; Toutenhoofd and Strehler, 2000). The expression patterns
orresponding to the three CaM genes display a broad differential
istribution in the developing (Kortvely et al., 2002) and the adult
at CNS under both physiological (Kovacs and Gulya, 2002, 2003;
alﬁ et al., 1999; Solá et al., 1996) and pathophysiological condi-
ions (Palﬁ et al., 2001; Palﬁ and Gulya, 1999; Vizi et al., 2000).
uantitative analysis of the expression patterns of these genes indi-
ated a differential dendritic targeting of the CaM mRNAs (Kortvely
t al., 2003; Palﬁ et al., 1999, 2005); differential intracellular tar-
eting of selected CaM mRNA populations could serve for the local
ranslation of the necessary CaM proteins that regulate the numer-
us target proteins in that particular cytoplasmic compartment
Kortvely and Gulya, 2004).ted microglia. Area (A) in m2, perimeter (P) in m,  and TI values (calculated as
0 ng/ml; CALMID50: 50 nM CALMID; TFP10: 10 M TFP. Scale bar for all silhouettes:
CaM expression could be regulated by a number of differ-
ent physiological and pathophysiological cues. Although its gene
expression is generally very stable (Kortvely and Gulya, 2004; Palﬁ
et al., 2002), we  have identiﬁed many factors that could differen-
tially affect the expressions of the individual CaM genes in neurons
with distinct phenotypes from different brain regions (Orojan et al.,
2006; Palﬁ et al., 1999, 2002; Bakota et al., 2005), e.g. inﬂammation
(Orojan et al., 2008), ischemia (Palﬁ et al., 2001), dehydration (Palﬁ
and Gulya, 1999), and chronic ethanol treatment and withdrawal
(Vizi et al., 2000). Apart from the neurons, the microglia display
a considerable amount of CaM. This CaM expression, however, is
strongly dependent on the phenotype. After a kainic acid chal-
lenge, CaM immunoreactivity was  earlier demonstrated in reactive
microglia of the hippocampus (Solá et al., 1997), where the thick-
ened and shortened microglial processes accumulated CaM protein.
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Fig. 6. Effects of CaM inhibitors on selected morphological parameters of pure microglial cells.
Surface area (A, B) in m2, perimeter (C, D) in m,  and TI values (E, F) of the microglia for CALMID (A, C, E) and TFP (B, D, F) were analyzed in pure unchallenged and LPS-
challenged microglial cell cultures. All statistical comparisons were made by using SigmaPlot (v. 12.3, Systat Software Inc., Chicago, IL, USA) and analyzed with Kruskal–Wallis
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mean  ± S.E.M.) were computed from at least three independent culturing experim
reated  cells. LPS: 100 ng/ml; CALMID5: 5 nM CALMID; CALMID50: 50 nM CALMID;
In our studies, CaM was localized both in developing microglial
ells of primary cortical cultures established from E18 wild-type
at embryos maintained for up to 28 days (DIV1-28) and in pure
icroglial cells subcultured from DIV7 cultures for 4 days (sub-
IV4). Moreover, the presence of CaM protein was demonstrated
ot only in reactive microglia (treated with LPS alone or in combi-
ation with one of the CaM inhibitors), but also, at a lower protein
evel, in unchallenged proliferating ameboid or even ramiﬁed,
icroglial cells. We  observed morphologically and functionally dif-
erent microglial populations within the range from weak to strong
evels of CaM expression during culturing, as evidenced by their
uantitative assessment by ﬂuorescent immunocytochemical and
estern blotting methods. In mixed primary cortical cultures, ame-son procedures for statistically signiﬁcant differences between the groups. Values
*Statistically signiﬁcant from control (p < 0.05); #statistically signiﬁcant from LPS-
: 10 M TFP.
boid microglia, the predominant form in the early stages but always
present (in much smaller numbers) during culturing (Szabo and
Gulya, 2013), expressed strong CaM immunoreactivity through-
out the cytoplasm, while ramiﬁed microglia, the typical form in
the later stages of microglial development, showed a weaker and
more evenly distributed CaM immunoreactivity. A similar intra-
cellular distribution of CaM protein expression was  observed in
pure microglial cultures. In unchallenged and LPS-challenged cul-
tures, most of the microglia was ameboid and had strong CaM
immunoreactivity throughout the cytoplasm. Treatments with
CaM inhibitors, both in unchallenged and LPS challenged cells,
resulted in a weaker and more homogenously localized CaM
immunoreactivity.
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Fig. 7. Immunocytochemical localization of actin-binding proteins in pure microglial cells. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred  to the web  version of this article.)
Iba1 immunoreactivity (A, D, G, J, M;  shown here in green) and phalloidin ﬂuorescence (B, E, H, K, N; shown in red) were colocalized in unchallenged and untreated
(control) cells and in microglia treated with LPS or CaM inhibitors in pure microglial cultures (subDIV4). Merged pictures (C, F, I, L, O) show the Hoechst 33,258-labeled cell
nuclei  (blue) and the colocalization of Iba1 immunoreactivity and phalloidin ﬂuorescence. Filamentous actin often forms continuous ring-like lamellipodia in unchallenged
microglia (B). In LPS-challenged microglial cells, lamellipodia were less dominant, but the toxin stimulated podocyte formation, as indicated by several puncta delineated
b dia for
o lls. TF
p ; TFP1
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i
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iy phalloidin ﬂuorescence (arrow, E). When CALMID50 was  used, strong lamellipo
f  ﬁlamentous actin (arrows, H, K), giving a double-ringed appearance of these ce
halloidin ﬂuorescence microscopy (N). LPS: 100 ng/ml; CALMID50: 50 nM CALMID
We  found that the intracellular localization of CaM immunore-
ctivity described above was closely related, and typically
omplementary, to the ﬁlamentous actin cytoskeleton, comprised
ainly of branched F-actin (Rotty et al., 2013). F-actin was  visual-zed in our studies by the distributions of an actin-binding protein,
ba1, and phalloidin, a bicyclic heptapeptide that recognizes F-actin
nly, e.g. the form that possesses cellular functionality. Iba1 is an
ntracellular Ca2+-binding protein that plays an important role inmation was observed, often accompanied by a perinuclear cytoplasmic streaming
P treatment abolished the formation of ﬁlamentous actin bundles as detected by
0: 10 M TFP. Scale bar in panel A for all pictures: 50 m.
regulation of the intracellular actin dynamics through the direct
binding of actin, enhances membrane rufﬂing and participates in
phagocytosis and cell motility (Ohsawa et al., 2000, 2004), functions
that require large amounts of cortical F-actin. Our immunocyto-
chemical observations showed that ramiﬁed cells (characterized by
larger TI values) that displayed minimal or no rufﬂing at all had only
modest quantities of CaM proteins in the cell cortex as compared
with ameboid or reactive microglia. Coincidentally, the amount of
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Fig. 8. Effects of CaM inhibitors on the intracellular localization of CaM immunoreactivity in pure microglial cells. (For interpretation of the references to colour in this ﬁgure
legend,  the reader is referred to the web version of this article.)
Representative  immunocytochemical pictures showing the intracellular distribution of CaM immunopositivity (red) in pure microglia cells (subDIV4). The merged pictures
show  the cell nuclei (blue) that were stained with Hoechst 33,258. The unchallenged and untreated (control) microglia (A–C) and LPS-challenged cells (D–F) showed mainly
perinuclearly localized CaM immunoreactivity. LPS-challenged and treated cells (G–I), and more typically CALMID50-treated microglia (J–L) displayed CaM distribution often
m eatme
d g/ml; 
5
c
g
d
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l
eore  targeted to the cell cortex and developing lamellipodia (arrowheads). TFP tr
istribution of CaM immunoreactivity in the surviving microglia (M–O). LPS: 100 n
0 m.
ortical F-actin was likewise less in ramiﬁed microglia, and the reor-
anization of the actin cytoskeleton determined the intracellular
istribution of CaM. Concomitantly increased levels of Iba1 and
aM protein expression, however, were evident both in unchal-
enged ameboid and in LPS- or LPS and CaM inhibitor-challenged,
.g. activated/reactive microglia. Our observations relating to thent resulted in a signiﬁcant cell death (see Fig. 4) and a homogenous cytoplasmic
CALMID50: 50 nM CALMID; TFP10: 10 M TFP. Scale bar in panel A for all pictures:
intracellularly redistributed CaM vs. F-actin are consistent with the
ﬁndings in mast cells in previous studies. For example, Sullivan et al.
(2000) demonstrated that CaM promoted the disassembly of corti-
cal F-actin, while Psatha et al. (2004) found that the disassembly of
the actin cytoskeleton eliminated CaM localization.
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Fig. 9. Effects of CaM inhibitors on Iba1 and CaM protein expression in pure microglial cells, as detected by Western blot analysis.
Quantitative Western blot analysis of Iba1 (A, C) and CaM (B, D) immunoreactivities in pure microglial cell cultures (subDIV4). Representative Western blot pictures of
the  respective immunoreactivities are shown below the graphs together with the GAPDH immunoreactive bands that served as inner standards in the same gel. Protein
samples were collected from 3 separate culturings, each involving plating on at least 6 Petri dishes, electrophoresed and quantitatively analyzed as described in the Section
2.  The integrated optical density data (mean ± S.E.M.), normalized to GAPDH immunoreactivities, were analyzed with Kruskal–Wallis one-way ANOVA on ranks, followed
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inding adaptor molecule 1; CaM: calmodulin; LPS: 100 ng/ml; CALMID5 and CALMI
-phosphate dehydrogenase.
LPS activation renders microglia ameboid, induces several pro-
nd anti-inﬂammatory signaling molecules (Lim et al., 2015; Zhu
t al., 2014) and neurotoxic substances through binding to the
D14/MD-2/Toll-like receptor 4-complex (Fricker et al., 2012;
okes et al., 2011), and gives rise, among others, to cell spread-
ng by interfering with the organization of the actin cytoskeleton
hrough the alteration of integrin clustering (Abram and Lowell,
009). Microglia activation was shown to involve the signaling
athways nuclear factor B and p38 mitogen-activated protein
inase (Bachstetter et al., 2011; Cao et al., 2014; Kaushal et al.,l (p < 0.05); #statistically signiﬁcant from LPS-treated cells. Iba1: ionized calcium-
 and 50 nM CALMID; TFP10 and TFP20: 10 and 20 M TFP; GAPDH: glyceraldehyde
2007).  It must be noted, however, that the activation of microglial
cells by LPS is not proliferative (Suzumura et al., 1991).
In  our studies, LPS challenge did not display a signiﬁcant effect
on microglial cell survival or CaM and Iba1 protein expression, but
resulted in signiﬁcant cell spreading, documented in increases in
cell surface, perimeter and TI, and in a repositioning of intracel-
lular actin ﬁlaments toward podosome and ﬁlopodia formation.
In spite of this lack of interaction between the LPS challenge and
CaM protein expression, some of the effects of LPS are medi-
ated through CaM-related phenomena in macrophages (Sweet and
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Fig. 10. Effects of CaM inhibitors on the phagocytic activity of microglial cells in pure microglial cultures. (For interpretation of the references to colour in this ﬁgure legend,
the  reader is referred to the web  version of this article.)
Distribution of phagocytosed microbeads in pure microglial cultures. Representative pictures showing Iba1-immunopositive microglia demonstrate that the unstimulated
and untreated (control) (A–C), LPS-challenged (D–F), LPS + CALMID50-treated (G–I), CALMID50-treated (J–L) and TFP10-treated (M–O) microglia displayed different degrees
of  phagocytosis, as evidenced by the number of phagocytosed microbeads. Fluorescent dye-coated latex microbeads (d = 2 m) (green) were added to the media and
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thagocytosed by microglial cells. After exposure to the ﬂuorospheres, the culture w
hen  with Alexa Fluor ﬂuorochrome-conjugated secondary antibody, and the cell nu
FP10:  10 M TFP. Scale bar in panel A for all pictures: 50 m.
ume, 1996). An LPS challenge, for example, elevated the intracel-
ular Ca2+ concentration in brain macrophages via the activation of
hosphatidylinositol (3,4,5)-trisphosphate-sensitive stores that, in
urn, activated the actin cytoskeleton (Bader et al., 1994). Such an
nﬂammatory response was recently identiﬁed as one developed
hrough the activation of CaM-dependent kinase kinase 2 via Toll-sed, the cells were formalin-ﬁxed, labeled ﬁrst with anti-Iba1 antibody (red), and
lue) were stained with Hoechst 33,258. LPS: 100 ng/ml; CALMID50: 50 nM CALMID;
like  receptors (Racioppi et al., 2012). Thus, the effects of LPS could
be attributed, at least in part, to CaM-related phenomena regulating
the actin cytoskeleton without directly affecting the CaM protein
expression. In another study, CaM was involved in spontaneous
microglial ramiﬁcation and the activation of proliferation from qui-
escence as it inhibited the spontaneous ramiﬁcation and decreased
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Fig. 11. Effects of CaM inhibitors on the phagocytic activity of microglial cells in pure microglial cultures.
Quantitative analysis of the number of phagocytosed microbeads after treatment with CALMID (A) or TFP (B) in unchallenged and in LPS-challenged microglial cells. For
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Bhe  study of the effects of CaM inhibitors on the number of phagocytosed beads (m
rocedures. Data were analyzed with Kruskal–Wallis one-way ANOVA on ranks, fol
ontrol  (p < 0.05); #statistically signiﬁcant from LPS-treated cells. LPS: 100 ng/ml; C
he proliferation of these cells (Casal et al., 2001). The loss of rami-
cation was reported to be induced by the elevation of intracellular
a2+ via direct or indirect routes (Kalla et al., 2003) that eventually
esulted in CaM activation and/or accumulation in the cell cortex.
A  number of studies demonstrated that cell cycle and prolifera-
ion could be regulated by CaM inhibitors (Berchtold and Villalobo,
014; Borsa et al., 1986; Sunagawa et al., 2000). Borsa et al. (1986)
ompared the effects of CALMID and TFP in cycling and non-cycling
ells and demonstrated that they were both preferentially cyto-
oxic for cycling cells. Cell proliferation studies on the osteosarcoma
ell line (Tseng et al., 2004), pancreatic beta-cell line cells (Hügl
nd Merger, 2007) and human lung cancer stem-like cells (Yeh
t al., 2012) demonstrated that CaM inhibitors effectively inhib-
ted cell division. TFP inhibited cancer stem cell tumor formation
nd growth through Wnt/beta-catenin signaling (Yeh et al., 2012)
nd cell migration (Finlayson and Freeman, 2009; Linxweiler et al.,
013), and was shown to induce apoptosis in human lung adeno-
arcinoma cell lines (Chen et al., 2009). In our proliferation studies,
nstimulated microglia (subDIV4) exhibited a low PI value (2.5%)
ndicating the presence of only a few mitotically active cells. This
alue would not be considered a prognostic feature in a number of
uman cancer types (Brownhill et al., 2014; Yamaguchi et al., 2013).
roliferation was strongly inhibited by LPS and TFP as they reduced
he number of Ki67-positive microglia very effectively. CALMID,
owever, had no effect on cell proliferation in unchallenged cul-
ures, albeit it did have some inhibitory effect in LPS-treated cells.
ell viability was also similarly differentially affected as TFP was
ore effective than CALMID in inhibiting the survival of pure
icroglial cells.
Both  CALMID and TFP were previously shown to inhibit CaM
ctivity primarily by binding directly to the protein (Matsushima
t al., 2000; Sunagawa et al., 2000). However, CALMID and TFP prob-
bly exert many of their actions not only via their binding to CaM,
ut also by interfering directly with a number of upstream (Qin
t al., 2009) or downstream targets of CaM signaling (James et al.,
009; Sunagawa et al., 2000). For example, the Rho family GTPases,
.g. Cdc42, Rac and Rho, are known to be intracellular switches that
egulate remodeling of the actin cytoskeleton (Hall, 1998). They
articipate in membrane rufﬂing, lamellipodia and podosome for-
ation and phagocytosis (Dovas et al., 2009; Kanazawa et al., 2002;easholtz et al., 2004). As recent studies led to the consculsion
hat CaM can regulate the activation of both Rac1 and Cdc42 in
egakaryocytes and platelets (Elsaraj and Bhullar, 2008; Xu and
hullar, 2011; Xu et al., 2012), a direct involvement of CaM in S.E.M.), a total of 873 bead-labeled cells were counted in three separate culturing
 by pairwise multiple comparisons (Dunn’s method). *Statistically signiﬁcant from
5: 5 nM CALMID; CALMID50: 50 nM CALMID; TFP10: 10 M TFP.
cytoskeleton  remodeling was established. By acting on a number
of proteins simultaneously, these CaM antagonists could therefore
have more complex effects, which differ from each other and may
involve several signaling pathways, thereby further impairing a
number of cellular functions. Taken together, these features could
explain the differences seen in the efﬁcacies of these CaM inhibitors
as concerns various aspects of microglial morphology and function.
The ability of CaM to activate many target proteins depends on
its highly ﬂexible conformation, enabling it to interact with a wide
variety of proteins (Yamniuk and Vogel, 2004). We hypothesize
that this conformational ﬂexibility is limited to different degrees
when CaM inhibitors are applied; consequently, many of the CaM-
regulated effects will be differentially affected by CaM inhibition.
Thus, given the number of CaM-interacting target proteins and
their participation in the various intracellular signaling pathways
involved in, for example, the remodeling of the actin cytoskele-
ton during lamellipodia, ﬁlopodia or podosome formation (Evans
et al., 2003; Murphy and Courtneidge, 2011; Sunagawa et al., 2000;
Vincent et al., 2012), cell migration or phagocytosis (Sierra et al.,
2013), it is difﬁcult at present to give an accurate explanation as
to how different CaM antagonists might interfere with the out-
come of the signaling processes. It seems clear, however, that CaM
inhibition interferes strongly with both morphological and func-
tional aspects of the microglial cells. Future experiments may  shed
light on whether the effects of CaM inhibition seen in selected
morphological and functional properties of microglia are uniquely
characteristic of these cells or may  perhaps be typical of other cell
types too, and may  promote an understanding of the cell type-
speciﬁc roles of CaM.
5.  Conclusion
CaM is a key factor in the regulation of a number of morpholog-
ical aspects of the microglia through the modulation of the actin
cytoskeleton that affects the formation and maintenance of lamel-
lipodia, ﬁlopodia and podosomes of these cells. Acting on many
target proteins, among which actin is of paramount importance,
it regulates several cellular functions such as phagocytosis, cell
proliferation and survival. CALMID and TFP, two  prototypical CaM
antagonists acting through different molecular mechanisms on the
CaM protein, have differential effects on these morphological and
fuctional aspects, including Iba1 and CaM protein expression, when
tested both in unchallenged and LPS-challenged pure microglial
cells. In general, TFP was  more potent in provoking these struc-
5 arch B
t
C
s
a
A
t
r
E
C
A
M
p
g
2
t
i
t
R
A
A
B
B
B
B
B
B
B
C
C
C
C
C
D
D
E
E6 M. Szabo et al. / Brain Rese
ural alterations and functional changes. Dechipering the roles of
aM in microglial functions, perhaps through use of different CaM-
peciﬁc inhibitors, could be important in understanding the roles
nd modes of action of microglia in health and disease.
uthor Contributions
Conceived and designed the experiments: K.G., M.S. Performed
he experiments: M.S., K.D. Analyzed the data: MS, K.D. Contributed
eagents/materials/analysis tools: K.G. Wrote the paper: K.G., M.S.
dited the paper: K.G..
onﬂict  of interest
The  authors have declared that no competing interests exist.
cknowledgements
We  thank Mrs. Susan Ambrus for excellent technical help and
s. Diana Kata for helpful discussions. This work was supported by
rogram project grants to the University of Szeged from the Hun-
arian Ministry of National Resources (TÁMOP-4.2.1.B-09/1/KONV-
010-0005  and TÁMOP-4.2.2.A-11/1/KONV-2012-0052) through
he European Union Cohesion Fund to KG. The funders had no role
n the study design, the data collection and analysis, the decision
o publish, or the preparation of the manuscript.
eferences
bram, C.L., Lowell, C.A., 2009. The ins and outs of leukocyte integrin signaling.
Annu. Rev. Immunol. 27, 339–362.
hmed, Z., Shaw, G., Sharma, V.P., Yang, C., McGowan, E., Dickson, D.W., 2007.
Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers
for immunohistochemistry. J. Histochem. Cytochem. 55, 687–700.
achstetter,  A.D., Xing, B., de Almeida, L., Dimayuga, E.R., Watterson, D.M., Van
Eldik, L.J., 2011. Microglial p38 MAPK is a key regulator of proinﬂammatory
cytokine  up-regulation induced by toll-like receptor (TLR) ligands or
beta-amyloid (A). J. Neuroinﬂammation 8, 79.
ader, M.F., Taupenot, L., Ulrich, G., Aunis, D., Ciesielski-Traska, J., 1994. Bacterial
endotoxin induces [Ca2+]i transients and changes the organization of actin in
microglia. Glia 11, 336–344.
akota,  L., Orojan, I., Gulya, K., 2005. Intranuclear differences in calmodulin gene
expression in the trigeminal nuclei of the rat. Acta Biol. Szeged 49, 9–14.
erchtold, M.W.,  Villalobo, A., 2014. The many faces of calmodulin in cell
proliferation, programmed cell death, autophagy, and cancer. Biochim.
Biophys. Acta 1843, 398–435.
erridge, M.J., Lipp, P., Bootman, M.D., 2000. The versatility and universality of
calcium signalling. Nat. Rev. Mol. Cell. Biol. 1, 11–21.
orsa, J., Einspenner, M.,  Sargent, M.D., Hickie, R.A., 1986. Selective cytotoxicity of
calmidazolium and triﬂuoperazine for cycling versus noncycling C3H10T1/2
cells in vitro. Cancer Res. 46, 133–136.
rownhill, S., Cohen, D., Burchill, S., 2014. Proliferation index: a continuous model
to predict prognosis in patients with tumours of the Ewing’s sarcoma family.
PLoS One 9, e104106.
aceres,  A., Bender, P., Snavely, L., Rebhun, L.I., Steward, O., 1983. Distribution and
subcellular localization of calmodulin in adult and developing brain tissue.
Neuroscience 10, 449–461.
ao,  H., Zang, K.K., Han, M.,  Zhao, Z.Q., Wu,  G.C., Zhang, Y.Q., 2014. Inhibition of p38
mitogen-activated protein kinase activation in the rostral anterior cingulate
cortex attenuates pain-related negative emotion in rats. Brain Res. Bull. 107,
79–88.
asal, C., Tusell, J.M., Serratosa, J., 2001. Role of calmodulin in the
differentiation/activation of microglial cells. Brain Res. 902, 101–107.
hen, Q.Y., Wu,  L.J., Wu,  Y.Q., Lu, G.H., Jiang, Z.Y., Zhan, J.W., Jie, Y., Zhou, J.Y., 2009.
Molecular mechanism of triﬂuoperazine induces apoptosis in human A549
lung adenocarcinoma cell lines. Mol. Med. Rep. 2, 811–817.
lapham,  D.E., 2007. Calcium signaling. Cell 131, 1047–1058.
ovas,  A., Gevrey, J.C., Grossi, A., Park, H., Abou-Kheir, W.,  Cox, D., 2009. Regulation
of podosome dynamics by WASp phosphorylation: implication in matrix
degradation and chemotaxis in macrophages. J. Cell Sci. 122, 3873–3882.
rew, P.D., Chavis, J.A., 2000. Inhibition of microglial cell activation by cortisol.
Brain Res. Bull. 52, 391–396.lsaraj,  S.M., Bhullar, R.P., 2008. Regulation of platelet Rac1 and Cdc42 activation
through interaction with calmodulin. Biochim. Biophys. Acta 1783, 770–778.
rondu, N.E., Kennedy, M.B., 1985. Regional distribution of type II
Ca2+/calmodulin-dependent protein kinase in rat brain. J. Neurosci. 5,
3270–3277.ulletin 120 (2016) 41–57
Evans, J.G., Correia, I., Krasavina, O., Watson, N., Matsudaira, P., 2003. Macrophage
podosomes assemble at the leading lamella by growth and fragmentation. J.
Cell Biol. 161, 697–705.
Färber,  K., Kettenmann, H., 2006. Functional role of calcium signals for microglial
function. Glia 54, 656–665.
Finlayson,  A.E., Freeman, K.W., 2009. A cell motility screen reveals role for
MARCKS-related protein in adherens junction formation and tumorigenesis.
PLoS One 4, e7833.
Fricker,  M.,  Oliva-Martín, M.J., Brown, G.C., 2012. Primary phagocytosis of viable
neurons by microglia activated with LPS or A is dependent on
calreticulin/LRP  phagocytic signalling. J. Neuroinﬂammation 9, 196.
Fujita, H., Tanaka, J., Toku, K., Tateishi, N., Suzuki, Y., Matsuda, S., Sakanaka, M.,
Maeda, N., 1996. Effects of GM-CSF and ordinary supplements on the
ramiﬁcation of microglia in culture: a morphometrical study. Glia 18,
269–281.
Ginhoux, F., Greter, M.,  Leboeuf, M.,  Nandi, S., See, P., Gokhan, S., Mehler, M.F.,
Conway, S.J., Ng, L.G., Stanley, E.R., Samokhvalov, I.M., Merad, M., 2010. Fate
mapping analysis reveals that adult microglia derive from primitive
macrophages.  Science 330, 841–845.
Greenberg, S., 1995. Signal transduction of phagocytosis. Trends Cell Biol. 5, 93–99.
Hall, A., 1998. Rho GTPases and the actin cytoskeleton. Science 279, 509–514.
Hügl, S.R., Merger, M.,  2007. Prolactin stimulates proliferation of the
glucose-dependent beta-cell line INS-1 via different IRS-proteins. J. Pancreas 8,
739–752.
Ikura, M.,  1996. Calcium binding and conformational response in EF-hand proteins.
Trends Biochem. 21, 14–17.
Imai, Y., Ibata, I., Ito, D., Ohsawa, K., Kohsaka, S., 1996. A novel gene iba1 in the
major histocompatibility complex class III region encoding an EF hand protein
expressed in a monocytic lineage. Biophys. Biochem. Res. Commun. 224,
855–862.
James, L.R., Grifﬁths, C.H., Garthwaite, J., Bellamy, T.C., 2009. Inhibition of nitric
oxide-activated guanylyl cyclase by calmodulin antagonists. Br. J. Pharmacol.
158, 1454–1464.
Kalla, R., Bohatschek, M.,  Kloss, C.U., Krol, J., Von Maltzan, X., Raivich, G., 2003. Loss
of microglial ramiﬁcation in microglia-astrocyte cocultures: involvement of
adenylate cyclase, calcium, phosphatase, and Gi-protein systems. Glia 41,
50–63.
Kanazawa, H., Ohsawa, K., Sasaki, Y., Kohsaka, S., Imai, Y., 2002.
Macrophage/microglia-speciﬁc protein Iba1 enhances membrane rufﬂing and
Rac activation via phospholipase C-gamma -dependent pathway. J. Biol. Chem.
277, 20026–20032.
Kaushal, V., Koeberle, P.D., Wang, Y., Schlichter, L.C., 2007. The Ca2+-activated K+
channel KCNN4/KCa3.1 contributes to microglia activation and nitric
oxide-dependent neurodegeneration. J. Neurosci. 27, 234–244.
Kennedy,  M.B., 1989. Regulation of neuronal function by calcium. Trends Neurosci.
12, 417–420.
Kortvely, E., Gulya, K., 2004. Calmodulin, and various ways to regulate its activity.
Life Sci. 74, 1065–1070.
Kortvely,  E., Palﬁ, A., Bakota, L., Gulya, K., 2002. Ontogeny of calmodulin gene
expression in rat brain. Neuroscience 114, 301–316.
Kortvely, E., Varszegi, S., Palﬁ, A., Gulya, K., 2003. Intracellular targeting of
calmodulin mRNAs in primary hippocampal cells. J. Histochem. Cytochem. 51,
541–544.
Kovacs, B., Gulya, K., 2002. Differential expression of multiple calmodulin genes in
cells of the white matter of the rat spinal cord. Mol. Brain Res. 102, 28–34.
Kovacs, B., Gulya, K., 2003. Calmodulin gene expression in the neural retina of the
adult rat. Life Sci. 73, 3213–3224.
Kreutzberg, G.W., 1996. Microglia: a sensor for pathological events in the CNS.
Trends Neurosci. 19, 312–318.
Libich, D.S., Harauz, G., 2008. Backbone dynamics of the 18.5 kDa isoform of myelin
basic protein reveals transient alpha-helices and a calmodulin-binding site.
Biophys. J. 94, 4847–4866.
Lim,  H.W., Park, J.I., More, S.V., Park, J.Y., Kim, B.W., Jeon, S.B., Yun, Y.S., Park, E.J.,
Yoon, S.H., Choi, D.K., 2015. Anti-neuroinﬂammatory effects of DPTP, a novel
synthetic clovamide derivative in in vitro and in vivo model of
neuroinﬂammation. Brain Res. Bull. 112, 25–34.
Linxweiler, M.,  Schorr, S., Schäuble, N., Jung, M.,  Linxweiler, J., Langer, F., Schäfers,
H.J., Cavalié, A., Zimmermann, R., Greiner, M.,  2013. Targeting cell migration
and the endoplasmic reticulum stress response with calmodulin antagonists: a
clinically tested small molecule phenocopy of SEC62 gene silencing in human
tumor cells. BMC Cancer 13, 574.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement
with the Folin phenol reagent. J. Biol. Chem. 193, 265–275.
Matsushima, N., Hayashi, N., Jinbo, Y., Izumi, Y., 2000. Ca2+-bound calmodulin
forms  a compact globular structure on binding four triﬂuoperazine molecules
in solution. Biochem. J. 347, 211–215.
Mitchison, T.J., Cramer, L.P., 1996. Actin-based cell motility and cell locomotion.
Cell 84, 371–379.
Murphy, D.A., Courtneidge, S.A., 2011. The ‘ins’ and ‘outs’ of podosomes and
invadopodia: characteristics, formation and function. Nat. Rev. Mol. Cell Biol.
12, 413–426.Myllykoski, M.,  Itoh, K., Kangas, S.M., Heape, A.M., Kang, S.U., Lubec, G., Kursula, I.,
Kursula, P., 2012. The N-terminal domain of the myelin enzyme 2′ ,3′-cyclic
nucleotide  3′-phosphodiesterase: direct molecular interaction with the
calcium sensor calmodulin. J. Neurochem. 123, 515–524.
arch B
O
O
O
O
P
P
P
P
P
P
P
Q
R
R
S
S
S
S
S
S
S
S
S
S
S
antipsychotic agent, inhibits cancer stem cell growth and overcomes drug
resistance of lung cancer. Am. J. Respir. Crit. Care Med. 186, 1108–1180.
Zhu, M.D., Zhao, L.X., Wang, X.T., Gao, Y.J., Zhang, Z.J., 2014. Ligustilide inhibitsM. Szabo et al. / Brain Rese
hsawa, K., Imai, Y., Kanazawa, H., Sasaki, Y., Kohsaka, S., 2000. Involvement of
Iba1 in membrane rufﬂing and phagocytosis of macrophages/microglia. J. Cell
Sci. 113, 3073–3084.
hsawa, K., Imai, Y., Sasaki, Y., Kohsaka, S., 2004. Microglia/macrophage-speciﬁc
protein  Iba1 binds to ﬁmbrin and enhances its actin-bundling activity. J.
Neurochem. 88, 844–856.
rojan,  I., Bakota, L., Gulya, K., 2006. Differential calmodulin gene expression in the
nuclei of the rat midbrain-brain stem region. Acta Histochem. 108,
455–462.
rojan, I., Bakota, L., Gulya, K., 2008. Trans-synaptic regulation of calmodulin gene
expression after experimentally induced orofacial inﬂammation and
subsequent corticosteroid treatment in the principal sensory and motor
trigeminal nuclei of the rat. Neurochem. Int. 52, 265–271.
alﬁ,  A., Gulya, K., 1999. Water deprivation upregulates the three calmodulin genes
in exclusively the supraoptic nucleus of the rat brain. Mol. Brain Res. 74,
111–116.
alﬁ, A., Kortvely, E., Fekete, E., Gulya, K., 2005. Multiple calmodulin mRNAs are
selectively transported to functionally different neuronal and glial
compartments in the rat hippocampus. An electron microscopic in situ
hybridization study. Life Sci. 77, 1405–1415.
alﬁ, A., Kortvely, E., Fekete, E., Kovacs, B., Varszegi, S., Gulya, K., 2002. Differential
calmodulin gene expression in the rodent brain. Life Sci. 70, 2829–2855.
alﬁ, A., Simonka, J.A., Pataricza, M.,  Tekulics, P., Lepran, I., Papp, G., Gulya, K., 2001.
Postischemic calmodulin gene expression in the rat hippocampus. Life Sci. 68,
2373–2381.
alﬁ, A., Vizi, S., Gulya, K., 1999. Differential distribution and intracellular targeting
of mRNAs corresponding to the three calmodulin genes in rat brain: a
quantitative in situ hybridization study. J. Histochem. Cytochem. 47,
583–600.
rinz, M.,  Priller, J., 2014. Microglia and brain macrophages in the molecular age:
from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15, 300–312.
satha, M.,  Koffer, A., Erent, M.,  Moss, S.E., Bolsover, S., 2004. Calmodulin spatial
dynamics in RBL-2H3 mast cells. Cell Calcium 36, 51–59.
in,  J., Zima, A.V., Porta, M., Blatter, L.A., Fill, M.,  2009. Triﬂuoperazine: a ryanodine
receptor agonist. Pﬂugers Arch. 458, 643–651.
acioppi, L., Noeldner, P.K., Lin, F., Arvai, S., Means, A.R., 2012.
Calcium/calmodulin-dependent protein kinase kinase 2 regulates
macrophage-mediated inﬂammatory responses. J. Biol. Chem. 287,
11579–11591.
otty, J.D., Wu,  C., Bear, J.E., 2013. New insights into the regulation and cellular
functions of the ARP2/3 complex. Nat. Rev. Mol. Cell Biol. 14, 7–12.
acks, D.B., Porter, S.E., Ladenson, J.H., McDonald, J.M., 1991. Monoclonal antibody
to calmodulin: development, characterization, and comparison with
polyclonal anti-calmodulin antibodies. Anal. Biochem. 194, 369–377.
aijo, K., Glass, C.K., 2011. Microglial cell origin and phenotypes in health and
disease. Nat. Rev. Immunol. 11, 775–787.
anabria, H., Digman, M.A., Gratton, E., Waxham, M.N., 2008. Spatial diffusivity and
availability of intracellular calmodulin. Biophys. J. 95, 6002–6015.
cott,  I.S., Heath, T.M., Morris, L.S., Rushbrook, S.M., Bird, K., Vowler, S.L., Arends,
M.J., Coleman, N., 2004. A novel immunohistochemical method for estimating
cell cycle phase distribution in ovarian serous neoplasms: implications for the
histopathological assessment of parafﬁn-embedded specimens. Br. J. Cancer
90, 1583–1590.
easholtz, T.M., Radeff-Huang, J., Sagi, S.A., Matteo, R., Weems, J.M., Cohen, A.S.,
Feramisco, J.R., Brown, J.H., 2004. Rho-mediated cytoskeletal rearrangement in
response to LPA is functionally antagonized by Rac1 and PIP2. J. Neurochem.
91, 501–512.
eto-Ohshima, A., Kitajima, S., Sano, M.,  Kato, K., Mizutani, A., 1983.
Immunohistochemical localization of calmodulin in mouse brain.
Histochemistry 79, 251–257.
iddiqui, T.A., Lively, S., Vincent, C., Schlichter, L.C., 2012. Regulation of podosome
formation, microglial migration and invasion by Ca(2+)-signaling molecules
expressed  in podosomes. J. Neuroinﬂammation 9, 250.
ierra,  A., Abiega, O., Shahraz, A., Neumann, H., 2013. Janus-faced microglia:
beneﬁcial and detrimental consequences of microglial phagocytosis. Front.
Cell. Neurosci. 7 (6).
olá,  C., Tusell, J.M., Serratosa, J., 1996. Comparative study of the pattern of
expression of calmodulin messenger RNAs in the mouse brain. Neuroscience
75, 245–256.olá, C., Tusell, J.M., Serratosa, J., 1997. Calmodulin is expressed by reactive
microglia in the hippocampus of kainic acid-treated mice. Neuroscience 81,
699–705.
ong, X.Y., Hu, J.F., Sun, M.N., Li, Z.P., Zhu, Z.X., Song, L.K., Yuan, Y.H., Liu, G., Chen,
N., 2014. IMM-H004, a novel coumarin derivative compound, attenuates theulletin 120 (2016) 41–57 57
production of inﬂammatory mediatory mediators in
lipopolysaccharide-activated BV2 microglia. Brain Res. Bull. 106, 30–38.
Strack, S., Wadzinski, B.E., Ebner, F.F., 1996. Localization of the
calcium/calmodulin-dependent protein phosphatase, calcineurin, in the
hindbrain and spinal cord of the rat. J. Comp. Neurol. 375, 66–76.
Streit,  W.J., Walter, S.A., Pennel, N.A., 1999. Reactive microgliosis. Progr. Neurobiol.
57, 563–581.
Sullivan, R., Burnham, M.,  Török, K., Koffer, A., 2000. Calmodulin regulates the
disassembly of cortical F-actin in mast cells but is not required for secretion.
Cell Calcium 28, 33–46.
Sunagawa,  M., Kosugi, T., Nakamura, M.,  Sperelakis, N., 2000. Pharmacological
actions of calmidazolium, a calmodulin antagonist, in cardiovascular system.
Cardiovasc. Drug Rev. 18, 211–221.
Suzumura, A., Marunouchi, T., Yamamoto, H., 1991. Morphological transformation
of microglia in vitro. Brain Res. 545, 301–306.
Sweet, M.J., Hume, D.A., 1996. Endotoxin signal transduction in macrophages. J.
Leukoc. Biol. 60, 8–26.
Szabo,  M.,  Gulya, K., 2013. Development of the microglial phenotype in culture.
Neuroscience 241, 280–295.
Tokes,  T., Eros, G., Bebes, A., Hartmann, P., Várszegi, S., Varga, G., Kaszaki, J., Gulya,
K., Ghyczy, M.,  Boros, M.,  2011. Protective effects of a
phosphatidylcholine-enriched diet in lipopolysaccharide-induced
experimental neuroinﬂammation in the rat. Shock 36, 458–465.
Toutenhoofd,  S.L., Strehler, E.E., 2000. The calmodulin multigene family as a unique
case of genetic redundancy: multiple levels of regulation to provide spatial and
temporal control of calmodulin pools? Cell Calcium 28, 83–96.
Town,  T., Nikolic, V., Tan, J., 2005. The microglial activation continuum: from
innate to adaptive responses. J. Neuroinﬂammation 2, 24.
Tseng,  L.L., Huang, C.J., Hsu, S.S., Chen, J.S., Cheng, H.H., Chang, H.T., Jiann, B.P., Jan,
C.R., 2004. Effect of calmidazolium on Ca(2+) movement and proliferation in
human  osteosarcoma cells. Clin. Exp. Pharmacol. Physiol. 31, 732–737.
Vandonselaar, M.,  Hickie, R.A., Quail, J.W., Delbaere, L.T., 1994.
Triﬂuoperazine-induced conformational change in Ca(2+)-calmodulin. Nat.
Struct.  Biol. 1, 795–801.
Vertessy,  B.G., Harmat, V., Bocskei, Z., Naray-Szabo, G., Orosz, F., Ovadi, J., 1998.
Simultaneous binding of drugs with different chemical structures to
Ca2+-calmodulin: crystallographic and spectroscopic studies. Biochemistry 37,
15300–15310.
Vincent, C., Siddiqui, T.A., Schlichter, L.C., 2012. Podosomes in migrating microglia:
components and matrix degradation. J. Neuroinﬂammation 9, 190.
Vizi, S., Palﬁ, A., Gulya, K., 2000. Multiple calmodulin genes exhibit systematically
differential responses to chronic ethanol treatment and withdrawal in several
regions of the rat brain. Mol. Brain Res. 83, 63–71.
Wong, R., Schlichter, L.C., 2014. PKA reduces the rat and human KCa3. 1 current,
CaM binding, and Ca2+ signaling, which requires Ser332/334 in the
CaM-binding C terminus. J. Neurosci. 34, 13371–13383.
Wu,  Y., Wu,  M., He, G., Zhang, X., Li, W.,  Gao, Y., Li, Z., Wang, Z., Zhang, C., 2012.
Glyceraldehyde-3-phosphate dehydrogenase: a universal internal control for
Western blots in prokaryotic and eukaryotic cells. Anal. Biochem. 423, 15–22.
Xu, B., Bhullar, R.P., 2011. Regulation of Rac1 and Cdc42 activation in thrombin-
and collagen-stimulated CHRF-288-11 cells. Mol. Cell. Biochem. 353, 73–79.
Xu, B., Chelikani, P., Bhullar, R.P., 2012. Characterization and functional analysis of
the calmodulin-binding domain of Rac1 GTPase. PLoS One 7, e42975.
Yamada, M., Ohsawa, K., Imai, Y., Kohsaka, S., Kamitori, S., 2006. X-ray structures of
the microglia/macrophage-speciﬁc protein Iba1 from human and mouse
demonstrate novel molecular conformation change induced by calcium
binding. J. Mol. Biol. 364, 449–457.
Yamaguchi, T., Fujimori, T., Tomita, S., Ichikawa, K., Mitomi, H., Ohno, K., Shida, Y.,
Kato, H., 2013. Clinical validation of the gastrointestinal NET grading system:
Ki67 index criteria of the WHO  2010 classiﬁcation is appropriate to predict
metastasis or recurrence. Diagn. Pathol. 8, 65.
Yamniuk, A.P., Vogel, H.J., 2004. Calmodulin’s ﬂexibility allows for promiscuity in
its interactions with target protein and peptides. Mol. Biotechnol. 27, 33–57.
Yeh, C.T., Wu,  A.T., Chang, P.M., Chen, K.Y., Yang, C.N., Yang, S.C., Ho, C.C., Chen, C.C.,
Kuo, Y.L., Lee, P.Y., Liu, Y.W., Yen, C.C., Hsiao, M.,  Lu, P.J., Lai, J.M., Wang, L.S.,
Wu, C.H., Chiou, J.F., Yang, P.C., Huang, C.Y., 2012. Triﬂuoperazine anmicroglia-mediated proinﬂammatory cytokines production and inﬂammatory
pain. Brain Res. Bull. 109, 54–60.
